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ABSTRACT
This thesis addresses the hypothesis that the sonic hedgehog (Shh) signalling
pathway is up regulated in response to cellular injury and that this signal acts as
a potential pro-fibrogenic signal in pulmonary inflammation. In vitro studies
utilised human (A549) and mouse (CMT) type II like epithelial cell lines in an
analysis of epithelial response to injury. An immediate up regulation and release
of soluble Shh in response to hydrogen peroxide exposure was identified in
mouse epithelium, utilising both RT-PCR and a novel Shh ELISA developed
here. Subsequent up-regulation and release of GM-CSF was shown to be Shh
independent. Human epithelial cells demonstrated a similar release of Shh,
suggesting a common pathway in both species. In contrast GM-CSF was not up
regulated in human cells, but IL-8 up regulation did occur. The relevance of
these studies to in vivo signalling was ascertained through use of the FITC
instillation mouse model of inflammatory fibrosis.
Previous work by our group has illustrated epithelial up-regulation of Shh in
areas of inflammatory fibrotic disease in the FITC model, and in biopsies from
patients with idiopathic pulmonary fibrosis. Transoral intratracheal delivery of
FITC on two occasions six weeks apart reproduced previous histological
findings made in the lab using a surgical intratracheal FITC instillation.
However, use of improved immunohistochemical (IHC) techniques would
suggest that, unlike human disease, Shh expression in the FITC mouse model
is not solely restricted to epithelium in areas of inflammation or fibrosis. To
determine the Shh responder cell populations in human disease and determine
the validity of the IHC findings in the FITC model, a laser micro-dissection
technique was developed. Viable mRNA for sequences including the Shh
receptor patched (Ptc), and downstream signalling component smoothened
(Smo) have been recovered from archival formalin fixed human biopsy material,
sufficient for RT-PCR and agarose gel electrophoresis visualisation. mRNA
analysis of material derived from fibrotic areas of a single standard section of
archival human lung biopsy has now been performed.
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Observations correlating levels of FITC specific lgG1 antibody and disease
severity in FITC treated animals suggest an immuno-modulatory role for T
lymphocyte dependent, Th2 type antibodies in disease progression. In support
of this iBALT has also been identified in diseased lung and T-lymphocyte
depletion results in disease amelioration.
Taken together these findings suggest that Shh is an indicator of acute cellular
injury, but that the principal component of FITC induced fibrotic disease
progression is immune mediated and that this does not depend on Shh up
regulation.
16
CHAPTER 1 GENERAL INTRODUCTION
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1.1 INTRODUCTION
Previous work in our group1 had identified expression of the developmental
signalling ligand, Sonic Hedgehog (Shh) in the adult lung. Shh is a molecule
crucial for the correct branching morphogenesis and differentiation of the
embryonic lung. Shh expression was shown to be increased in inflamed and
fibrotic areas of chronic pulmonary fibrotic disease, primarily in the epithelium,
where expression of its receptor, Patched (Ptc), had also been identified,
although not always in the same epithelial cell populations1.
Ptc was also identified on pulmonary fibroblasts and infiltrating cells and this
lead to a hypothesis that Shh might be involved in epithelial mesenchymal
signalling in lung remodelling, such as that which occurs in chronic fibrotic lung
disease, given Shh's potent epithelial mitogenic function and putative role in
developmental fibroblast function. Further to this, novel observations made in
this lab concerning a post-embryonic function of Shh in the peripheral immune
system, would suggest that Shh expression in diseased areas might have some
immune modulatory function2,3.
This introduction begins with a description of the Shh signalling pathway and its
involvement in pulmonary development. This is followed by a brief description of
pulmonary biology and human interstitial fibrotic lung diseases, and mouse
models of these conditions, concluding with a discussion of the hypothesis,
aims and objectives of this thesis.
1.2 THE SONIC HEDGEHOG SIGNALLING PATHWAY
Despite its inherent complexity, development relies heavily on a restricted
number of signalling pathways, which remain largely conserved from Drosophila
to vertebrates. One such pathway is the hedgehog signalling pathway. First
identified as a segment polarity gene in drosophila, three vertebrate
homologues of hedgehog have now been identified, Shh, Desert Hedgehog
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(Dhh) and Indian Hedgehog (Ihh)4. Unless specified this thesis will deal entirely
with those features of Shh signalling identified in vertebrate studies.
Whilst Dhh and Ihh have been shown to have more restricted roles, Shh
signalling has been identified in a wide variety of systems, from midline, neural
tube and muscle precursor patterning, to polarising activity in limb development,
lung morphogenesis and radial patterning in the mouse intestine (reviewed
extensively by McMahon and colleagues5' 6). The Shh protein like the Ihh and
Dhh variants is highly conserved from mouse to man, where human Shh has
92.4% homology with the mouse homologue7. Knockout and overexpression
studies have shown that murine Shh shares almost all known functionality with
human Shh, shown through the discovery of allelic variants, cell line and
primary cell studies.
The production of the hedgehog protein is as unusual as it is complex and has
attracted substantial study, having been recently reviewed by Sukegawa and
colleagues8, it will be discussed only briefly here, and can be found summarised
in Figure 1.1 at the end of this section.
The Hh glycoprotein is produced as a 45-46kDa precursor. The C-terminus of
this precursor possesses no signalling function but acts to auto catalytically
cleave and cholesterol modify the N-terminus, generating a 19kDa hydrophobic
protein with a C-terminal cholesterol moiety9"13.
Cholesterol modification was originally thought to be a requirement for a
subsequent palmitoylation step14, however, recent studies would suggest that
the Hh can be generated with either or both modifications, as singly
palmitolyated or cholesterol modified Shh has now been identified in separate
tissues15. Studies by Feng and colleagues15 following on earlier studies16"18,
would suggest that these modifications have both synergistic and antagonist
functions in adapting Shh signalling activity. Thus, tissue restriction of these
modified forms of Shh may represent tissue specific adaptive changes to the
function of the Shh signalling pathway.
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Paradoxically, given the hydrophobic nature of these modifications, Shh has
been established as both a soluble and cell surface signal. Current investigation
would suggest that solubility is achieved by concealing hydrophobic moieties
within multimer micelles at the cell surface prior to release, in a process
requiring the 12 span membrane protein Dispatched (Disp)19 20 21. Whilst
cholesterol modification alone has been shown to be sufficient for
multimerization and membrane tethered modes of signalling, palmitoylation
facilitates multimerization but not membrane tethering15. This is notable given
that multimerization is necessary for Shh differentiation inducing activity in
neural explant studies, where palmitolylation increases, but cholesterol reduces
this function15,18. This would suggest that functional variation occurs with the
mode of delivery of Shh signal, be it cell contact or as a soluble multimer and
that further to this, by varying the modification type, Shh producing cells can
alter the function of that multimer on contact with responder cell populations15,
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A further level of control of the Shh signalling pathway occurs through
modulation of the concentration gradient by hedgehog interacting protein (Hip)
and by heparan sulphate proteoglycans (HSPG)22.
Hip is up regulated in response to Hh and interacts with and sequesters all
three hedgehogs with affinity comparable to Ptc, regardless of modification
state as it lacks a sterol sensing domain22. In Drosophila, the Tout velu (Ttv)
gene product23 is essential for the movement of cholesterol modified Hh. The
vertebrate homologs of Ttv, the exostoses gene family (EXT) encode GAG
transferases involved in HSPG synthesis24 25. This would suggest that the
activity of the Ttv gene product and its vertebrate homolog, might be the
generation of a proteoglycan that mediates the transfer of Hh between cells, or
its presentation to Ptc23, 26, 27, although this remains a contentious issue28 and
studies have been largely restricted to Drosophila.
The manner in which the Shh signal is delivered to the 12 span receptor, Ptc29
30, has been a point of much conjecture, given conflicting reports concerning
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intracellular and membrane localisation of Ptc31,32, and the identification of 2 Ptc
isoforms and a third receptor megalin33.
The identification of megalin (gp330/LRP-2) a member of the low-density
lipoprotein (LDL) receptor family, as a Shh binding receptor, was interesting as
it is expressed exclusively in epithelial cells of the embryo and the adult, where
its primary function is the endocytosis of a wide range of ligands34. A number of
authors now suggest that megalin could act to deliver Shh internally to Ptc, or
that megalin might mediate the movement or clearance of Shh across epithelial
barriers35, although these questions remain unanswered.
No direct signalling function has as yet been ascertained for megalin, although
interestingly, given the previously ascribed function of HSPG in Shh movement,
the uptake of other megalin family ligands such as hepatic lipase and
circumsporozoite protein, is absolutely dependent on HSPG binding previous to
LRP interaction36 37. Thus, rather than mediating Ptc uptake of Shh as some
authors have suggested, the necessity for Ttv function in Drosophila may lie in
its interaction with megalin. Were this found to be true for EXT / Megalin
interaction in vertebrates it would present an excellent means of delineating
megalin function at epithelial sites.
Although there have only been two conclusively established signalling receptors
identified for Ptc, the pathway retains an inordinate level of complexity, not
through differences in affinity, as both Ptc receptors, Ptc1 and Ptc2 are bound
by all Hh family members with similar affinity38, but through spatial localisation
of ligand and receptor sub types, and use of cell type restricted pathways
downstream of Shh signalling function, in combination with the control exerted
at the level of ligand generation as discussed previously.
Ptc1 and 2 appear to have distinct expression profiles, and recent data would
suggest a restriction to hedgehog sub types, where Ptc2 has a greater
importance in Dhh signalling than Shh or Ihh signalling38. Another point of
variation arises from the method of the delivery of the Shh signal as discussed
previously. Although some authors have attributed this variation to differing
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affinity of Ptc for modified variants of Shh. A consensus interpretation would
now suggest that in some cells Ptc occurs in lipid rafts, and that it is the effect
that cholesterol and palmitoyl modification has on the ability of Shh to
incorporate into these rafts that is responsible for the observed variation in
function with differentially modified and delivered Shh signal15 39-42
Ptc is classically described as occurring in a receptor complex in which Ptc is
the membranous ligand-binding subunit and Smoothened (Smo), a G protein-
coupled receptor-like molecule43, is the intracellular signalling component44
where Ptc acts as a direct45 negative regulator of Smo. This inhibition is
removed by Ptc-Shh interaction, allowing Smo to transduce the Shh signal into
the cell.
Some studies however, would suggest that Ptc, rather than being found on the
cell membrane, like most classical receptors, is instead found primarily in
intracellular vesicular structures resembling endosomes, with barely detectable
amounts found in the membrane46. In contrast, the internal signalling
component of the pathway, Smo, is found predominantly localised to the
membrane47. This has led some to hypothesise that Ptc may chaperone Smo,
compartmentalising it, rather than directly inhibiting its function27.
Given the identification of megalin as a receptor, it is also possible that Ptc need
not be delivered to the membrane, but might have Shh shuttled to it in a cell
sub-compartment, either actively by megalin, or via passive internalisation of
membrane raft incorporated Shh. In such a situation Ptc might be viewed as a
channel localising cell Shh to discrete endosomes.
Others have further developed this hypothesis, suggesting that Ptc can function
as a channel. Inactivating mutations in Ptc are similar to those that abolish
transport activity in bacterial protein transporters and Ptc has a high degree of
homology with the bacterial proton-driven molecular transporters of the RND
family and their eukaryotic members such as NPC-147, 48. Therefore, some
publications have suggested that rather than act as a direct receptor, Ptc might
actually function as an entry point for Smo modulators, such as those identified
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by the Beachy lab49 and others50 51. In such a situation, Shh-Ptc binding might
be envisioned as preventing the entry of Smo antagonists, or facilitating the
entry of agonists. This raises the possibility of small molecule treatment of Shh
associated conditions such as basal cell carcinomas and Parkinson's disease.
Thus the current model of Smo signalling, although contentious is one of a
catalytic, rather than stoichiometric system of Ptc mediated control, with active
and inactive Smo conformations selected by binding of ant/agonists at
independent sites generating negative co-operativity. Phosphorylation of Smo is
another area of conjecture, which would appear to differ in its necessity for
pathway activation between species.
Smo influences gene expression through the Gli family of zinc finger
transcription factors, of which there are three, GIM-3. These molecules have
high homology in their five zinc finger domains but only limited homology
outside this region. The Gli are inhibited in the absence of Smo signal, via
sequestration in the cytoplasm by suppressor of fused Su(fu), which also
targets them for proteosomal destruction. Further roles for Su(fu) include
nuclear recruitment of the histone deacetylase associated molecule Sap18
when bound to Gli, preventing Gli mediated transcription. Su(fu) inactivation is
postulated to occur through Smo mediated phosphorylation.
Gli2 and 3 are expressed in the absence of a Shh signal. Gli2 possess an N-
terminal repressor domain, inhibiting C-terminal transcriptional activator function
and Gli3 is autoproteolytically cleaved into a repressor molecule. Functionality
of these domains appear to vary with cell type, resulting in a confused literature,
however a general consensus would suggest that in the absence of Shh signal,
Gli2 possesses weak activator function and Gli3 a repressor function 52 53.
Shh signalling results in the removal of the repressor domain of Gli2 and the
inhibition of Gli3 autoproteolysis. Active Gli2 would appear to be the primary
transcription factor involved in Shh signalling as although it up regulates GIH
which has been shown to share some GH2 functionality, GIH but not GH2 is
dispensable for lung development54.
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Other potential intracellular signalling mechanisms and transcriptional mediators
have been suggested, including the Forkhead gene family, Foxfl, but recent
studies would suggest that Shh responsive genes are restricted to those with
functional Gli binding sites55,56.
Shh signalling can induce expression of a variety of signalling proteins and
transcription factors in development, but has only been directly linked with
regulation of Ptc and GIH expression in all systems, and HNF3/3 in cells of the
central nervous system29' 57 58. However, work with Shh responsive cell lines
would suggest that a number of factors involved in cell growth and apoptosis
may also be modulated by Shh signalling59. Surprisingly, Smo, despite being
increased in responder cells, is not a gene upstream of the Gli, instead it would
appear that Smo has increased stability in active responder cells50.
The majority of the putative downstream effector functions for the Shh pathway
were elucidated from developmental observations, made through over
expression and knockout studies of pathway members, and through
immunohistochemical and in situ analysis of sequential activation with
development. The specific role of Shh in lung development is discussed in the
subsequent section, both as an extension to the studies described here, and to
demonstrate its potential as a signalling molecule in the adult lung.
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Figure 1.1: The Shh Signalling Pathway
(1) Autocatalytic addition of a cholesterol moiety to the C-terminus of the Shh
protein, can be followed by a palmitoylation step (2). (3) Membrane association
results in signalling either as a cell contact entity, or via secretion, in a process
absolutely requiring Disp. Soluble signals occur as a multimer. (4) Neighbouring
and responder cell populations restrict this signal gradient via non signalling Ptc
expression or expression of Hip, whilst its sustenance is thought to involve
HSPG associated gene products [EXT gene products]. (5) Shh Ptc binding
results in Smo activation via removal of Ptc inhibition, occurring through either
Ptc mediated chaperoning of Smo to agonist containing vesicles or entry/exit of
antag/agonists. Megalin may also deliver Shh to Ptc microvesicles. (6) The
exact manner and location of Smo/Gli interaction is poorly characterised, but in
Drosophila homologues, this involves multiple de/phosphorylation steps. (7)
Smo allows activation of Gli responsive genes by activating Gli2 and
inactivating Su(Fu), facilitating the dissociation of the histone deacetylation
associated protein Sap-18, and nuclear localisation of Gli2 for the up regulation
of downstream genes.
1.3 SONIC HEDGEHOG IN LUNG DEVELOPMENT
Lung development initiates with an evagination of two ventral buds of foregut
endothelium into the surrounding mesoderm. This is followed by a series of
lateral branching steps, establishing the lobation of the lung. During this initial
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branching step the intruding buds of proliferating cells differentiate into tubules
of progenitor pulmonary epithelial cells. Reiterated budding and branching of
these tubules results in the formation of the full respiratory tree, (recently
reviewed by Cardoso60).
Branching and budding occurs as a result of a complex network of interacting
signalling pathways, of which the Shh signalling pathway is one. Shh is
expressed along the length of the epithelium of these tubules, with greatest
expression gradating from the proliferating tips. The target cells for the Shh
signal are most likely the mesenchymal cells into which the tubules tips intrude.
These mesenchymal cells express Ptc1, Hip1 and all three Gli members with up
regulated Ptc1 expression restricted to cells underlying those areas of greatest
epithelial Shh expression61'62.
Shh mutagenesis studies have been the most instructive techniques for the
elucidation of Shh function, and have lead Bellusci, Lebeche and colleagues to
put forward the following model of Shh function61,63.
Areas of mesenchymal Fibroblast Growth Factor 10 (FGF-10) expression act as
an epithelial chemo-attractant. Progressive growth of tubules to this source is
halted by FGF-10 mediated up-regulation of Bone Morphogenic Protein 4
(BMP-4) expression in the tubule tips and by concomitant mesenchymal
Transforming Growth Factor |3 (TGF-p) expression. Shh expressed in the tubule
tips represses FGF-10 expression, removing the chemoattractant stimuli. This
results in the formation of a cleft and reduced Shh expression. Low FGF-10
levels are maintained by residual Shh and local TGF-|3 production, which also
leads to matrix deposition. Branching then occurs via lateral outgrowths of
epithelium from the clefted tubule to new sources of FGF-10, forming new, high
Shh expression, tubule tips.
26
1.4 SONIC HEDGEHOG AND IMMUNITY
The Shh signalling components, Shh, Ptc, Smo and GN1-3, are expressed in
murine foetal and adult thymus. Cells entering the thymus are pluripotent bone
marrow derived progenitors which become progressively more lineage
restricted through their passage in the thymus, facilitated by specific retention or
destruction signals. These signals are generated through the ability of each cell
to recognise thymic epithelial signals during a series of defined maturation
steps, and ignorance of self. These cells become Thymic lymphocytes (T-cells),
capable of orchestrating immunity against antigenic compounds via a
specialised T Cell Receptor (TCR) receptor, genetically rearranged during
maturation to generate a full repertoire of antigen affinities, where individual
cells express only one variant.
( bone marrow f j Figure 1.2: T-Lymphocyte
Development
Commited Lymphocyte Progenitor (CLP)
cells are generated in the bone marrow.
Here they can generate new B
lymphocytes or they can circulate to the
thymus to generate cells of the T cell
lineage. Upon first contact with the thymic
epithelium CLP cells are refered to as
Double Negative (DN) cells in reference
to the absence of CD4 or CD8 protein
expression. Signalling interactions with
the thymic epithelium leads to a complex
set of TCR rearrangements, marked by
differing expression of CD44 and CD25
on the surface of the DN cells, which
along with other signals selects those DN
cells suitable to transcend each
developmental stage (1-4). Exogenous
Shh has been shown to prevent the
transition from a DN to a Double Positive
cell (DP) which marks a commitment to a
thymocyte lineage. This observation has
been confirmed with the Shh neutralising
antibody 5E1 which enhances
progression through this stage of T-
lymphocyte differentiation.
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Shh expression was found restricted to thymic epithelium and Smo expression
to cells committed to the T-cell lineage. Outram et al, referencing neutralising
antibody and exogenous r-Shh studies suggest that these Smo positive
thymocytes are maintained in a non-proliferative state by an epithelial derived
Shh signal, facilitating T-Cell Receptor (TCR) p gene rearrangement at the DN3
stage, necessary for the generation of a full repertoire of TCRp expressing T-
lymphocytes64. Further to this these authors suggest Shh signalling may be
involved in the expression of CD44 (cellular adhesion) and CD25 (activation
marker) in these precursors at the DN2 stage.
1.5 PULMONARY STRUCTURE AND FUNCTION
1.5.1 THE UPPER RESPIRATORY TRACT
The upper respiratory tract acts as a conduit for gas exchange, warming and
humidifying air on its passage from the mouth and nose through the trachea
and bronchi, then into the bronchioles, terminal bronchioles and acini of the
lower respiratory tract. Potentially injurious, reactive or infective agents are
also removed from inspired air, during this transition, preventing their entry
into the delicate epithelial structures of the gas exchange surfaces.
The upper airway surfaces have a primarily defensive function, stratified with
multifunctional cells of connective, nervous, secretory and immunological
function, making gas exchange impractical. Reflexes such as glottic closure
and coughing prevent the entry of larger particulates into the airways, whilst
smaller items, driven by turbulent airflow of the bifurcating bronchi and
bronchioles, become lodged in the thick mucus lining of the airways.
The mucus lining is produced by the mucus glands of the upper airway and
contains opsonising IgA antibodies transcytosed with secretory component
by the underlying bronchial epithelium and anti-microbial and proteinase
inhibitors produced by specialised non-ciliated epithelial cells called Clara
cells65. Unlike the predominant ciliated bronchial epithelial cell, whose
primary function is to sweep mucus from the lung, the Clara cell is
multifunctional, performing secretory and immunological functions. These
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cells can be identified by expression of Clara cell protein 10 (CC10)66, whilst
a subclass of Clara cell termed a variant Clara cell (vCC)67' 68, can be
identified by low CyP450 expression67"69, and are found associated in
neuroepithelial bodies with pulmonary neuroepithelial cells70. These bodies
have putative neural synapse connections and are believed to represent a
neurologically controlled secretory cell population. Further to this, vCC have
now been identified as a repopulating cell for the epithelium in mouse, similar
in function to progenitors identified in the mucus ducts of the upper airways71.
Whether vCC cells represent a transient amplifying cell, with limited
proliferative capacity or a pluripotent stem cell remains to be clarified. The
main repopulating cell of the airways is the non-cilliated basal cell which
underlies the stratified cell layer at the basement membrane72. Basal cells
have the capacity to replace almost all epithelial and some subepithelial cell
types in the lung. Interestingly, these cells have recently been identified as
expressors of Shh which, given the prominent signalling role of Shh in the
branching morphogenesis of the lung epithelium, might suggest a role for
Shh in epithelial repopulation in the adult lung73'74.
1.5.2 THE LOWER RESPIRATORY TRACT
This is not an absolute transition, but can be marked by reduced airway
associated smooth muscle and the loss of the overlying sticky mucus layer,
leaving an underlying thin surfactant rich serous layer, to continue into the
terminal bronchioles 75.
The epithelium also reduces in thickness, now largely composed of ciliated
and Clara cells in the bronchioles with occasional vCC/neuroepithelial
clusters, underlain by thin fibroblastic projections and an ECM rich interstitial
layer. Entry into the specialised gas exchange surfaces of the terminal
bronchioles and acini mark another transition. These surfaces are populated
by two types of epithelial cell, the flat type I epithelium specialised for gas
exchange, and the cuboidal secretory Type II cell, which has putative
progenitor function for Type I cells. In mice, type II cells predominate (-90%),
whilst humans have equal proportions of type I & II cells, although type I have
the greatest (-95%) surface area.
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1.6 MAINTENANCE OF EPITHELIAL INTEGRITY
The surface of the lung is approximately the size of a singles tennis court
through which the entire blood volume travels every minute, separated from
the external environment by just two cell layers at the gas exchange
surfaces. These surfaces continually interact with or are affected by
particulates and potentially pathogenic organisms and whilst numerous
defensive mechanisms provide substantial protection, inevitably sometimes
these defence mechanisms fail. Epithelial surfaces then become injured, and
denudement of the respiratory surfaces occurs. Rapid reestablishment of the
integrity of the epithelial surface is absolutely essential to prevent the
establishment of infection, excessive transudation of profibrotic plasma
proteins into the airspaces and the initiation of a potentially harmfully
inflammatory cell recruitment process. The mechanisms involved in this
process are a point of much debate, but undoubtedly differ with location in
the lung.
At the bronchi and bronchiole surfaces, within 20 minutes of columnar
epithelial cell removal, basal cells become flattened and cover the basement
membrane, this is then superseded by a rapid i^m/min migration of overlying
epithelium, restoring normal architecture. The prompt recovery of these
surfaces following epithelial shedding and lack of associated inflammation
would suggest that this is a normal response to injury and infection, similar to
that observed in the digestive tract. This would serve to rapidly remove
infected or damaged epithelial cells with the mucus prior to establishment of
infection or neoplastic growth76.
The alveolar surface, lacking stratified layers, brings the external milieu into
close contact with the circulation, requiring prompt repair to prevent systemic
infection. Necrotic shedding or apoptotic clearance of type l/ll cells results in
exposure of the underlying basal lamina, consisting of lamin, collagens and
other connective molecules. This matrix acts as a reservoir for epithelial
proliferative factors such as Keratinocyte Growth Factor (KGF) and FGF-10,
and accumulates transudated plasma derived growth factors. In response to
these molecules and a loss of contact inhibition type II epithelial cells are
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thought to differentiate into rapidly proliferating Repair cells / Intermediate
cells, which migrate across the surface of the basal lamina, differentiating
towards type I cells, secreting anti-microbial compounds and proinflammatory
cytokines such as IL-1 as they do so. This occurs in balance with epithelial
expression of IL-1 ra, a IL-1 receptor antagonist, in order to prevent erroneous
inflammation and immune infiltration75"77 and results in the restoration of
normal lung architecture.
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Figure 1.3: Epithelial Cell Subset Localisation and Function
1.7 LUNG RESPONSES TO INFECTION AND INJURY
The lung is continually exposed to injurious and potentially pathogenic
particulates. This requires a predominantly anti-inflammatory environment at
the pulmonary surfaces, to enable engulfment and removal of particulates by
alveolar macrophages, prior to the stimulation of inflammatory cell infiltration
and innate reactivity, which can be potentially damaging to the pulmonary
system. Indeed many functional proteins and carbohydrates in the lung milieu
have dual anti-inflammatory roles65.
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Whilst conventional investigation would decree that immunological
intervention is required to remove persistent infective agents or particulates
from the respiratory surface, a growing body of evidence would now suggest
that stromal and epithelial cells in combination with alveolar macrophage
derived signals have both the signalling and functional capability to deal with
potentially pathogenic events in isolation from circulating effectors.
Alveolar macrophages (AM) act as the sentinels of the respiratory surface,
phagocytosing particulate and opsonised debris from the epithelial surfaces.
In contrast to the immune antigen processing and presentation function of
interstitial macrophage, AM engulf and inactivate particulates, but possesses
only limited presentation capabilities, and are largely anti-inflammatory in
phenotype78.
In response to a threshold concentration of bacterial contaminants e.g.
Lipopolysaccharide (LPS), AM can reverse this phenotype producing a
number of pro-inflammatory cellular signals including in humans Platelet
Activating Factor (PAF), Tumour Necrosis Factor a (TNFa), Interleukins 1
and 8 (IL-1) (IL-8) and Granulocyte Macrophage Colony Stimulating Factor
(GM-CSF)79. Responses in mice are similar, but IL-8 is replaced by
Macrophage Inflammatory Protein 2 (MIP-2) as the cytokine characteristic of
a pro-inflammatory macrophage.
PAF, released by activated AM and particulate injured epithelium80 can up-
regulate mucin production in the larger airways and increase cilia activity,
removing contaminating material from the lungs. More specifically, PAF can
up-regulate hydrogen peroxide (H202) production by epithelial cells,
generating harmful hydroxyl molecules analogous to the respiratory burst
function of the neutrophil, which serves to kill bacterial contaminants in the
mucus. Concomitantly, signals such as TNFa increase Manganese
Superoxide Dismutase (Mn-SOD) (anti-oxidant) production by epithelial cells,
limiting injury from exogenous and endogenous oxidants.
Epithelial cells can also signal in an autocrine and secretory fashion in the
complete absence of AM; exposure to particulates has been shown to
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directly activate epithelial cell production of TNFa, IL-1 (3 and IL-6,
accompanied by Type II cell specific changes in Surfactant Protein C (SPC)
and the 10KDa Clara Cell Specific Protein CC1081. In the event of damage or
infection surpassing these functions, TNFa and IL-1 (3 can act directly locally
in a paracrine fashion, but are also implicated in the up regulation of local
secondary mediators.
TNFa and IL-1 p are functionally very similar and are collectively referred to
as the early response cytokines. Produced by epithelium and immune cell
populations such as macrophages, their primary function is the initiation of
local inflammation and endothelial activation. Activation results in the up
regulation of a number of cell adhesion molecules on the luminal surfaces of
the endothelial cells lining the blood vessels, such as Intercellular Cellular
Adhesion Molecule 1 (ICAM-1), E-Selectin and P-Selectin, facilitating the
margination and transmigration of inflammatory cells from the blood into the
lung architecture.
Cells entering the lung do so under the direction of signalling gradients of
molecules called chemokines. IL-8 is one such molecule, expressed by AM,
and by endothelium in response to early response genes. This recruits
neutrophils, basophils and T-lymphocytes to the respiratory surface. Once
within the interstitial layers, cells migrating on endothelial derived gradients
require further directional cues. Apical MCP-1 (Monocyte Chemoattractant
Protein-1) expression and up regulated adhesional receptor expression by
TNFa /IL-1 p stimulated epithelial cells forms one such gradient, which is
amplified in an autocrine fashion through epithelial activation by MCP-182.
Early response genes continue to participate in inflammation with the arrival
of inflammatory cells. They increase the phagocytic and respiratory burst
functions of macrophages and neutrophils and prime for increased cytokine
secretion upon activation. A prime example of a cytokine induced in activated
AM and epithelial cells is granulocyte macrophage colony stimulating factor
(GM-CSF). This promotes neutrophil and monocyte survival and
differentiation in the interstitial spaces. It also removes the AM mediated
maturation inhibition of dendritic cells, facilitating their progression to the
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lymph nodes to stimulate adaptive immunity79'83. Lymphocyte activity is also
facilitated by a GM-CSF mediated reduction in AM lymphocytostatic activity
at the site of injury or infection84,85.
1.8 ADAPTIVE IMMUNITY AT THE MUCOSAL SURFACE
The development of immunity to a specific pathogenic or particulate antigen
is a highly complex series of events and will be addressed here only briefly
and at a level necessary for explanation of immunological features at the
pulmonary surface, and the potential for the involvement of Shh. Whilst the
majority of immunological features addressed here were elucidated in mouse
and tissues other than the lung, subsequent investigation has illustrated
similar processes in the human lung. The major point of variation is that given
the interaction of the lung with the external milieu, it is comparatively difficult
to mount an adaptive immune response to respiratory stimuli, attributable to a
largely anti-inflammatory cytokine environment, present to prevent immunity
against inocuous antigens and the development of allergy. More advanced
coverage of these topics can be found in texts such as Janeway et al,
Immunobiology86. Material from this section can be found summarised in
Figure 1.4 and Figure 1.5.
Individual naive T lymphocytes leaving the thymus after Shh facilitated TCR
gene rearrangement posses a highly specific TCR and broadly conform to
two subsets, those expressing the CD4 co-receptor and those expressing the
CD8 co-receptor. Both co receptors mediate their intracellular signalling
through co-localisation with the TCR signal transducing CD3 molecule (not
shown in Figure 1.4, for reasons of clarity). Activation of these cells into
effector populations occurs in the lymph nodes and spleen in a process
summarised in Figure 1.4 and below. Dendritic cells are the main activator of
naive T-cells, due in part to an enhanced co-stimulatory function, although
activated macrophages can also serve this function in the right
microenvironment.
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1.8.1 CD4 CELL ACTIVATION
Recognition of Major Histocompatibility Complex II (MHC II) : antigen results
in a physical TCR : CD4 association, inducing conformational activation of
adhesion receptors, through CD3 mediated TCR signalling. This facilitates
binding of the costimulatory ligand CD80 or CD86 expressed on APC, by
CD28 receptor on the bound T-cell. Termed signal one, these events induce
IL-2 secretion as an autocrine proliferative factor by the bound T cell and
induces CD154 ligand up-regulation. CD154 (CD40L) is bound by the
receptor CD40 on the APC and may lead to further activating signals from
the APC and constitutes signal two.
1.8.2 CD8 CELL ACTIVATION
Recognition of MHC I: antigen results in a physical TCR : CD8 association,
inducing conformational activation of adhesional receptors, through CD3
mediated TCR signalling. This facilitates binding of the costimulatory ligand
CD80 or CD86 expressed on APC, by the CD28 receptor on the bound T-
cell. However, in order to avoid stimulation of anti-self reactivity, given that
MHC I present all internal peptides, CD8 cells require increased
costimulatory levels compared to CD4 cells. Dendritic cells typically present
signal one with sufficient CD86 for effective co-stimulation. However, other
APC will require another stimulus, either CD4 mediated CD40 stimulation, or
recognition of a conserved pathogen pattern, e.g. LPS or double stranded
RNA, by Toll like receptors in order to supply sufficient co-stimulation. CD4
binding to the same APC further aids this response through local IL-2
secretion. Recent studies suggest that such supplemental activation of APC
may increase expression of the 4-1BB ligand (also refered to as (CD137L),
which serves as a secondary signal to the CD8 cell to enable activation87.
1.8.3 EFFECTOR CELL FUNCTION
CD8+ cells recognise intracellular antigens, such as virus proteins, presented
on MHC I molecules common to almost all cells; inducing death upon
recognition, either directly or through the recruitment of complement proteins.
In contrast, CD4+ cells recognise exogenous antigens such as bacterial
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fragments, presented on MHC II molecules, restricted to antigen presenting
cells such as dendritic cells and macrophages. CD4 antigen specific binding
of these cells results in their activation, both as secretors of cytokines, and in
the case of macrophage, increased phagocytic surveillance.
Activated CD4+ T-cells can be classified for the purposes of this introduction
into two functional sub-types, Th1 and Th2, differentiated according to APC
derived cytokine signals at the time of antigen presentation. There are similar
sub-type classifications in CD8+ cells and APC86. Th1 are classically defined
as inflammatory, they secrete IFN-y and express CD40 to activate cells such
as macrophages. Th2 cells are specialised for humoral immunity through B-
lymphocyte activation via CD28 and CD154 expression, and the production
of the B-cell growth factors IL-4, IL-5, IL-9 and IL-13. This is discussed in
greater detail within the legend of Figure 1.5.
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Figure 1.4: T Cell Activation
CD4+T cell recognition of antigen presented on the MHCII of APC, via TCR :
CD4 interaction facilitates CD28 : CD80/86 interaction which constitutes
signal one. This results in the secretion of the autocrine activator IL-2 by the
CD4+ T cell, leading to the upregulation of CD154 and the further activation
of APC costimulatory expression. CD8+ T cell recognition of antigen on MHC
1 occurs via a TCR: CD8 interaction, facilitating the interaction of CD28 :
CD80/86. However, full activation of the CD8+ T-cell requires total activation
of the APC, which depending on the type of APC may require exogenous IL-
2 or signalling through other pathogen recognition systems. A fully activated
APC will present 4-1BBL to the CD8+, facilitating its activation via 4-1BB
binding.
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1.8.4 SHH IN ADAPTIVE IMMUNITY
Shh and Ptc have been identified in both resting and activated murine and
human peripheral CD4+ T lymphocytes, human macrophages, CD8 T
lymphocytes and secondary lymphoid tissue. Work by Lowrey and colleagues
demonstrated that contrary to its role in development, endogenously produced
Shh maintains normal mouse T lymphocyte proliferation and survival, and that
exogenous Shh can enhance this response2. Work by Stewart and colleagues
with human T lymphocytes has shown enhanced expression of the activation
antigens CD25 and CD69 with exogenous Shh, along with increased
production of IL-2, IL-10 and IFN-y3.
More recent work by Lowrey and colleagues would suggest that Shh can
compensate for CD28 in in vitro T lymphocyte activation (J.Lowrey, personal
communication). These studies would suggest that Shh expression in the
adult may maintain and enhance immunological responses, this may have
particular relevance at the respiratory surface which will be discussed later.
1.9 IMMUNE AND NON-IMMUNE ASSOCIATED LUNG
FIBROSIS
In the event of lung injury or chronic disease exaggerated repair responses
can occur, termed remodelling. This response is typically found associated
with an inflammatory cell infiltrate and results in permanent disruption of
normal lung architecture, with features such as scarring and fibrosis, smooth
muscle hyperplasia and "bronchiolisation" of the respiratory surfaces.
Remodelling is a characteristic feature of chronic fibrotic lung disorders and of
mouse fibrotic models.
The classical approach to the delineation of fibrotic progression has been to
identify the initiating inflammatory insult, and the polarisation (Th1TTh2) of the
immune response. However, a number of studies would now suggest that
whilst an injurious event may be a catalyst, the involvement of an
39
inflammatory infiltrate is not an absolute requirement for fibrotic progression in
a number of pulmonary fibrotic conditions90 91.
Instead, fibrosis can be regarded as a series of progressively less reversible
remodelling steps, the end stage of which is irreversible scaring, resulting
from the deposistion of excess ECM by pulmonary fibroblasts, either through
up regulated deposition of collagen (one of the main components of the ECM)
or increased fibroblast numbers. Equally changes in the ratio of collagen
degrading Matrix MetalloProteinases (MMP's) and their inhibitors (TIMP's),
can lead to ECM accumulation, but is usually dependent on a collagen switch
to a less degradable type, before becoming irreversible scarring.
The extent to which infiltrate is required to facilitate fibrotic progression differs
with disease phenotype. Diseases or conditions associated with inflammatory
infiltration, are typically Th2 polarised in cytokine profile, with the exception of
gramuloma associated diseases such as sarcoidosis92.
Th2 polarisation is more fibrogenic than Th1, as it includes cytokines with
potent ECM modulating activity such as IL-4 and IL-13. Profibrotic effects can
be direct, such as increased collagen production in pulmonary fibroblasts in
response to IL-1393, or indirect, via alterations in the balance of collagen
degrading MMPs and TIMPs94. Th2 cytokines can also activate secondary
signals, such as the release of TGF-|32, GM-CSF or IL-8 from IL-4 or IL-13
stimulated epithelial cells93 95
However, Th2 polarity alone cannot be the cause of fibrosis, as not all Th2
lung conditions result in fibrosis. A more plausible explanation may lay in a
deregulated response or disruption of normal signalling balance in susceptible
individuals. Indeed, recent studies have shown increased expression of high
affinity receptors for IL-13 and IL-4 in fibrosis patients96"98 where
polymorphisms in ligand have shown little correlation99. Equally, IL-6, an anti¬
proliferative signal for normal human fibroblasts, is actually mitogenic for
fibroblasts from fibrosis patients100"102.
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Equally, the susceptibility of an individual to the development of fibrosis, may
rely on their response to, or ability to generate, secondary, epithelially derived
signals, such as GM-CSF.
GM-CSF up regulates prostaglandin E2 (PGE2) in fibroblasts, an anti-
fibrogenic lipid. PGE2 acts by inhibiting proliferation and collagen synthesis
and by up regulating collagen degrading mechanisms103. Thus, GM-CSF is
anti-fibrotic, which could lead to a delay in wound healing. However, GM-CSF
has also been shown to possess a proliferative function with type II
epithelium104 and a proliferative function with (anti-inflammatory) AM. Thus it
is likely that GM-CSF facilitates rapid repair of denuded sites preventing the
establishment of fibrotic plaques as a result of extended denudation.
However, it may be the ability to switch off these secondary signals, which
could affect fibrosis susceptibility. Protracted production of IL-8, an initiating
factor in the recruitment of inflammatory infiltrate, could lead to fibrosis in
inflammation associated fibrotic conditions, whilst over expression studies
with GM-CSF have illustrated that continued GM-CSF expression leads to
TGF-pi mediated myofibroblast accumulation105, a scarring associated
fibroblast subtype, and reversion of the anti-inflammatory phenotype of AM106,
potentially increasing local inflammatory activity and associated fibrosis.
To further discuss fibrotic remodelling and related mouse models, it is first
necessary to review some associated medical terminology.
1.10 LUNG FIBROSIS
The heterogeneous nature of the fibroblast population and the multitude of
defensive and remodelling mechanisms operating in the lung, combined with
individual susceptibility factors, mean that fibrotic lung conditions are
frequently classified by histology and clinical diagnosis, rather than exclusively
by causative agent, as the response of the individual to that agent will dictate
the success of any subsequent treatment.
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As representative examples of the different pathologies discussed in this
thesis, two types of fibrosis are considered here. Bronchiolitis Obliterans
Organising Pneumonia (BOOP), an example of an airway obstructive fibrosis
resulting from inflammatory signalling, and Idiopathic Pulmonary Fibrosis
(IPF), an example of interstitial lung disease, resulting from fibrosis inducing
signalling pathways.
Information given here is derived from indicated references and materials
obtained from postgraduate courses attended at the European Respiratory
Society Annual Meeting 2003, and American Thoracic Society Annual
Meeting 2004 (See Section 7.5).
1.10.1 BRONCHIOLITIS OBLITERANS ORGANISING PNEUMONIA
First described as a distinct entity in 1985 by G.R. Epler M.D107, 108
(www.epler.comT BOOP most commonly occurs between the ages of 40 and
60, although it can occur at any age. Clinically these patients present with
symptoms including fever, mild cough and breathlessness and in some
patients, there is an associated decrease in vital and diffusing capacities with
influenza like symptoms. Radiologically, patchy opacities can be observed in
the lung, which biopsy reveals as connective tissue masses within the lumens
of terminal and respiratory bronchioles, continuing into the alveolar spaces
(Figure 1.6). Within these fibrotic masses, which frequently exhibit abundant
capillarization, are invaginating or free floating polyps of mononuclear
inflammatory cells. The surrounding airways appear inflamed and exhibit
features of atelectasis, but the architecture is not irreversibly disrupted. Within
these areas reactive proliferating type II epithelial cell populations can be
identified along with increased numbers of macrophages. Distal to this
occlusion obstructive pneumonia may develop, characterised by foamy, lipid
laden macrophages.
Preliminary IHC investigation undertaken during the course of this
investigation identified Shh and Gli expression in the type II epithelial cells in
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these areas, with foci of nuclear localised Gli1 indicating active signalling in
individual cells (Figure 1.6).
Figure 1.6: Shh Signalling in BOOP Biopsies
[A] H&E, [B] Shh, [C] Shh, [D] Ptc [E] GN1 [F] Gli1
[A] The lighter central material in this H&E stain is fibrotic. [B] Shh IHC is
specific for bronchial epithelium and Type II like cells associated with fibrotic
foci [C]. [D] Fibrotic foci are also found associated with Ptc positive cells. [E]
The occurrence of Gli expression in Shh positive bronchial cells suggests
some autocrine signalling capability. [F] Gli1 expression and nuclear
localisation in areas of fibrosis would indicate an active Shh signalling
pathway in these regions.
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The cause of BOOP, when known, is used to sub classify these conditions, as
are distinctive pathological features without those covered in the central
definition of BOOP given above.
Idiopathic BOOP is corticosteroid responsive, where 65-80% of patients are
completely cured following treatment. A subset exhibit stabilisation, whilst
others exhibit complete resolution of disease without therapeutic intervention
at all. Whether these variations represent patient variation or a differing
disease process is a matter of continuing discussion. But, crucially, with
correct treatment this disorder, worldwide has only a 5% mortality rate, which
is in stark contrast to that of IPF.
1.10.2 IDIOPATHIC PULMONARY FIBROSIS
IPF is contained within the Interstitial Lung Disease (ILD) classification, which
encompasses a wide range of end stage inflammatory and fibrotic disorders,
and has recently undergone dramatic reclassification in order to address more
recent diagnostic advances and problematic geographical variation in
terminology 109. ILD is classified into those conditions of known aetiology,
such as asbestosis, and those conditions of unknown aetiology, now referred
to as idiopathic interstitial pneumonias (IIP). The most common and
progressive of these conditions is Idiopathic Pulmonary Fibrosis (IPF),
previously known as cryptogenic fibrosing alveolitis, in which Stewart et al
identified epithelial expression of Shh1.
IPF affects more males than females, usually over 50 years of age, with 75%
of patients being current or former smokers. It carries a grave prognosis of
survival, typically 4-5 years post diagnosis. Some familial clustering has been
observed, suggesting some genetic predisposition, although, there is as yet
no specific evidence of a disease associated gene abnormality. Clinical
diagnosis of IPF requires the exclusion of identifiable cause, exertional
dyspnoea, non-productive cough and lower respiratory crackles with chest
auscultatation. Confirmation of disease requires a Usual Interstitial
Pneumonia (UIP) pattern of disease in HRCT or wedge biopsy. Absence of
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this pattern results in a diagnosis of non specific interstitial pneumoniae
(NSIP), which carries a better prognosis, as unlike IPF, this is corticosteroid
responsive.
UIP pathology is patchy and heterogeneous in progression, characterised by
remodelling lung where "honeycombing" is the defining feature. This
describes an area of fibrotic lung where the lung architecture has collapsed to
reveal macroscopically visible spaces. Cellular infiltrates may also occur,
typically dominated by lymphocyte and monocyte populations with
granulocytes. The occurrence of eosinophils in this infiltrate may be
associated with a reduced prognosis of survival. A pathological hallmark of
UIP is the presence of discrete areas of fibroblastic proliferation, termed
fibroblastic foci, usually underlying hyperproliferative type II epithelial cells.
Stewart et al identified membrane and cytoplasmic Shh expression in areas of
remodelling hyperplastic epithelium in this condition (Figure 1.7[A-D]). The
presence of epithelial and mesenchymal expression of Ptc, in both diseased
and non diseased areas, suggested that a recapitulation of this developmental
signalling pathway might be involved in the remodelling process, such as that
performed by TGF-p.
TGF-p, a developmental signalling molecule, with both pro and anti fibrotic
function in the adult lung, exhibited a marked up regulation in UIP, but not
bronchiectasis, despite fields of similar disease morphology (Figure 1.7 [J-L]).
Differences in Shh expression were also observed between UIP and
bronchiectasis. Bronchietasis biopsies exhibited an epithelial, perinuclear dot
Shh expression pattern in diseased areas, not observed in UIP. This would
suggest that an element of the Shh expression process may be disease
specific1 (Figure 1.7 [F]).
Indeed, whilst bronchiectasis is thought to originate with airway damage,
where subsequent chronic infection causes enlargement and dilation of the
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airways, UIP is believed to have an immunological basis in its progression,
linked in some way with aberrant epithelial mesenchymal interaction110. Thus,
it maybe, that this difference in expression pattern, is attributable to a differing
mechanism of disease progression.
Previous work by Wallace et al in this laboratory, identified circulating
antibodies to a 70-90KD protein in IPF patient serum, which were not
observed in normal controls111'112. This protein was later localised to type II
cells, suggesting an autoantigen111'112. Experiments in vivo with a polyclonal
antibody raised against the epithelial antigen and a human type II epithelial
cell line showed up regulated tenascin and TGF-p production113. Where
tenascin is an extracellular matrix protein associated with active scar
formation, well characterised with TGF-p, as being present in the lungs of
patients with IPF114"116, up regulated in areas of active fibroplasias or
fibroblastic foci114'115.
Thus it could be hypothesised that the autoantibodies observed in IPF maybe
directly involved in the Shh up regulation, or indirectly through protracted
TGF-p and tenascin expression and that regulation of Shh in bronchietasis





( ~ % —*
j? ' y'' — * -jo
'












% . _ • « a *:9
TGF-p
Figure 1.7: UIP Biopsy IHC Analysis
Photos taken from the thesis and publication1 of Dr G.A Stewart. Photo's from
UIP biopsy are denoted in black, bronchiectasis cases in red. [A] x100 image
of strong Shh staining restricted to specific areas of lung observed in large
cuboidal epithelial cells, positive staining hypertrophic muscle arrowed. The
boxed area in [A] is shown in [B] at x400 where metaplastic epithelial cells are
strong Shh expressors, similarly shown in a x600 magnification image in [C].
[D] A x600 image of type II epithelial cells stained positively for Shh. [E] A
x600 image of Shh expression in infiltrating cells. [F] A x600 image of Shh
staining in bronchiectasis illustrates a differing staining pattern. [G] A x600
image of Ptc staining in type II cells and in [H] infiltrating cells. [I] A x600
image of bronchiectasis showing a similar pattern of Ptc staining. TGF-p
staining was positive in epithelial cells both at airway junctures [J] and normal




1.11 ANIMAL MODELS OF PULMONARY INFLAMMATION
AND FIBROSIS
Despite the vast array of animal models for human lung fibrosis currently in
use, there is still no definitive model which recapitulates all the features of
human lung fibrosis. In fact, given the inherent variation in human
physiopathology with lung fibrosis, it is perhaps unreasonable to expect that
this would be the case. The difficultly arises from the fact that in humans most
fibrotic conditions develop as a consequence of months, perhaps years of
aberrant extracellular matrix deposition. Thus whilst the more acute fibrotic
responses of rodents to particulates such as asbestos and silica have been
shown to be broadly similar to those induced in humans, and fibrotic models
can be established by adenoviral transfer and in vivo overexpression of pro-
fibrotic agents, it has been more difficult to establish models of chronic
fibrosis.
Part of the difficultly lies in the fact that, like humans, strains of mice vary in
their response to different pulmonary stimuli, the most frequently made
comparison being that of the tendency for the C57BI6 strain to mount Th1
mediated responses, making them relatively fibrosis resistant, versus the Th2
polarisation of the Balb-c strain, making them relatively susceptible to the
development of fibrosis and allergy. Thus even withstanding the species
comparison there is variation in model systems according to the mouse strain
utilised.
An excellent review by Chua et al. has recently been published concerning
the use of animal models and the inherent problems in their development117.
Subsequent sections make reference to three commonly used animal models,
the 2,4,6-trinitrobenzene sulfonic acid (TNBS) hapten model, the bleomycin
model and the FITC model.
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1.11.1 THE TNBS HAPTEN MODEL
The particular model of Hapten Immune Pulmonary Interstitial Fibrosis (HIPIF)
described here was initially characterised in hamsters, but was subsequently
developed into a mouse model. Pulmonary fibrosis is induced by
epicutaneous application of a water soluble form of the hapten TNBS (3%
solution) to the abdomens of Balb-c mice (100^1/mouse). This is followed five
days later by an intratracheal challenge with 50pJ of a 1%TNBS solution.
Haptens are non immunogenic but because of their chemical reactivity,
covalently bind to proteins and lipids disrupting function and making new
modified molecules which appear as antigenic to the immune system. Thus
whilst ensuing immune responses are primarily against the hapten
component, autoimmune elements in the immune response also perpetuate at
the point of initial sensitisation.
The intratracheal delivery results in a focal recall response against hapten
conjugates and leads to an autoimmune mediated fibrosis with features
similar to those observed in human IPF118. The immune response is antigen
specific, requires both CD4 and CD8 T cells and the development of fibrosis
in these animals is completely dependent on the presence of alveolar
macrophages119.
The advantages of this model are that it is highly reproducible and the
induced immune response has been well characterised through a number of
complex adoptive transfer experiments120. The disadvantages are that it has
primarily been used as a means to demonstrate the role of APC in
autoimmunity and tolerance, thus the induced pathology has not been as well
characterised as for other models.
1.11.2 THE BLEOMYCIN MODEL OF LUNG INJURY
Bleomycin is used as a cytotoxic agent in the treatment of human cancer, but
was soon found to have toxicity in the pulmonary system and acted dose
dependently as an inducer of lung fibrosis. This activity has been utilised in
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the establishment of a number of rodent injury models. These are the most
commonly used models of fibrotic lung injury. Induction of disease likely arises
from the ability of bleomycin to bind DNA/iron and its subsequent involvement
in free radical formation and lipid peroxidation, but as yet, the central cause
has yet to be explained.
Method of delivery differs with animal species and like the FITC model,
discussed below, a number of modifications have occurred to the technique
across publications and labs. The lab of Galen Toews, Ann Arbor, Michigan,
as an example inject a single 30pil injection of 0.025U of bleomycin (in saline)
into the surgically exposed tracheae of a mouse anaesthetised by sodium
pentobarbital121..
Following instillation, rapid type I epithelial cell necrosis occurs, leading to
denudement and transudation of inflammatory factors and thickening of the
respiratory surfaces (acute alveolitis), an inflammatory infiltrate becomes
prominent and inflammation spreads interstitially and is maintained for 12
days post instillation. During this period fibroblasts are activated and
proliferate, resulting in a two fold increase in lung collagen content by three
weeks post challenge. Subsequent loss of elasticity in the lung through
fibroblastic growth leads to a high rate of fatality in these mice.
Some studies would suggest that this fibrotic progression in this model is Th1
mediated, and that TGF-p and TNF-a play crucial roles. However recent work
using CCR2 knockouts (the MCP-1 (CCL-2) receptor) would suggest that GM-
CSF in combination with low TNFa can protect against fibrosis development,
likely through up regulation of the anti-fibrotic protein PGE2 103,122.
1.11.3 THE FITC MODEL OF PULMONARY INFLAMMATION AND
FIBROSIS
The fluorescein isothiocyanate (FITC) hapten instillation model was first
characterised in our lab by S Roberts123. FITC was surgically instilled
intratracheal^ under halothane anaesthetic and mice sacrificed up to 5
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months later. This technique was later modified by Dr Gareth Stewart, to use
avertin anaesthetic instead of Halothane, and a transoral method of instillation
of FITC was selected. This method was then further modified by Dr Sharon
Ahmed to incorporate a 2 step delivery of FITC separated by a 6 week period.
FITC is a fluorescent compound which readily forms non-specific covalent
attachments within the protein matrices of the interstitium. FITC can be
identified here over 5 months post instillation, bound to putative slow turnover
proteins, where circulating FITC specific IgG antibodies can still be detected
(Roberts et al unpublished observations). In terms of pathology, epithelial cell
remodelling and mononuclear cell infiltration in areas of persistent FITC
deposition have been described, superseded by the formation of fibrotic
plaques and honeycombing, reminiscent of a UIP phenotype. The specifics of
this model will be discussed in greater detail in Chapter 3.
Using this model Gareth Stewart et al identified Ptc expression in bronchial &
alveolar epithelial cells and AM. There was no difference in expression
between FITC and PBS treated mice, although Ptc was also found on the
mononuclear infiltrate localised around areas of FITC deposition in FITC
treated mice.
When compared with PBS treated mice, and areas lacking FITC, foci of FITC
deposition showed up regulated Shh expression at 7 days post instillation,
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Figure 1.8: IHC of the FITC Model from a Paper by Dr GA Stewart1
Representative Shh (A-C), Ptc (D-F) and TGF-p (G-l) IHC on mouse sections
after a single surgical intratracheal delivery of PBS or FITC. Time points for 7
days and 5 months post instillation are shown.
1.12 A ROLE FOR DEVELOPMENTAL GENES IN ADULT
DISEASE?
Given the complex network of signals that occur in development, it is possible
that Shh upregulation in lung disease results inconsequentially from
protracted expression of other recapitulated developmental signalling
molecules such as TGF-p. However, recent studies have elucidated a
plethora of post embryonic functions for the hedgehog signalling pathway,
suggesting that Shh may have a crucial role in post embryonic systems.
Research has centred largely on the role of Shh in the brain, where it has
been described as having inductive, proliferative, neurotrophic and
neuroprotective activities, being involved in neurological disorders such as
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Multiple Sclerosis and Parkinson's disease124. Other areas of research include
the role of Shh signalling in the development of basal cell carcinomas,
(reviewed by 125), disorders of the digestive system, and its role in cell cycle
progression in activated peripheral T-cells2.
1.12.1 SHH AS A STEM CELL MODULATOR
A number of studies have highlighted the potential for Shh signalling as a
differentiation modulator, but only the recent publications of Watkins et al
have conclusively investigated this at the post embryonic pulmonary
surface73. Watkins and colleagues depleted Clara cells from mouse airways
via their sensitivity to naphthalene injury, leaving the naphthalene resistant
vCC population. This resulted in a transient peak in Shh and Gli expression 3
days post depletion that coincided with the reestablishment of a complete
epithelial barrier. It was suggested that Shh signalling might be involved in this
repopulation step, since this peak preceded an increase in the number of
pulmonary neuroepithelial cells - a cell type identified as a potential epithelial
progenitor67,68
Epithelial coverage is already completed by the peak of Shh expression, thus
a causative role in epithelial proliferation is unlikely, and this is confirmed in
our studies where we observe bronchiolar Shh expression restricted to areas
of complete epithelial coverage. It is interesting that coverage normally occurs
in the absence of differentiation, which typically occurs following re-
establishment of epithelial integrity. Given the necessity for confluence for
Shh signalling in some cell Shh bioassays59,126 it is interesting to speculate
that perhaps Shh is a differentiation and proliferation modulation signal.
Hypothetically this could occur as follows:
Loss of cell contact induces proliferation and Shh production by stem cell
populations, but these cells only become responsive to their own Shh signal
once an intact epithelial barrier had been re-established.
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Whether such a signal would act to induce differentiation in these cells or
maintain their stem cell phenotype would be difficult to determine. Reasoning
for such speculation arises through the well characterised progenitor
modulating role of Hh in a range of post embryonic systems including T
lymphocyte development64 and haematopoiesis127.
The work by Bhardwaj in haematopoiesis was notable for it clearly defined the
downstream effector of Shh function as BMP-4, where Shh addition to an
enriched population of human CD34+Lin-CD38- progenitor cells resulted in
increased self renewal, albeit in combination with many other growth factors.
The use of BMP-4 in this process was notable given innovative in vivo studies
from the lab of Brigid Hogan and colleagues which have demonstrated a
potential progenitor cell modulating function for BMPs in epithelium; cells
exposed to high levels of BMP-4 retained undifferentiated characteristics128'
129. In light of these studies, were Shh to modulate pulmonary epithelial
progenitor function through the BMPs, it would likely be in conjunction with a
number of other signals, such as FGF-10, perhaps in a recapitulation of the
process of cell fate designation which occurs in the embryonic lung128.
An example of Hh mediated progenitor cell modulation in injury comes
indirectly from several sources130'131. Pepinsky et al demonstrated that Shh
administration can accelerate nerve recovery following sciatic nerve crush
injury130. A possible explanation for this response comes from studies by
Bambakidos et al, using a rat demyelination model131. These authors
observed increased proliferation of nestin+ve stem cell like progenitors in
areas of chemical demyelination following direct Shh administration. This
suggests that exogenous Shh at a site of injury induces proliferation in stem
cell populations, although the specificity of this progenitor proliferation was not
addressed in this study.
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1.12.2 SHH AS A MODULATOR OF FIBROSIS
The recapitulation of developmental genes such as Shh in remodelling and
fibrotic processes is not without precedent; certainly TGF-p and Tenascin
have been shown to have prominent roles in both development and fibrosis132'
133. However, the localisation of Shh expression, and therefore its involvement
in pulmonary disease remains undetermined as whilst Watkins et al have
demonstrated bronchiolar epithelial expression of the Shh signalling
components in mouse73, our lab has demonstrated both bronchiolar and
alveolar expression of Shh in mouse and human, where alveolar Shh
expression was restricted to the type II like cells of inflamed remodelling
areas1.
Interestingly, a murine model of allergen induced inflammation, despite
greater inflammation than the FITC model, showed no Shh up regulation1'123.
This was highly suggestive of Shh expression as a fibrosis associated factor.
Shh and FGF are commonly associated signalling molecules and are co
expressed in a number of systems both pre- and post-natally134"137 and
hedgehog signalling has been linked with collagen fibre induction in the neural
system138. Shh also has substantial cell cycle modulating capabilities139, 140
and participates in well characterised proliferative mesenchymal interactions
in the developing lung. Thus the localisation of Shh to areas of fibrosis in IPF
may present a causal relationship with fibrosis in the IPF patient.
However, the up regulation of Shh at sites of epithelial injury comes amongst
a plethora of other modulating signals and could therefore represent a
downstream marker of a much larger process initiated by the underlying
mesenchymal/fibroblastic cells, which play a crucial role in epithelial
maintenance.
Mesenchymal cells produce specific epithelial growth factors such as KGF
and FGF-10. These are up regulated in response to injurious stimuli, resulting
in increased epithelial proliferation and rapid reestablishment of an intact
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epithelial layer, (for a review see Ware et al141). Studies using FGF-10,
FGFR2b and Shh knockout mice have recently confirmed Shh to be
downstream of FGF-10 signalling142. Thus Shh expression on epithelium at
sites of fibroblastic proliferation, such as that observed in IPF, may be a
consequence of this repair process rather than an instigator of repair. In this
situation Shh could be considered a regulatory factor, given its ability to down
regulate FGF-10134.
Alternatively expression at the alveolar surfaces of IPF patients and in the
FITC instillation mouse model, might relate to a specific element of the
disease process. Although without known cause, IPF progression is believed
to have an immunological basis, linked in some way with aberrant epithelial
mesenchymal signalling110 One hypothesis might be that Shh expression
might modulate the cross talk between disease process and T-cells, perhaps
involved in the stimulation of auto antibody generation against epithelial
antigens observed in these patients. Similar hypotheses could be drawn from
the observations made in the fibrotic FITC mouse model of IPF pathology123.
Fibrosis and inflammation are believed to be induced in this model through
the persistence of the intratracheally instilled irritant FITC, which lodges in the
interstitium and binds resident proteins. The observation that antibodies are
then raised to FITC would suggest that anti-self antibodies are also raised in
this model, given the ability of FITC to covalently attach itself to host proteins,
effectively making normal lung proteins part of an antigenic molecule..
1.12.3 SHH AS AN INDICATOR OF INJURY
Shh would appear to share many of its effects with KGF and FGF-10139, most
notably, stimulation of increased cellular resistance to injury and death143,144.
Shh exhibits this effect in a number of cell types139'145,146, but it has yet to be
established at the pulmonary interface. Perhaps the best example of this
activity is in Parkinson's disease, where exogenous administration of Shh in
both a marmoset and mouse model of the disease results in improved
locomotion and function147,148. Tsuboi and colleagues148, citing work by Miao
et al146, have suggested that this is likely due to Shh acting as a
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neuroprotective agent against dopaminogenic neuron cell death, which is
central to disease progression.
Indeed current research would show that Shh can induce the anti-apoptotic
protein Bcl-2 in keratinocytes and T-lymphocytes2, and that its presence
prevents the apoptosis of neuroepithelial cells145. Therefore in a pulmonary
situation of injury, such as exposure to environment oxidants, Shh release,
along with KGF and FGF-10, may serve to temporarily increase surrounding
epithelial cell resilience, and prevent complete denudation of an epithelial
surface and the risk of secondary infection.
Sustaining viability of injured cells carries with it the increased probability of
populating the epithelium with cells which have incurred genetic damage.
Indeed, this may help to explain the higher incidence of small and non-small
cell lung cancers following epithelial trauma, and the preponderance for the
involvement of Shh signalling in these carcinomas68.
Up regulation of Hh signalling following injury, can be found in a number of
model systems. Pola et al149,150 have demonstrated the up regulation of Shh
and Ptc1 expression in a rodent hind limb ischemia model. Furthermore, the
same group demonstrated that the administration of Shh induced robust
neovascularisation, enhanced blood flow, and the up regulation of the
angiogenic factors, vascular endothelial growth factor (VEGF) and the
angiopoietins, Ang1 and Ang2149,although any direct association is a matter of
conjecture 151, 152. The findings from other groups have been broadly in
keeping with those of Pola et al (2001) demonstrating that Shh is capable of
inducing VEGF expression151 and angiogenesis152.
Such angiogenic modulation could have important implications at the
respiratory surfaces of IPF patients, where we have observed Shh expression
in association with areas of fibrosis.1. Shh expression here may represent an
attempt by the lung to revascularise and remodel the fibrotic architecture.
Although current studies would suggest that Shh expression is not
substantially greater in BOOP, where, given the neovascularisation of
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vacuous fibrotic deposits, greater Shh expression might be expected, were
angiogenesis a function of pulmonary Shh. Interestingly, VEGF itself is found
up regulated with epithelial injury, thus Shh mediated VEGF up regulation
might have other functions at the respiratory surface.46
1.13 AIMS, OBJECTIVES AND HYPOTHESES
In summary of the discussion contained with this introduction, the hypotheses
raised prior to this body of work are listed below:
• Shh expression is an indicator of acute or chronic epithelial cell injury.
• Shh upregulation initiates defensive functions independent of systemic
immunity, i.e. the activation of epithelial cytokine production,
maintenance of stem cell function and effects on alveolar macrophage
and fibroblast function.
• Shh expression in UIP and the FITC lung model indicates an active
association of Shh signalling with the development of fibroblastic foci
• Disease progression in the FITC instillation mouse model is potentiated
by Th2 anti-FITC antibody
The main objective of this thesis is therefore to address these hypotheses
either directly, or through the establishment of techniques to facilitate their
analysis. Subsequent Chapters of this thesis aim to address these
hypotheses. Chapter 3 details investigations performed using a modified FITC
mouse model, where an increased dose of FITC is transorally intratracheal^
delivered twice, six weeks apart. Studies using this model are compared with
previous findings and approaches made at addressing the immunobiology
behind disease progression; via antibody analysis, primary cell extraction
studies and use of new IHC protocols.Chapter 4 details in vitro studies using
epithelial cell lines as an approach to delineate the response of epithelium to
58
injury and exogenous Shh, and includes the development of a novel method
for the quantitative detection of soluble Shh. Chapter 5 details the
development of laser capture microdissection protocols for the confirmation of
active Shh signalling at the genetic level in mouse FITC and human UIP
sections, with an intention to identify putitative producer and responder
populations in confirmation of IHC observations.
59
CHAPTER 2 MATERIALS AND METHODS
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2.1 TISSUE CULTURE
2.1.1 GENERAL CELL CULTURE
All subsequent references to Foetal Calf Serum (FCS) (Labtech International,
Rigmer, Sussex) refer to FCS heat inactivated at 56°C for thirty to forty five
minutes in a water bath to inactivate complement. All cell lines were checked for
LPS and mycoplasma contamination using the limulus amebocyte lysate
coamatic assay (Quadratech Ltd, Surrey, UK) and Mycoplasma PCR ELISA
(Roche Diagnostics Ltd, Surrey, UK) kits respectively, as per manufacturers
instructions. Initial cell line culture established a cell bank storage system for
these lines by culturing large numbers of cells then freezing in 50% FCS : 50%
culture media containing 20% DMSO (Sigma-Aldrich Ltd, Poole, Dorset, UK),
where cells were first suspended in FCS, then the DMSO containing fraction
added with vigorous swirling to generate an even DMSO distribution, prior to
aliquoting and freezing. All tissue culture was performed in class II safety
cabinets using relevant plastics produced by Costar (Corning-Costar, Schiphol-
Rijk, Netherlands)
CELL LINES
Cell lines listed below are adherent and were passaged via trypsinisation
following two washes with serum free media, with the exception of the CCL-226
line which was also split via cell scraper removal. All lines were split sub-
confluence in a ratio necessary to facilitate passage every 3-4 days. Relevant
details are defined at the end of each cell line section as approximates of
trypsin volume per medium (75cm2) flask / average time for sufficient lifting /
split ratio.
A549 (European Collection of Cell Cultures (ECACC)):
The A549 human pulmonary type II epithelial cell line is of lung carcinoma
origin153, it has been well characterised as a type II epithelial cell and is
frequently used in expression and response investigations of human
epithelium113'143'154'155. The A549 cell line was cultured in RPMI 1640 (Sigma-
Aldrich), supplemented with 2mM L-glutamine (Invitrogen Life Technologies,
Paisley), 100U/ml penicillin / streptomycin (Invitrogen). Initial culture following
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defrost also used a supplement of 10% FCS, this was reduced following 2
successful passages to 5% as the rapid proliferation produced in 10% was not
suitable for many of the desired experiments. Of note, A549 continue to grow to
healthy confluence in <2.5% FCS. (4mls/7mins/1:9)
CMT (ECACC):
The CMT mouse pulmonary type II like cell line, abbreviated to CMT in this
work, was derived from a C57BL/6 lung carcinoma156(ECACC) and although
less utilised in the literature than A549, was derived from well characterised
source material. Tumour structure was described as of alveolar patterning, with
predominant type II like cells exhibiting pre-secretory pulmonary surfactant
machinery. These cells were separated from fibroblast outgrowths in culture by
repeated trypsinisation until a uniform phenotype was observed. The luminal
borders of these cells are coated in microvilli, resembling brush cells, whilst
shorter variants resemble respiratory ciliated cells. Thus it is likely that this cell
line represents a mixed bronchiolar/alveolar epithelial subtype that could
represent either two separate populations, or an interchangeable phenotype.
The CMT cell line was cultured in Waymouths media (Invitrogen) supplemented
with 2mM L-glutamine, 100U/ml penicillin/streptomycin. As with A549, initial
culture post defrost was performed with a 10% supplement of FCS reduced to
5% with two successive passages. Of note, despite references to the
contrary156, 2.5% FCS is sufficient to maintain CMT cells and a little proliferation
and monolayers will continue in serum free media, but prolonged exposure to
these conditions through passage leads to a halt in proliferation.
(8mls/15mins/1:10)
CCL-226 / C3H/10T1/2 (American Tissue Culture Collection (ATCC)):
The C3H/10T1/2 line consists of embryonic mouse fibroblast cells which were
cultured for use in the establishment of a bioassay system. Owing to difficulties
in the development of the bioassay these cells were cultured in a variety of
different media including RPMI-1640 and DMEM (Sigma-Aldrich) supplemented
with 10% FCS or 10% charcoal stripped FCS (Labtech), 2mM L-glutamine and
0.0007% pMercaptoethanol (Sigma-Aldrich). Of note, if allowed to reach
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sustained confluence, proliferative capacity may be lost and permanent
morphological cell phenotype changes can occur. These cells were found to
proliferate best in the absence of the standard 10OU/ml penicillin/streptomycin
supplements. (various/5mins/1:10).
CCL-206 (ATCC):
This is a fibroblast cell line derived from the lung of a normal new born ddY
mouse157,158. This cell line has been frequently used as an example of a lung
fibroblast cell159,16°, but there is a paucity of data relating to the original method
of its isolation158. The CCL-206 cell line was cultured in DMEM supplemented
with 2mM L-glutamine and 10% FCS. Of note, these cells exhibited reduced
proliferation and appeared less healthy when cultured with standard 100U/ml
penicillin / streptomycin supplements. (5mls/5mins/1:8).
NIH-3T3 (ECACC):
This is a fibroblast like cell line derived from embryonic NIH swiss mouse cells
used as a vehicle for plasmid bioassay and reporter vectors and cultured in
DMEM supplemented with 2mM L-glutamine and 10% FCS. Of note these cells
could be grown normally in penicillin/streptomycin supplemented media, but
were not for reasons of increased transfection efficiency. (5mls/5mins/1:6).
NS-1 (SHH) (Developmental Studies Hybridoma Cell Bank, USA):
This hybridoma cell line, designated NS-1 was derived from the fusion of NS1
myeloma cells with cells taken from the spleen of a female Balb-c mouse
immunised four times with baculovirus expressed rat Shh161. The line was
cultured in RPMI supplemented with 100U/ml penicillin / streptomycin and 2mM
glutamine, plus 10% FCS and pMercaptoethanol. This hybridoma produces





MethylThiazolyldiphenyl-Tetrazolium bromide (MTT) stock was prepared by
dissolving a 100mg pot of MTT powder (Sigma-Aldrich) in 20mls of sterile room
temperature PBS (Sigma-Aldrich). Upon solution, this is passed through a 2^m
syringe filter (Sartorius, Goettingen, Germany) and stored at 4°C in a foil
wrapped universal. Of note, is that this solution is light sensitive and exhibits a
drop in signal if stored for greater than 10-14 days and is not stable when
frozen.
MTT is a yellow solution, converted into an insoluble purple substrate by
intracellular mitochondrial enzyme activity, which can be read using visible
wavelengths in a standard plate reader. This conversion reduces cellular
function and is thus toxic at certain concentrations and duration of exposure. To
account for this, MTT was titred into cell culture, to determine optimum
concentration and time of exposure. Leaching of blue into the media
demonstrated reduced membrane integrity and was taken as the upper limit of
use, and the Optical Density (OD) of detection used as the lower determinant.
The duration of exposure was selected from the most consistent data within this
range i.e. CMT cells were co-cultured with MTT for 3 hours, whilst, A549 were
co-cultured for only 45 minutes. However, the general protocol is described
below, any derivations from this are recorded in relevant figure legends.
Cells were washed with serum free media / PBS, aspirated and replaced with
serum positive media to a volume of 450pil in a 24 well plate, followed by 50pJ of
MTT stock per well. Cells were then incubated for a cell specific duration, then
the medium discarded. The PBS wash step of the remaining MTT monolayer,
which is commonly included in most protocols was excluded due to a loss of
cells through lifting. Aspiration of remaining media with a yellow Gilson tip, was
found to reduce residual media carryover to less than that obtained with a PBS
wash step. The monolayer was then left to dry completely in a sterile hood.
Once dry, 350pJ of DMSO was added to each well, and the plate gently rocked
to ensure the complete solution of the blue MTT precipitate. 100[xl of this
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solution was then transferred to a 96 well plate and read at 490nm/ref 630nm in
a 96 well plate reader (see Section 2.7).
2.2.2 MTS AND LDH ASSAYS
Due to limitations in the use of MTT related to the loss of cells through lifting
during the course of the assay, another approach was taken, utilising a
Promega (Promega, Southampton, UK) cell titre assay. This uses a compound
called 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl
)-2H tetrazolium (MTS). A variant of the MTT compound, working along the
sample principles, but where the product is soluble, allowing in situ
measurements, without the need for media removal or a DMSO solubilisation
step. Of note, although this kit does draw attention to the need for media
colouration controls. Studies here suggest that reproducibility can only be
achieved using phenol red free media, not available for all cell lines.
Cell necrosis was recorded as per manufacturers instructions using the Tox7
LDH toxicology kit (Sigma-Aldrich).
2.3 SHH CULTURE REAGENTS
2.3.1 RECOMBINANT SHH PROTEIN
Recombinant Shh amino-terminal peptide (r-Shh) (R&D Systems, Abingdon,
UK) was obtained as a bulk stock to avoid batch variation such as endotoxin
contamination. The peptide is supplied in a PBS solution containing 50jig BSA
per 1^ig peptide, this was aliquoted and stored at -20°C. The peptide is derived
from a DNA sequence of mouse origin expressed in E. Coli and has a predicted
molecular mass of 20kDa and purity of greater than 97%. Using the LAL
method the manufacturer estimates endotoxin levels to be below 1.0 Endotoxin
Units per mg of protein, where the test has a maximum sensitivity of 0.001
Endotoxin Units. r-Shh activity is measured by alkaline phosphatase induction in
C3H10T1/2 cells, the ED of which is typically 0.6-3mg/ml. This peptide has
been shown to induce Shh specific responses in human, mouse, rat and chick
systems.
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2.3.2 5E1 ISOLATION AND PURIFICATION
The 5E1 antibody is produced by a hybridoma cell line derived from the fusion
of the NS1 myeloma line with cells taken from the spleen of a female Balb-c
mouse immunised four times with baculovirus expressed Rat Shh161. 5E1 is a
mouse lgG1 antibody which has been shown to have functional neutralising
function with chick, rat and mouse Shh protein. Mapping studies with human
protein have shown that it binds to the same residues as the receptor Ptc161,162
5E1 was purified from NS1 hybridoma line via the following method.
Supernatants were taken from the NS-1 hybridoma cell line when slightly yellow
and centrifuged several times to remove debris. Supernatant was then
concentrated via dialysis (Medicell International Ltd, London UK) on poly¬
ethylene glycol, then purified using Hi-Trap (Amersham Pharmacia Biotech)
columns according to the manufacturers instructions.
Briefly, the column was filled and flushed with 20mM phosphate buffer,
supernatant loaded (following pH adjustment to pH.7.2), column washed with
further phosphate buffer, then eluted with 0.1 M glycine-HCL, pH 2.7. Eluted
samples were then tested for protein concentration with the BCA protein
quantification kit and stored aliquoted in PBS at -20°C.
2.3.3 CYCLOPAMINE
Cyclopamine (Toronto Research Chemicals, Ontario, Canada) a Smo inhibitor
was initially stored aliquoted at 1mM in DMSO, but primarily in limulus
amebocyte tested : (endotoxin free) (LAL) water.
2.4 SONIC BIOASSAY
Two approaches, novel to this lab, were taken to determine the biological
activity of Shh. The first was a differentiation induction assay using the
C3H/10T1/2 cell line with Alkaline Phosphatase activity (ALP) used as a read
out. The second utilised the NIH-3T3 line for transient transfections with a
luminescent construct responsive to Gli activity. Neither of these methods
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reached final stage use, still being under development at the time of
submission. Thus the protocols described below are those which were found to
be the most successful, but where they are likely to require substantial
optimisation. Variations in protocol are discussed at greater length in Chapter 3.
2.4.1 C3H/10T1/2
C3H/10T1/2 cells were plated at 50000 cells per well in 10Opil of media with
charcoal stripped serum (Luke Eckersley, Manchester University, UK, personal
correspondence) in a 96 well plate, left five hours to adhere, then supplemented
with 100fxl of either r-Shh peptide (Sigma-Aldrich) diluted in medium or CMT cell
line supernatant, where Shh has been shown to induce ALP activity in these
cells.
Use of charcoal stripped media was suggested as a means of removing factors,
(lipid residues) from sera, which might interfere with Shh signalling, as previous
studies I had conducted, and those of Luke Eckersley had shown only marginal
differentiation of cells with r-Shh in normal serum containing media.
This cell density was selected to give around 60% confluence at the moment of
r-Shh exposure, reaching full confluence one day previous to the culmination of
the assay, 5 days later. Prolonged confluence of this cell line has been shown
to induce differentiation, thus further incubation of these cells would have been
counterproductive.
Medium was removed after 5 days and the cells washed, first in PBS, then
20mM Tris/0.15M NaCI (Sigma-Aldrich). Cells were then lysed through a 1 hour,
37°C incubation with 1M Diethanolamine/0.5mM MgCI2, p.H.9.5 (Sigma-
Aldrich). ALP activity in this lysate was then visualised using a 2mg/ml P-
Nitrophenyl phosphate (Sigma-Aldrich) solution for various times greater than
30 minutes and stopped with 25pJ of 3M NaOH per 10Optl reaction solution, and
read at 405nm. Cell lysates had their protein content quantified via bicinchonic
acid assay (BCA) kit (Pierce/Perbio, Northumberland, UK), and data presented,
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per minute, per mg protein. A Calf Alkaline Phosphatase (CAP) was used to
confirm substrate viability. See Figure 2.1.
CALF ALKALINE PHOSPHATE STANDARD
0 0.13 0.25 0.50 1.00 2.00 4.00 8.00
ml) of CAP per 100ul of Lysis Buffer
Figure 2.1: Calf Alkaline Phosphatase Standard Control Curve
2.4.2 GLI LUCIFERASE REPORTOR CONSTRUCT
This assay utilised two plasmid constructs, the Gli reporter plasmid: kindly
donated by Beachy et al (John Hopkins, School of Medicine, Baltimore) and the
pRL-TK control plasmid from Promega, www.oromeQa.com E2241 / EMBL
Accession no AF025846.
The Gli plasmid was shipped as a glycerol stock and consisted of an 8 fold
repeat of the Gli binding site inserted between Sac1 and Nhe1 cut sites in a
pGL3-basic plasmid which contains lactamase for Amp resistance selection and
firefly luciferase www.promeqa.com. See Figure 2.2
The pRL-TK control plasmid contains a Renilla luciferase under the control of
the Herpes Simplex Thymidine Kinase. This is used as both a transfection and
expression normalising control for the Gli plasmid. The plasmid can be used at
as low as 20:1 ratio, i.e. 1pg Gli reporter to 50ng Renilla control.
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k : lens crystalline minimal promoter (TATA)
SV40 polyA
The parent vector pGL3hasic is from Promega,
Information on pGL3b is available through their website.
Figure 2.2: Plasmid Map of Gli Construct
PLASMID SELECTION
The Gli reporter plasmid was amplified using E. coli cells grown in ampicillin
conditions. Briefly, Agar was prepared from 2.5g yeast, 50g tryptone, 5g NaCI,
7.5g agar, 500mls water containing 1 NaOH, pellet, autoclaved on the same
day. This was microwave heated, cooled slightly and supplemented with
ampicillin to "lOO^ig/ml, mixed and poured into plates, left to set for 1 hr then
stored overnight in the fridge, then placed upside down in an incubator to
remove condensation and to warm the agar. To an aliquot of 200pil competent
cells (XL1 blues), 0.5pJ of plasmid was added (personal communication Beachy
et al), incubated on ice for 1 hr, heat-shocked at 42°C for 30 seconds, then
incubated on ice for 2 minutes. 250[xl of room temperature Luria Bertanti (LB)
broth was then added and placed at 37°C on its side in a shaker for 1 hr. 10OfAl
was then spread per plate and left for 24hrs in an incubator to cultivate.
Colonies were then picked using a yellow tip to generate starter cultures. The
tip was dropped into 5mls of LB broth in a 50ml falcon tube taken from a stock
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prepared with 10 capsules (Sigma-Aldrich) in 500ml dH20, autoclaved, &
ampicillin added to 100[xg/ml. The tip was left in the tube, lid loosely closed and
placed in a 37°C incubator shaker overnight.
PLASMID ISOLATION AND VALIDATION
The plasmid was isolated and purified from 1.5ml aliquots of the starter cultures
by using the Promega Wizard plasmid DNA purification system, as per
manufacturer's instructions, and quantified using a UV visible
spectrophotometer Ultra-Spec2000 (Amersham Pharmacia Biotech, Little
Chalfort, UK).
Restriction digests were then performed to confirm plasmid isolation in each
starter prep isolate by using 1jxl 10xbuffer, 1pJ Nco1, 1 pil Kpn1, O.VI BSA, 1.9[xl
H20 and 5ptl of plasmid (total 1^ig), and visualised with orange G loading buffer
(BDH, Poole, UK) on a 2% agarose gel (Cambrex, Rockland, USA). The
desired insert was 28 + 4bp of overhang + 3bp to kpnl and 63bp to Nco1: total




For long term storage a glycerol stock of the starter culture containing the
greatest plasmid expression was prepared by adding 300|il of autoclaved
glycerol to 1 ml of culture, if repeated, the glycerol would be better made to 30%
and added as an equal volume for greater ease of use. Glycerol stocks were
maintained at -70°C.
PLASMID AMPLIFICATION
The high expressing starter culture was then diluted 1/500 into LB broth and
cultivated for 24hrs at 37°C with vigorous shaking. The cells were then isolated
by centrifugation at 6000g and re-suspended in buffer P1 of the endofree
plasmid maxi kit (Qiagen, Sussex, UK), and isolation proceeded according to
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manufacturers instructions. The sample was eluted in Tris EDTA (TE) buffer to
a concentration of 3.4mg/ml and aliquoted in 4pl aliquots at -20°C.
DUAL LUCIFERASE ASSAY
This method was still under optimisation at the time of thesis submission, thus
the method described is only an example of those tried, which varied with cell
density, concentrations of lipofectamine and reporter and control plasmids. The
duration, volume and concentration of samples added for analysis and culture
media used was also varied. Lipofectamine time and concentration were
determined by titration (see Chapter 3).
CELL TRANSFECTION
NIH-3T3 cells were plated at 2x105 cells per ml/1x105 per well in 24 well plates,
24 hours before transfection. Immediately prior to transfection, solutions A and
B were prepared:
Solution A: For each transfection, 2 pg of total DNA* was diluted into 100 pi of
serum-free medium (without penicillin/streptomycin (Invitrogen)) (*100ng Renilla
luciferase (stock 20pg) for every 2pg of firefly luciferase).
Solution B: For each transfection, 5pl of lipofectamine (1mg/ml) (Invitrogen)
reagent was diluted into 100 pi serum-free medium (without
penicillin/streptomycin (Invitrogen).
The two solutions were combined, mixed gently and incubated at room
temperature for 30 minutes to generate lipid-DNA complexes. 0.8 mis of serum-
free D-MEM without penicillin / streptomycin was then added to yield a 1ml final
volume. This solution was mixed gently and 250pl added to each well of NIH-
3T3 cells previously washed and aspirated with 2 ml of serum-free D-MEM
without penicillin / streptomycin. A minimum of two wells of non-transfected
control cells were maintained.
Cells were incubated with this solution for 5h at 37°C in a 5% C02 incubator.
This was then supplemented with 250pl of D-MEM without penicillin /
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streptomycin containing 20% calf serum, without removing the transfection
mixture. (Results with protocols using complete aspiration and replacement of
transfection mix, did not differ). Cells were incubated overnight and media
replaced with penicillin / streptomycin positive media prior to the addition of test
solutions.
APPLICATION OF THE BIOASSAY
Supernatants and r-Shh control solutions were administered at various times
post transfection, but most recently 24hrs after transfection. No difference was
observed in response with time of delivery.
Both Cyclopamine, a Smo inhibitor, and 5e1 an antibody capable of blocking
Shh binding, were incubated with solutions as specific negative controls. Shh
solutions with Cyclopamine were incubated together for 5-30 minutes prior to
addition, as were 5e1 Shh combinations. (Cyclopamine was stored aliquoted at
1mM in DMSO or limulus amebocyte lysate tested : (endotoxin free) (LAL)
water).
Passive lysis buffer from the Stop and Glow Dual Luciferase Kit (Promega) was
prepared by adding one volume to 4 volumes of distilled water. Media was then
removed from wells by gently washing in PBS. This must be completely
aspirated prior to the addition of the small 150^,1 volume of passive lysis solution
to avoid dilution. The wells were then placed on a rocker for various lengths of
time ranging from 20 minutes - 1 hour, where duration of lysis was found not to
affect luminescent readings.
The lysate material was then transferred to an Eppendorf tube (Eppendorf,
Hamburg, Germany), if protein quantification was required this sample was
centrifuged at maximum speed (approx 13,000g) in a refrigerated centrifuge for
30 seconds to clear the lysate and allow isolation of the protein containing
supernatant. If protein quantification was not required then no centrifugation
was performed. In this condition the luciferases are stable for at least 6 hours at
room temp, up to 16 hrs on ice and can be stored at -20°C short term or -70°C
long term.
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From this point forward the stop and glow kit protocol (Promega) was followed:
briefly 20pil of each cell lysate sample was transferred to the wells of a 96 well
cellstar plate (Greiner-bioone ltd, Gloucestershire, UK), 100pJ of Luciferase
Assay Reagent II (LAR II) added, mixed and read on a luminometer (Fluoroskan
Spectrometer / Luminometer (Labsystems, Cambs, UK)) with a 2 second pre-
read delay followed by a 10-second measurement period (extended to minute
long measurement periods in some studies, but with no effect). 100pJ of Stop
and Glow reagent was then administered, the plate shaken briefly and read,
again with a 2 second pre-read delay followed by a 10-second measurement
period (also extended to minute long measurement periods in some studies but
with no effect).
As a control for cellular luminescent noise non-transfected controls were also
lysed and read 3-4 times following both the LAR II and stop and glow additions.
Recent studies using a single purpose luminometer would suggest that the dual
luminometer / fluorometer used here, does not have the required sensitivity for
this assay. Future protocol optimisation with single purpose hardware may
improve detection with this assay.
2.5 ANIMAL TECHNIQUES
All mice used in this thesis were female Balb-c mice (B&K Universal, Hull, UK),
maintained in the MFAA animal facility at The University of Edinburgh Medical
School. All animal work was carried out with Home Office and local ethical
committee approval.
Avertin (Tribromoethanol anaesthetic) was used from a pre-prepared frozen
stock of ; 2.5g 2,2,2-tribromoethanol (Sigma-Aldrich), 5ml 2 methyl-2-butanol
tertiary amyl alcohol; (Sigma-Aldrich); made up to 200ml with dH20. FITC
solutions were prepared by suspending FITC powder (Sigma-Aldrich) at 3mg/ml
in sterile PBS with vigorous shaking.
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2.5.1 INTRATRACHEAL ADMINISTRATION
Following a two week acclimatisation period, mice were anaesthetised with
0.3ml of Avertin given intraperitoneal^. Each mouse was placed in a support
where the upper incisors were placed across a steel wire support, maintaining
the head at a 45° angle to horizontal, facing the researcher. A weighted string
was then looped around the bottom teeth to hold the mouth open, the tongue
pulled forward using curved forceps and the trachea visualised using a cold
fibre-optic light. A pipette was then used to dispense 50^il of a 3mg/ml FITC
solution (in PBS) or sterile PBS alone into the end of a blunted 25-gauge
needle, to which a 1ml syringe was then attached. The needle was then
inserted into the trachea of the mouse, and the syringe carefully depressed,
delivering the liquid into the lung. The mouse was then removed from the
support and laid on its side. Mice were monitored on a regular basis during their
recovery from the anaesthetic, where complete recovery generally occurred
within a couple of hours. Of the 120 mice used in this thesis only 4 failed to
survive to their appropriate time points, 3 of unknown cause, 1 from suspected
tracheal trauma.
2.5.2 LUNG EXTRACTION
The specifics of the lung extraction protocol differed according to the end
application of the tissue. The method used for the preparation of mouse lung
tissue for immunohistochemical analysis is described here. Derivations from this
protocol for specific applications are described subsequently.
Mice were dispatched using a lethal intraperitoneal injection of 0.5ml
pentabarbitone (Sagatal) (Merial Animal Health, UK). The peritoneal cavity and
neck were then exposed and a set of watchman scissors used to expose,
stretch and lift the trachea, which was then transected laterally using a fresh
scalpel. A blue needle covered in a 1 inch stretch of flexible tubing was then
inserted into the trachea for approx 2cm, and tied off mid cartilage ring via fine
suture.
0.5ml of saline was then inserted into the lungs and withdrawn for cytokines,
followed by a 0.8ml volume which was also inserted and removed for cellular
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material, pooled with the centrifugated component of the initial wash. The right
ventricle of the heart was then cut and a fine bore tube from a tapped tank of
PBS inserted under approximately 0.25 metres of header pressure. The swollen
atrium was then cut and clearing of the lungs facilitated by expanding them with
air via the tracheal intubation. The lungs were then excised and expanded with
formalin via the tracheal tube.
2.5.3 EPITHELIAL CELL ISOLATION PROTOCOL
This protocol has been used by others in the laboratory where studies have
shown that the majority of epithelial cells isolated are Clara Cells. The recipes
for the solutions used in this protocol are listed below.
Lungs were extracted as described previously (Section 2.5.2), but were
expanded with 0.8ml trypsin (Sigma-Aldrich) which is rapidly withdrawn. The
heart and lymph nodes were left attached to avoid the possibility of piercing the
lung during their removal. The lungs were then suspended in contact with 37°C
0.15M NaCI (Sigma-Aldrich) and reloaded with a syringe of trypsin solution
under natural gravitational pressure alone and left for 15 minutes, topping up
trypsin if required. The lung was then transferred to a Petri dish, where
connective tissues, heart and lymph nodes were removed and the remaining
lung parenchyma chopped into 1-2mm cubes using curved scissors in 1ml FCS.
The material was then transferred via wide bore transfer pipette to a tube and
supplemented with dissociation solution, approx 4ml/lung and gently swirled for
4 minutes. This solution was then pushed through 30pm gauze covered
syringes and a final volume of 4mls centrifuged at 32xg for 6 minutes at 10°C,
this was then removed and re-suspended in dissociation solution and re-
centrifuged. The pellet was then re-suspended in 3ml of attachment medium
and placed in a small Petri dish at 37°C 5% C02 for 1,5hrs, where cytospin
morphology would indicate that this extract is rich in alveolar macrophage,
fibroblasts and epithelial cells.
Following this attachment step, contaminating alveolar macrophage and
fibroblasts remained attached to the Petri dish and epithelial Clara cells could
be isolated as clumped balls of cells by gently rocking the dish. Epithelial cells
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were then counted (approximately) and transferred, via centrifugation to further
culture in a culture medium at 1x105 cells per ml, 10Opil per well in a 96 well
plate.
The solutions used in this protocol were prepared as follows:
DISSOCIATION SOLUTION
12.5mg DNase (Roche Diagnostics, Mannheim, Germany) (protects cell's) in
50mls of PBS without calcium or magnesium, containing 500^ig gentamycin
(Sigma-Aldrich) (inhibits 50s ribosomal unit of bacteria and mycoplasma) and
800[xg tylosine (Sigma-Aldrich) (acts against mycoplasma and Gram +ve
bacteria), filter sterilised, kept at RT and used fresh for each experiment.
TRYPSIN SOLUTION
65mg crystalline trypsin (type I) (Sigma-Aldrich) (endopeptidase) into 26mls
PBS with calcium and magnesium. Time was allowed for the reaction to
proceed prior to filter sterilisation, used fresh at 37°C.
ATTACHMENT MEDIUM
RPMI-1640, 2mM L-glutamine, 100U/ml penicillin/streptomycin, 60ng/ml
gentamycin.
CULTURE MEDIUM
RPMI-1640, 2mM L-glutamine, 100U/ml penicillin/streptomycin, 60fxg/ml
gentamycin and 2% Ultraser G (Ciphergen biosystems/Biosepra, Cal, US).
2.5.4 FIBROBLAST ISOLATION
As above, but the larger material retained from the gauze step was used for cell
isolation. Pieces were laid in approximately 7mls of medium in small (25cm3
growth area) filter top flasks pre-coated overnight at 4°C with type 1 collagen
(Sigma-Aldrich) at 5pig/cm2. A range of media were trialled including primary rat
fibroblast medium (Cell Applications, CA, US) and DMEM with and without FCS
and/or collagen coating [see Chapter 4 for the most advantageous conditions].
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Media were replaced 3 times in two hours after plating, then twice in the
subsequent 24hrs, then once every 48hrs. Of note not more than five fragments
could be placed in any one flask, as this resulted in significant necrotic death.
Outgrowing fibroblasts were trypsinated after 10-12 days.
2.5.5 T-LYMPHOCYTE DEPLETIONS
All depletions were performed by Steve Roberts et al prior to the initiation of the
work detailed in this thesis, only the block processing and immunohistochemical
staining procedures were conducted through the work here, but for reference
depletions were conducted as follows:
24hrs prior to FITC instillation according to the model one method (one surgical
instillation of 2mg/ml FITC in a 50pil volume of PBS, under halothane
anaesthesia), mice were given 40fig of the relative depleting antibody (listed
below), resulting in a greater than 50% depletion by 7 days as ascertained by
flow cytometry of both spleen and lymph node. The antibodies shown below
were grown from ECACC cell line stocks.
Cell Line Name Isotype Reactivity Principal Cell Type
YTS154.7.7.10 lgG2b Anti-Thy-1, Mouse T-lymphocytes
YTS169.4.2.1 lgG2b Anti-Lyt-2, Mouse CD8 T-Lymphocytes
YTS191.1.1.2 lgG2b Anti-L3T4, Mouse CD4 T-Lymphocytes
85060405 lgG2b Anti-Phytochrome Control Antibody
2.5.6 ALVEOLAR MACROPHAGE
BALf and AM were extracted in the manner described in Section 2.5.2.
However, in order to maximise AM recovery, where in vitro studies were
required in addition to cytospins, 5 separate washes of 0.8ml of saline
previously warmed to 37°C were used, where lungs were gently massaged with
blunt forceps. Isolates were pooled and kept on ice at all times to reduce
cellular activity and macrophage loss through adherence to the bijou. Saline
and saline + 0.2% BSA (Sigma-Aldrich) were used, but found not to affect AM
recovery. AM extracts were centrifuged at 300xg for 10minutes at 4°C and the
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resulting pellet re-suspended in F10 medium containing 20% FCS with cells at
7.5x104 cells per ml, 150pJ per well of a 96 well plate. Cell densities and media
FCS content were identified here by individual titre, where they were shown to
yield the greatest survival possible with a cell number high enough to yield
cytokine data in supernatants but low enough to facilitate the greatest number
of replicates per mouse.
Plated AM were left for 1-2 hours then media removed including contaminating
red blood cells, and replaced with medium containing 10% FCS. LPS (Sigma-
Aldrich) from E. coli 055:B5 used in activation studies was vigorously vortexed
prior to use and prepared in media immediately prior to addition or 10 minutes
before, when using Polymyxin (Sigma-Aldrich) treated medium. Polymyxin was
prepared as a 50mg/ml stock as per manufacturers instructions, and used by
adding 1fxl to 5mls media or 1jxl to LPS or Shh prior to its dilution to 5mls,
yielding a final concentration of 10ptg/ml, which has been shown by others to
give a 60-70% inhibition of LPS reactivity163.
2.6 COLLAGEN ASSAY
Based upon information derived from personal communication with the
producers of the Biocolour™ collagen estimation kit (Biocolor Ltd,
Newtownabbey Nl) and a number of references, the following protocol was
devised and optimised.
Lungs were removed as described previously, but the BALf was collected in,
and lungs transported with, PBS containing a proteinase inhibitor cocktail
(Roche). Lung tissue was cut into small pieces in a Petri dish and excess liquid
pressed out and material weighed in a bijou. Material was then transferred to
(1ml per 100mg) 0.5M glacial acetic acid (Sigma-Aldrich) containing (1ml in
100ml) peptidase inhibitor (Sigma-Aldrich).This material was then briefly
vortexed, then left rotating at 4°C for 24hrs. Material was then centrifuged at
maximum speed (approx 800g) in a refrigerated centrifuge for 5 minutes, and
150ptl of supernatant transferred to Eppendorf tubes. To this supernatant
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aliquot, 1ml of dye reagent was added. This was inverted twice, then tubes
loaded into 50ml tubes and placed on a roller at room temperature for 35
minutes. Samples were then removed from the 50ml tube and centrifuged at
maximum speed (approx 10,000g) for 12 minutes in an ultrafuge. These were
then inverted on paper towel to remove supernatant and excess liquid from
inside the tube using cotton buds. To these tubes 1ml of Alkaline reagent was
then added, the tube capped and vortexed repeatedly. This was left to stand for
5 minutes prior to reading in a spectrometer or plate reader at 540nm, then
calibrated to a linear collagen standard curve.
24hr lysates were also assessed for total protein content using the BCA protein
assay as per manufacturers instructions, and collagen results given as a value
of total protein.
2.7 ELISAS & CYTOMETRIC BEAD ARRAYS
2.7.1 SHHELISA
In this novel ELISA, further discussed in Chapter 3, Shh levels in plate bound
cell supernatants and BALf were quantified through the use of two antibodies,
the 5E1 antibody mentioned previously and a biotinylated goat anti-mouse IgG
antibody (R&D). The latter had been preabsorbed with human IgG and rat
serum.
In this assay samples were bound to high binding Enzyme ImmunoAssay (EIA)
plates (Corning-Costar) with a 1:1 dilution in carbonate-bicarbonate buffer
(Sigma-Aldrich). These were measured against an 8 point standard curve of r-
Shh (R&D Labsystems), which was made in one part culture medium, one part
carbonate-bicarbonate (Sigma-Aldrich), with a top standard of 200ng/ml. All
standards and samples were loaded in 50^il volumes per well and incubated
overnight at 4°C.
Unless stipulated, all subsequent steps are separated by wash steps (full well
volumes x5) using 0.005% Tween 20 (Sigma-Aldrich) in PBS (Oxoid, Hamps,
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UK), where the final wash step was banged out on a flat surface covered in
absorbent towelling. Recipes for diluting fluid and block buffer are given below:
BUFFERS
Diluting Fluid:(0.1%BSA, 0.05%Tween-20 (Sigma-Aldrich) (pH7.2-7.4 & 0.2|j,m
filtered (Corning-Costar)
Block Buffer: (1%BSA (Sigma-Aldrich), 5% Sucrose (Sigma-Aldrich), 0.05%
Azide (Sigma-Aldrich))
Plates were washed, then blocked for 2 hours at room temperature with 300pil
per well of block buffer. Plates were then washed again and 5E1 added at
640ng/ml in diluting fluid, also 50pil per well and incubated at room temperature
for 2hrs. Plates were then washed, and a 50pil volume of biotinylated goat anti-
mouse IgG antibody added to each well, at 250ng/ml in diluting fluid. This was
also incubated for 2hrs at room temperature. The biotinylation signal was
developed and visualised using a streptavidin/substrate system whereby,
following a wash step, 50pil of streptavidin (R&D) (diluted 1 in 200 in diluting
fluid) was delivered to each well for 20 minutes at room temperature, followed
by washing and 50pJ of 3,3,5 tetramethylbenzidine (TMB) (Sigma-Aldrich) or
substrate A&B (R&D) for 25 minutes or appropriate timing at room temperature.
This process was stopped (without a wash step), with the addition of 25jxl of 2N
H2S04 (Sigma-Aldrich).
All ELISA data were recorded on Dynex or Anthos 2001 plate readers (Dynex
technologies, Sussex, UK / Anthos Labtech Instruments, Wals, Austria), using
Revelation / Stingray software respectively at a wavelength of 450nm, with a
subtracted reference at 560nm or 650nm.
2.7.2 SERUM ELISAS
ELISAs for FITC specific serum antibodies were developed from a template of
concentrations used in a DerP1 specific ELISA. All volumes are 50^il with the
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exception of blocking (300^1) and stop solution (25[xl). Wash steps were
performed between steps, as for the Shh ELISA with PBS/0.05%Tween20.
BUFFERS
Diluting Fluids: 1%BSA in PBS for IgG ELISAs, PBS-Tween for IgE ELISAs.
Streptavidin dilutions were always performed in PBS, plate coating always
performed in 0.05M carbonate buffer (Sigma-Aldrich).
Blocking Buffers: 3% BSA in PBS for IgG ELISAs, 5% BSA in carbonate buffer
for IgE ELISAs.
IgGi SPECIFIC
High binding EIA plates were bound overnight at 4°C with 125ng/ml
FITC/BSA(Sigma-Aldrich), 50pJ per well. This was washed and blocked for 1 hr
at 37°C. Blocking buffer was washed off and 50^il samples volumes added per
well from 1:3 serial dilutions of samples performed in a separate non-binding
flexi plate. Samples were incubated for 1 hr at 37°C. Plates were then washed
and a 1 in 8000 dilution of biotinylated rat anti-mouse lgG1 (Serotec-MCA336B)
administered for 1 hr at room temperature. Following a wash step the ELISA
was developed and visualised using a 1 hr room temperature 1 in 200
streptavidin addition, and a 25 minute room temperature TMB incubation,
stopped with 2NH2S04 for 450/560nm quantification.
lgG2 SPECIFIC
High binding EIA plates were bound at 4°C overnight with 125ng/ml FITC/BSA
(Sigma-Aldrich). These were washed and blocked for 2hr at 37°C. Block was
then thrown without a wash step and 1:3 serial dilutions of samples
administered as described above. Samples were incubated for 1 hr at 37°C.
Washing was followed by addition of a 1 in 1000 dilution of biotinylated rat anti-
mouse lgG2a (PharMingen, San Diego, CA) administered for 1 hr at 37°C. This
ELISA was then developed and visualised as for the lgG1 ELISA.
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TOTAL IGE
High binding EIA plates were bound at 4°C overnight with 2^ig/ml mouse anti-
IgE [clone 35-74] (PharMingen). This was thrown out and blocking buffer
administered for a 2hr incubation at 37°C without an intervening wash step.
Plates were then washed and serially diluted samples administered as
described for IgG ELISAs. These were quantified against an 8 point standard
curve of purified mouse IgE [Clone 27-74] (PharMingen) with a top standard of
500ng/ml. Samples and standards were incubated for 1 hr at 37°C, prior to
washing and administration of 2pig/ml biotinylated mouse anti-lgE [clone R35-
118] (PharMingen) detection for 1 hr at 37°C. This ELISA was developed and
visualised using a 1 hr Room temperature incubation of a 1 in 200 dilution of
Streptavidin, a wash step, followed by a 5 minute room temperature TMB step,
stopped with 2NH2S04 for 450/560nm quantification.
FITC SPECIFIC IgE
Samples were IgG depleted using fast flow protein G (Amersham) once for 30
minutes at room temperature and for a second time overnight at 4°C to ensure
complete depletion. Beads were used at the maximum concentration possible
where an 85pl pellet of beads was resuspended to 10Opil. This was added 1:1 to
a 1:4 dilution of sample. Beads were recycled using 5-10 centrifuged washes in
0.1 M glycine buffer (pH2.5-3) followed by 5-10 centrifuged washes in 20mM
sodium phosphate as per manufacturer's instructions.
High binding EIA plates were bound at 4°C overnight with 125ng/ml FITC/BSA
(Sigma-Aldrich), with a control plate coated with 4pg/ml Der P1. This solution
was then thrown and block administered and incubated for 2hr at 37°C, without
the intervening wash step. Serially diluted samples were then administered as
discussed previously, and incubated overnight at 4°C. Control samples included
a depleted DerP1 exposed allergic mouse sera as a positive control.
Following a wash step, 50pil per well of 4^ig/ml biotinylated mouse anti-lgE
[clone R35-118] (PharMingen) was administered and incubated for 1 hr at 37°C.
This was developed and visualised using a 1 hr room temperature incubation of
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a 1 in 200 dilution of streptavidin, and TMB stopped with 2NH2S04 at a suitable
time interval for 450/560nm quantification. In the case of samples analysed
here, DerP1 controls came up rapidly within minutes whilst preservation of FITC
IgE plate up to 1 hr post addition of substrate did not result in any detectable
signal.
2.7.3 DUOSET KITS
Duoset ELISAs for GM-CSF, TNF-a and TGF-p (R&D) were performed as per
manufacturers instructions, but with all volumes halved from 100^1 to 50^,1
except, block buffer. Samples were added as 1:1 dilutions. Both total and active
TGF-p were analysed with the specified ELISA.
2.7.4 CYTOMETRIC BEAD ARRAYS
Two kits were used in the work contained in this thesis, namely the mouse and
the human inflammation kits (BD Biosciences/PharMingen). The human kit
contained antibodies to IL-8, IL-113, IL-6, IL-10, TNF-a & IL-12p70. The mouse
kit contained antibodies for TNF-a, IL-12p70, IFN-y, MCP-1, IL-10, IL-6. Kits
were prepared as per manufacturers instructions and run on a Becton Dickinson
FACS Caliber flow cytometer, with the exception that all volumes were halved
and bead to mastermix calculations performed as a division of total volume by
total number of beads rather than suggested set volume of each bead. This
reduced excess bead wastage maximizing the number of samples run per kit.
2.8 IMMUNOHISTOCHEMISTRY
Mouse lungs were fixed in buffered neutral formalin for 48hrs prior to processing
and embedding in paraffin wax. Blocks were stored at lab temperature out of
direct light. Sections for immunohistochemistry were cut at 3^im thickness on a
microtome and floated at 42°C prior to mounting on superfrost slides (BDH,
Poole, UK). Slides were incubated overnight at 37°C, then stored at room
temperature away from direct light.
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Protocols varied with antibody utilised. The common core protocol is described
below and variations from this are described under specific antibody headings.
Formalin fixed paraffin embedded sections were prepared for
immunohistochemistry by dewaxing in xylene (Genta Medical, York, UK), where
slides were submerged for 2x5minutes, followed by 1 minute submersions in
100%, 70% & 50% methylated spirit (Genta Medical) for serial rehydration to
water. From here slides underwent antigen retrieval with antigen unmasking
solution (Vector, CA, USA) where 5mls is added to 500mls of water in a plastic
container, slides are then submerged and microwaved on full power for 3x5
minutes. Slides were then cooled for 20 minutes in flowing tap water. This was
then followed by a peroxidase blocking step, where slides were incubated in a
2% FI2O2 solution (Sigma-Aldrich) for 15 minutes, then washed in PBS for 2
minutes.
Slides were then loaded into sequenza coverplate clips (Thermo Shandon,
Cheshire, UK), which allow use of small 125|jJ volumes to cover sections
through utilisation of capillary action across the surface of the slide. Reagent
deliveries to these clips were separated by two to three full PBS washes.
Once the sequenza was loaded, slides were biotin and avertin blocked using a
Vector kit. Three drops of each (approx 125pil) were applied for 15 minute room
temperature incubations, separated by PBS wash steps. This was then followed
by the specific primary and secondary antibodies, where secondaries where
biotinylated. Bound secondary was visualised with RTU Vectorstain (Vector) for
30 minutes at room temperature, followed by use of the diaminobenzidine
(DAB) chromogen development systems (Dako Cytomation, CA, USA), where 1
drop of concentrate was added per ml of supplied buffer and administered to
sequenza for 5 minutes at room temperature. Slides were then counter stained
in haematoxylin (ShandonAThermo) for 5 seconds (to stain the nucleus) and
rinsed in tap water for 5 minutes. This was followed by submergence in Scot's
tap water (Sodium bicarbonate 17.5g, magnesium sulphate 100g (Sigma-
Aldrich), five litres of water) for 1 minute. Slides were then rinsed in tap water
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and dehydrated through three alcohols and three xylenes, 1 minute each, prior
to cover slip addition with DPX mountant.
Cell culture immunohistochemistry was performed in NUNC culture cover slides
(Nalge Europe Ltd, Hereford, UK), or on superfrost slide cytospins fixed in 90%
dry acetone, 10% methanol (Fisher Chemicals, Leistershire, UK). Cytospins
were loaded directly into sequenzas. Coverslide cultures were not amenable to
sequenza, so immunohistochemical analysis was performed in wells using
various volumes per well, most frequently 250pl.
2.8.1 SHH&PTC
Goat polyclonal anti Shh (N-19) & Ptc (C-20) antibodies were supplied by Santa
Cruz (Delaware, CA, USA) (Stock 200ng/ml). N19 was raised against an N-
terminal Shh peptide of human origin which was identical to the corresponding
region of the mouse sequence. The antibody has been shown to detect mouse,
rat and human Shh protein. C-20 was raised against a carboxy terminal Ptc
peptide of human origin which differed from the corresponding mouse sequence
by one amino acid. This antibody has been shown to detect mouse, rat and
human Ptc protein. Positive binding was detected through the use of a
biotinyated rabbit anti-goat secondary (Dako Cytomation) raised against goat
serum antibodies (primarily IgG) and preabsorbed with human serum. Relevant
cross reactants as determined by ELISA (Dako technical, personal
communication) include: human immunoglobulins <1%, FCS <2%, mouse and
rat immunoglobulins 25%.
Slides had non specific antibody binding blocked with protein block (Dako
Cytomation Glostrup, Denmark) for 10 minutes. Primary antibodies were added
in a 1 in 30 dilution in Antibody Diluent (DAKO Cytomation) (with the exception
of blocking studies and Nunc coverslide applications(see Chapter 3)). These
were incubated in sequenza overnight at 4°C. Following a 30 minute period of
room temperature acclimatisation, slides underwent a 30 minute incubation with
a biotinyated rabbit anti-goat secondary at a 1:400 dilution in Dako Diluent.
Specificity was checked via pre-incubation studies with commercial blocking
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peptides consisting of the relevant peptide immunogen as described above
(100pig/ml) (Appendix Figure 7.2).
2.8.2 FITC
Rabbit Polyclonal anti-FITC antibody (Dako Cytomation) was stored at -70°C in
a 1:1 dilution in normal goat serum, this was utilised at a final dilution of 1 in 250
in Dako diluent. Antibody incubation was limited to 30 minutes at room
temperature followed by administration of a biotinylated goat anti rabbit
secondary (Dako Cytomation) diluted 1:300 in Dako Diluent for 30 minutes at
RT. Specificity is illustrated by negativity on PBS instilled and normal lungs and
positive binding on FITC instilled lungs.
2.8.3 CC10
The antibody used in CC10 IHC is derived from a rabbit immunised against
urine protein 1 from pooled urine (tubular proteinuria). This protein has
significant homology with rabbit uteroglobin and with human Clara cell protein.
Slides had non specific antibody binding blocked with protein block for 10
minutes. Rabbit polyclonal anti-CC10 antibody (Dako Cytomation) was used at
1:300 in Dako diluent for 2hrs at RT. This was followed by a RT 30 minute
detection step with biotinylated goat anti-rabbit secondary detection (Dako
Cytomation) diluted 1:300 in Dako Diluent.
2.8.4 GLI
Gli1 staining was performed on human lung sections using an IgG polyclonal
rabbit anti-Glil preparation from Abeam. This antibody was raised against
synthetic peptide corresponding to the carboxy-terminal region of mouse Gli1.
This antibody has shown to be reactive with both human and mouse protein and
activation of the protein is marked through a transition from cytoplasmic to
nuclear staining. Positive binding was detected with a biotinylated goat anti
rabbit antibody (Dako) derived from goats immunised with rabbit serum
immunoglobulins. The antibody reacts with all known classes of rabbit
immunoglobulin. Human cross reaction is minimal. Specificity has been
illustrated with mouse tissues through the staining of Gli1 knockout tissues, and
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positivity in mouse and human through staining of glioma, a pathology
associated with upregulated Gli1 expression.
Slides had non specific antibody binding blocked with protein block for 10
minutes. The Gli antibody was added in a 1 in 400 dilution in Antibody Diluent
These were incubated in sequenza overnight at 4°C. Following a 30 minute
period of room temperature acclimatisation, slides underwent a 30 minute
incubation with a biotinyated goat anti-rabbit secondary at a 1 in 300 dilution in
Dako Diluent.
2.8.5 SPECIALIST STAINS
Standard Haemotoxylin and Eosin (H&E) staining for nucleus and cytoplasm
visualisation was performed by dehydrating sections as described previously,
followed by submergence for 1 minute in haemotoxylin (Shandon/Thermo). This
was followed by 5 minutes in running tap water then 1 minute in Scot's tap
water, followed by another 5 minute tap water step. Slides were then
submerged in acidified Eosin (Solmedia, Romford, UK) for 30 seconds, followed
by rapid dehydration through an alcohol series to xylene and DPX mountant.
This staining regime results in sections where individual cells have their nucleus
stained dark purple and the cytoplasm pale pink and is commonly used to
differentiate cell types by nuclear shape and overall morphology .
The Picrosirius stain also utilised in this thesis illustrates areas of collagen
deposition in pink. For the purposes of work in this thesis this stain was also
combined with fast green which stains cellular cytoplasm green, but is hence
forth refered to inclusively as picrosirius stain.
The silver trichrome staining method also employed in this thesis stains nuclei
red and connective tissue green. The advantage of the trichrome method is that
it is qualitatively more sensitive to low level increases in connective tissue
deposition, however cytoplasmic and connective tissue staining can become
easily confused in areas of collapsed lung architecture. In these situations the
distinct and bright pink staining of collagen in the Picrosirius stain allows
immediate recognition of areas of fibrosis and the intensity of staining can be
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proportional to the extent of fibrosis such that, in some solid tissue systems, this
stain has been used with computerised microscope systems to quantify levels
of fibrosis.
Trichrome and Picrosirius stains were performed in the Pathology Dept, R&D
lab, Royal Infirmary of Edinburgh. Others such as Giemsa and Methyl green are
discussed in Section 2.12.4.
2.9 SCORING TECHNIQUES
2.9.1 ASHCROFT
Based on the scoring system devised by Ashcroft et al in 1988164, this system
apportions numerical scores to randomly selected microscope fields. Ashcroft et
al proposed the following scale of damage to apply to over 50% of the tissue
within a field excluding main airways, blood vessels and inflammatory exudate
in air spaces. The original study examined human disease biopsies at x10
magnification. To adjust for the difference in size between human and murine
acini we use x40 magnification. This method has been used by several other
groups to assess murine lung fibrosis165,166.
To allow for differences between FITC+ve and FITC-ve areas of the lung
sections stained with anti-FITC antibody were used for scoring. A field was
considered FITC+ve if over half the tissue within the field stained and negative if
less than half the field stained.
As proposed by Ashcroft et al the damage was assessed by assigning fields to
an odd number on their scale and only using even numbers if it was difficult to
decide between two odd numbers (Table 2.1).
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Grade of Histological features
fibrosis
0 normal lung
1 minimal fibrous thickening of alveolar or bronchiolar walls
2
3 moderate thickening of walls without obvious damage to
lung architecture
4
5 increased fibrosis with definite damage to lung structures
and formation of fibrous bands or small fibrous masses
6
7 Severe distortion of structure and large fibrous areas:
honeycomb lung is placed in this category
8 Total fibrous obliteration of field
Table 2.1: Ashcroft Scoring Criteria
36 FITC+ve and 36 FITC-ve fields were assessed as this was in the middle of
the range of field numbers proposed by Ashcroft et al and also covered nearly
the entirety of the biopsy when proceeeding from one outside edge in non-
overlapping rows across the section. Some areas where there was poor or over
inflation [usually at lobe margins] were ignored. The sections were assessed on
a multi-header microscope and a consensus number was reached between two
observers for each field. The median score for fibrosis was determined for both
FITC+ve and FITC-ve areas and the group mean established. An example of





Figure 2.3: Ashcroft Scoring Illustrations




Scoring peripheral lung inflammation was done on an H&E section at x200
magnification scoring 10 consecutive fields where the lungs were correctly
inflated and where the field contained a complete transection of at least one
bronchiole less than half a field width in diameter and blood vessel as well as an
alveolar airway. The lungs were all perfused and lavaged before fixation thus no
comment can be made on the infiltrate in alveolar airspaces. Inflammation was
scored in:
— The perivascular compartment as:
o 1= no infiltration, 2= <20, 3= <100 and 4= >100 cells around blood
vessel walls
— The bronchiolar epithelium as:
o 1= no infiltration, 2= <5, 3= <10 and 4= >10 cells in the
bronchiolar epithelium
— The peri-bronchiolar alveolar tissue* as:
o 1 = no infiltration, 2= <20, 3= <100 and 4= >100 cells in the peri¬
bronchiolar alveolar tissue
— The alveolar walls as:
o 1 = no infiltration, 2= focal cellular expansion of the alveolar walls
by 2-3 cells, 3= by 4-5 cells, 4= >5 cells
* Peri-bronchiolar alveolar tissue was defined as sub-bronchiolar tissue,
beneath basement membrane and smooth muscle, not immediately adjacent to
a blood vessel, i.e. cells have moved away from the perivascular compartment
presumably along a chemoattractant gradient.
The worst score in each compartment per field was used to set the score for
that field. For each field a combined score was given which equalled the sum of
all the scores on the field, this was averaged for the 10 fields per section.
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2.10 PROTEIN EXTRACTIONS
Protein extraction methods were varied according to tissue type and final use of
the extract, i.e. a variety of extraction buffers were used for cell line lysates for
westerns, but only a few of these proved to be compatible with the BCA protein
assay kit.
For cell line and brain protein extractions (embryonic and adult) the following
Sigma-Aldrich components were prepared on ice:
Tris HCL pH 7.5 1M 5ml
Sucrose (Final Cone 0.32M) 10.9g
EDTA 0.5M pH 8 (Final Cone 1 mM) 0.2ml
10x Proteinase inhibitor cocktail 1 ml
PMSF 10pJ
with water to 10Omls
Cellular material in this lysis buffer (approx 106 cells in 200^1) was sonicated on
ice for 1 minute in 5 second bursts. Brain tissue was first homogenised in a 1 ml
glass homogeniser (Uniform, Jensons, UK) on ice with an average of 50 strokes
per 1ml
For protein extraction from lungs inflated with OCT™ (Sakura Finetek Europe,
Zoeterwoude, Netherlands) and snap frozen in liquid nitrogen (See Section
2.12.2), the following was used:
0.1% Triton-X (Sigma-Aldrich) 10pl
0.1 mM Sodium Orthovanadate (Na2V04) (Sigma-Aldrich) 5pJ
Proteinase Tablet (Roche Diagnostics) x1
with water to 10mIs
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2.11 RNA EXTRACTIONS
With the exception of trials of using trizol (invitrogen) extraction (as per
manufactures instructions) RNA isolations were performed using Qiagen kits
(Qiagen Ltd, Sussex, UK), both mini (for cell line and tissue extractions) and
micro (for laser microdissection) as per manufacturers instructions. Qiagen's
Qishredders were also used throughout for mini kit isolations, although recent
studies would suggest that they are an unnecessary step for cell culture
isolates. Low concentration studies would also suggest that the Qiashredder
columns reduce final RNA yield (data not shown).
Culture well lysates were prepared by adding RLT (including 2-
Pmercaptoethanol (Sigma-Aldrich)) to PBS washed cells, removing to an
Eppendorf tube, and freezing at -70°C. Volumes used were dependent on cell
number, but on average 110pil per 24 well plate well. This allowed for the
pooling of three wells to approximately 330^1, thus when an equal volume of
70% alcohol is added the total volume does not exceed that of 700^1, the
maximum loading volume of the Qiagen columns. All procedures used the
option of on column DNA digestion. Minikit elution's were performed in 30[xl-
40pil, micro in 14pil.
Isolation of RNA from whole tissue was varied according to tissue type and
condition. RNA extractions from adult and embryonic brain were performed in
glass micro-homogenisers in RLT prior to extraction via Qiagen mini kits as per
manufactures instructions. Larger fresh tissue such as lung was processed
using Trizol, whilst formalin fixed material, for use as a control in laser
microdissection was processed using RLT.
2.11.1 RLT TISSUE EXTRACTION
Formalin fixed human lung tissue was used in a preliminary attempt to develop
a real time standard curve. RNA was extracted in two ways, freeze shattering
and physical abrasive separation. Material was first processed as normal to
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remove formalin, then removed prior to wax embedding and either frozen at -
70°C or used immediately, see below.
FREEZING
Frozen formalin fixed materials were transferred to a metal strainer, and
submerged in liquid nitrogen, these were then crushed with a compression gun
(Biospec Products Inc, Bartlesville, OK, USA) (pre-cooled with isopropanol on
dry ice) into small pieces, which were transferred to RLT for overnight
incubation with proteinase K as for microdissected material (See Section
2.12.5).
PHYSICAL DISSOCIATION
Material transferred directly to a metal strainer following processing was
chopped into small pieces and pushed through in 4mls of RLT with the end of a
syringe. Material transferred to a cell culture sieve was pushed through, then
material was frozen for storage or immediately incubated overnight with
proteinase K as with microdissected material.
2.12 LASER CAPTURE/CATAPULT METHODS
The techniques used in the preparation, isolation, processing and analysis of
section material have all been optimised and developed in this thesis. Protocols
described here represent the most recent ones used, a more extensive
discussion ascertaining to their development can be found in Chapter 5.
2.12.1 MATERIALS
WATER
RNase free water was generated by adding 1ml of Diethyl Pyrocarbonate
(DepC) enzyme (Sigma-Aldrich) to 100mls of distilled water, and incubated
overnight in a non-pressurised container, protected from light. This was then
autoclaved to inactivate the enzyme and sterilise the water.
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Scot's tap water was prepared using 250mls of RNase free water with 0.875g of
Sodium bicarbonate and 5g of MgS04.
GLASSWARE
All glassware was baked in foil at 220°C for 40 minutes, whilst more perishable
items were washed in RNase removing solutions (Ambion, Huntington, Cambs,
UK & Sigma-Aldrich) and rinsed in nuclease free water.
DISSECTION SLIDE PREPARATION
Superfrost slides were used in Laser Capture Microdissection (LCM) studies
and are supplied RNase free. Laser Pressure Catapult (LPC) studies used
membrane coated microscope slides (PALM, Bernried, Germany) which were
prepared as follows:
Slides were sprayed with a complete coverage of RNase zap (Ambion) and
were transferred to a plastic sealed holder (5 per box). Two further sprays were
then applied, and the box sealed and inverted several times. This was then
washed out with RNase free water, several times. Slides were then dried for 30
minutes at 37°C in a sealed silica gel (BDH) container, then exposed to UV at
(254nm) for 30 minutes. This kills any enzyme activity on the slide and makes
the membrane adhesive, ready for section floating and mounting as described
previously, but with RNase free water.
2.12.2 FROZEN LUNG SECTIONS
Lungs were removed as described previously, but final inflation was performed
with an optimised ratio of 1:1 of OCT & Saline. These were then transferred to a
foil cup and under maintained pressure / inflation, the cup was filled with OCT.
This was then placed directly into liquid nitrogen.
Lungs were cut at 10^m on a cryostat (Bright, Huntingdon, UK) either onto -
20°C superfrost slides for visualisation, or placed directly into Eppendorf tubes
for RNA extraction. Frozen mounted sections, were air dried for 20 seconds
prior to fixation in -20°C 70% ethanol for 5 minutes. These were then removed
and air dried for up to 30 minutes. Slides were then taken to Dep-C treated
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water for 30 seconds then fresh Dep-C treated water for a further 30 seconds to
remove OCT prior to staining.
2.12.3 FORMALIN FIXED LUNG SECTIONS
Mouse lungs were fixed in buffered neutral formalin for 48hrs prior to processing
and embedding in paraffin wax. Blocks were stored at lab temperature out of
direct light. Formalin sections were cut at various thicknesses using a
microtome sprayed with RNase away and rinsed with RNase free water. Blocks
were cooled on RNase free ice prior to cutting.
SLIDE MOUNTING
Sections were floated on 42°C RNase free water for 1-2 minutes prior to slide
mounting. For LCM studies, slides were mounted as standard and stored in a
silica gel box at various temperatures (see Chapter 5) for 1 Hr-overnight prior to
dewaxing (see 2.12.4).
For LPC studies the section was mounted onto the membrane slide and
incubated overnight at 37°C in a silica gel box, prior to dewaxing (see 2.12.4)
2.12.4 STAINING METHODS
Preparatory steps for staining differed according to type of dissection, material
and stain. Frozen sections could be stained directly following OCT removal with
water, whilst embedded material required dewax/rehydration.
LCM was conducted using sections mounted on normal superfrost slides, which
were dewaxed for 2x5minutes in xylene then approximately 1 minute in each of
the descending alcohols of 100%, 95% 75% and 50% then to water for 2
minutes, optional staining then dehydration through alcohols to a 10-15 minute
xylene incubation.
LPC membrane slides were found to undergo significant degradation with
prolonged xylene exposure, thus dewax steps were restricted through the
course of the work presented here to 2x2minutes with agitation. Recent studies
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(data not included in this thesis) have shown that Histoclear™ (National
Diagnostics, Hull, UK) is an excellent alternative to xylene, dewaxing without
lifting. Rehydrating alcohol steps were as above, but performed in Falcon tubes.
These slides were not dehydrated previous to catapulting owing to the solubility
of the Giemsa stain in alcohols.
METHYL GREEN (Dako)
Slides were submerged for 2-5 minutes, rinsed in nuclease free water then air
dried at RT in an RNase free box with silica gel.
H&E (Sigma-Aldrich)
Slides were submerged for 3 minutes in Mayers haematoxylin (Sigma) followed
by 3 minutes in RNase free Scot's tap water. Slides were transferred to eosin
(pre-acidified with glacial acetic acid 250jal to 50mls) for 1 minute, then quickly
run through increasing ethanols. Slides were then air dried at room temperature
in an RNase free box with silica gel for LPC, or via submergence in a xylene
series for LCM.
GIEMSA (BDH)
Slides were covered for 1 -2 minutes and staining checked by washing slide in
DepC water and looking under microscope. If over stained, slides were de-
stained in alcohol. Water was then used to rinse slides, which were then air
dried and transferred to a silica gel box
2.12.5 LASER MICRODISSECTION DIGESTION BUFFERS
A number of different buffers were used for the digestion of frozen and formalin
sections and dissected material. The three main ones trialled are detailed
below:
— PALM buffer (All Sigma-Aldrich)







— RLT buffer (Qiagen)
o +/- pmercaptoethanol 10pl/ml as per manufacturers instructions
— Cells to cDNAII lysis buffer (Ambion)
The above recipes correspond to frozen digests, for formalin fixed samples
PALM and RLT buffers were supplemented with 10pJ of proteinase K and
incubation times varied from 10 minutes to 5 days, see Chapter 5.
Digestions performed using the Ambion cells to cDNA II kit and paraffin block
kits (Ambion) were done as per manufacturers instructions. A failure to produce
viable RNA resulted in supplementation of lysis buffer (which already contains
proteinase K (personal correspondence)) with 2-3 times more proteinase K.
Incubation times were also varied from 10 minutes to 4hrs. These kits are
effectively very similar in methodology, differing only in that the paraffin block kit
contains xylene and alcohol reagents. These kits differ from conventional
methods in that RNA is not purified and that the reverse transcription is
performed on crude lysate (via Murine Moloney Leukaemia Virus enzyme). PCR
is then conducted with 10xSuper Taq (Enzyme Technologies Ltd, Cambridge,
UK) as per manufactures instructions. The kits are supplied with
oligonucleotides and random decomers. The majority of studies used decomers
as they gave the greatest electrophoresis band intensity from low concentration
cell line control RNA samples.
2.12.6 PROCESSING OF PARAFFIN EMBEDDED BIOPSY MATERIAL
WHOLE SECTIONS
Cut section material was stored in 1.5ml Eppendorf tubes at room temperature
in darkened conditions. Prolonged storage has been shown to have no effect on
viability for up to six weeks of storage. Further storage duration has not been
analysed.
Material was centrifuged for 2 minutes in an ultrafuge at maximum speed to
pellet and 1 ml of fresh xylene added to each tube. Samples were inverted to
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mix and left at room temperature for 10 minutes. This was then spun for 1
minute in an ultrafuge at maximum speed. The supernatant was then carefully
pipetted off and 1ml of molecular grade 100% ethanol added (Sigma-Aldrich).
This was inverted to mix, then spun in an ultrafuge for 1 minute on maximum
speed. The supernatant was again pipetted off and this was repeated for 70%
and 50% ethanol additions, completing with 1ml of DepC water, which was
ultrafuged for 3 minutes on maximum speed. This supernatant was then
carefully pipetted off and another 1ml added and centrifugation repeated prior to
the addition of 150pl of RLT (containing 2-pmercaptoethanol, 295^1 DepC
water and 10 pil proteinase K) to each tube. The Tube was then shaken to
ensure complete submergence of material and incubated overnight in a shaking
incubator at 55°C. Following this period the sample was either frozen at -70°C
or applied to the Qiagen RNeasy Microkit as per manufacturers instructions.
Notably, use of the Qiashredders here was found to reduce yield, thus these
were excluded, where normal cell lysate and tissue extractions included them.
LASER DISSECTED MATERIAL
For laser capture, twice autoclaved RNase free 'safelock' 1.5ml Eppendorf
tubes were prepared containing 150[xl RLT+2 pmercaptoethanol, 295^1 DepC
water and 5 pil proteinase K, into which the membrane cap (see Chapter 5) was
pressed, and the tube forcefully inverted and placed upside down in a 55°C
shaker overnight, processed as for whole sections with Qiagen RNeasy
microkit.
For laser catapulting, 80^1 of RLT (without 2-pmercaptoethanol) was placed in
the lid of a standard RNase free 0.5ml Eppendorf tube. Once all material had
been catapulted into this, 0.8pJ of 2-pmercaptoethanol was added per lid, the lid
closed and pulse centrifuged briefly in an ultrafuge at maximum speed. To this
tube a solution of (70pJ RLT+2-mercaptoethanol, 295 jxl DepC water) and 10 pi
of proteinase K was added, inverted forcibly with gentle vortexing, pulse
centrifuged to force the material into the base of the Eppendorf tube and placed
to incubate at 55°C overnight. The 450pl of RNA containing extract was then
purified and isolated using the Qiagen RNeasy microkit.
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2.13 REVERSE TRANSCRIPTION AND PCR
Initial studies into frozen microdissection utilized the specialist Promega access
RT-PCR kit as per manufacturers instructions, as did (3-Actin check PCR for
genomic contamination. However conditions were found to be inflexible for new
primers and random hexomers were required, (see Chapter 5). Thus real time
RT-PCR reagents and gold Taq were utilized in the majority of studies.
2.13.1 REALTIME RT-STEP
RNA extractions were run through a standard fi-Actin PCR to check for genomic
contamination. In those reactions when low yield RNA sequences were
investigated, RNA checks were also used with mastermixes used for cDNA
PCR to allow for potential variation in stability of any contaminating DNA. e.g.
checks were performed with (3-Actin, but other genomic sequences might be
more stable or other primers might be more effective. However, at no point was
contamination identified in any of the low yield isolates from microcolumns,
when on column digestion was performed, with either (3-Actin or any of the other
genes of interest used here.
RNA was quantified on a visible UV spectrophotometer, and diluted to 100ng/pil.
This was then reverse transcribed using the real time reverse transcription
reagents supplied by Applied Biosystems according to the manufacturers
instructions. Hexomers were used as these pick up total RNA, necessary if 18s
was to be utilised as a housekeeping gene. An example of a reaction mix is
given in Table 2.2.
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Nuclease Free Water 3.7
RNA 4
Table 2.2: Real Time Reverse Transcription Mastermix
The above was made up in 0.2ml tubes and run for: 25°C: 10mins; 48°C:
40mins; 95°C: 5mins, 4°C hold step. In those reactions where RNA
concentrations were lower than 100ng/pJ, or below detection, as in the case of
some laser microdissection studies, volumes up to a maximum of 7.7pil were
applied to the mix through substitution of water.
Real time RT mixes were then diluted to 10Opil via the addition of 80pil of
nuclease free water and stored as 15^1 aliquots. This was then used in the
subsequent reaction.
For laser micro-dissection, this dilution was not performed. To investigate the
effect of excess reagent carryover resulting from this adaptation, on PCR
function, preliminary experiments assessed PCR reactions using a known
concentration of RNA diluted in concentrated reagent mastermix or normal
mastermix. Bands were found to be brighter in undiluted mastermix reactions,
suggesting that carryover of RT reagents increased PCR function. This was
trialled on two primer sets.
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2.13.2 REAL TIME PCR
REAL TIME PCR (|xL)
PCR MM 12.5
18s Primer Probe 1.25
Nuclease Free Water 1.75
*Primer Probe Stock 7
RNA 2.5
*Primer Probe Stock
Nuclease Free Water 1620
Probe 300
Primers 90 of each
Table 2.3: Real Time PCR Mastermix
For those reactions where low yield cDNA was expected from the reverse
transcription step, such as laser microdissection, volumes up to 4.25^il were
loaded through substitution for water.
2.13.3 STANDARD PCR
Whist some primer sets could be used at a range of temperatures and
mastermixes, such as the fi-Actin sets, without any apparent affect on yield or
stringency, others had very strict requirements. An example of an optimisation
titration is displayed in Table 2.4.
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Tube rb 1dNTPs 2Mg 3Primers cDNA 4bsa H20 5Taq
Shh +ve
1 1.8 0.4 5 1 2 1 6.8 2
2 5 1 2 - 7.8 2
3 3 1 2 1 8.8 2
4 3 1 2 - 9.8 2
5 0.2 5 1 2 1 7 2
6 5 1 2 - 8 2
7 3 1 2 1 9 2
8 3 1
13-Actin
2 - 10 2
9 0.4 5 1 1 - 8.8 2
10 0.4 5 1 - - 9.8 2
Table 2.4: Titration of Primer Conditions
Volumes given as pi, final total tube volume 20^tl RB refers to reaction buffer.
1dNTPs from a 10mmol mix prepared from 1/10 dilution of 100mM base stock.
2MgCI2 from a 25mM stock. 3Primers taken from a mastermix of 20(xl Fwd, and
20 (xl Rev primers at 50pmol, plus 10 pi H20. 4BSA at 0.2% in water. 5Gold Taq
Polymerase (5units/pl) was used at 0.25units of enzyme/reaction taken from a
freshly prepared mastermix: e.g.: 20 samples, requires 20+2 for excess - equals
22 x 0.25 = 5.5 units of enzyme = 5.5/5 = 1.1 pi enzyme + 4.4 pi 10xReaction
Buffer + 38.5 pi H20; as 2 pi per sample x 22 = 44pl).
0.2ml tubes from Table 2.4 were loaded into a graduated (horizontally
graduated) PCR block set to a range of approximately 10-15°C across the
average annealing temperature supplied by the primer manufacturer or primer
design software. 6 copies of tubes 1 -10 were prepared where 1 -8 were loaded
in every other column of the block and copies of 9-10 loaded between as
positive controls.
Appropriate conditions were selected via narrowing of each range in
subsequent trials. DNA positive controls for check gel PCR were tail tip DNA
from routine genotyping undertaken in the lab. Positives for laser micro PCR
were cell line cDNA. These were generated by removing media from 70-80%
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confluent 75cm2 growth area flask (medium flask), washed thrice with 10mls
PBS, and RNA extracted in 4mls RLT, aliquoted in 1 OOjj.1 aliquots and frozen at
-70°C. These were then incubated overnight with proteinase K along with
microdissected material.
Agarose gels for electrophoresis were visualised using a visible UV
transilluminator and Grabbit software (version 2.55) where OD values were
analysed using Gel Blot pro v.3.30 software (UVP Ltd, Cambridge, UK).
The subsequent pages include tables of the RT primers and real time primers
and probe used in this thesis.
2.14 STATISTICAL ANALYSIS
Individual data sets were analysed with a paired T test and groups via a
repeated measures ANOVA and Student T-test using the INSTAT software
package (www.graphpad.com). P values are displayed as follows: * p<0.05 **


























































































































































































































































CHAPTER 3 HYDROGEN PEROXIDE INDUCED




The function of the epithelial surface gradates from a largely defensive and
structural role in the upper airways, to a predominantly gas exchange
function at the alveolar surface. Whilst upper airway defence mechanisms
such as mucus production and IgA translocation have been well
characterised, it is only comparatively recently that the endogenous defence
mechanisms of the lower airways have attracted substantial attention. These
bronchiolar and alveolar responses can be stimulated and regulated either by
direct stimuli from the apical milieu, or by secondary signals, such as those
delivered by the AM, underlying connective tissues or cells of the immune
system. Epithelial responses can include the secretion of cytokines and
chemokines with both local and systemic effects, as well as changes in
proliferation and subsequent differentiation. These responses can
occasionally become deleterious, such as in asthma and allergic rhinitis,
where epithelial activation can worsen hyper-responsive reactions to non¬
pathogenic interactions. Thus an understanding of the mechanisms involved
in these responses is essential in understanding the response of the
pulmonary surface to infectious and deleterious insults, and subsequently, its
response to the delivery of ameliorative or curative treatments.
The pulmonary epithelium of the lower airways constitutes a collection of cell
types with vastly differing morphological and functional properties. The
majority have some secretory function, although the cuboidal type II and
Clara epithelial cells are considered to have the most significant effect on the
lung milieu (see Chapter 1). In areas of bronchiole - alveolar injury these cells
are often observed as spreading and proliferating cells termed "repair" or
"intermediate" cells, which are thought to be prominent secretors of
cytokines. These can act as immune modulators, affecting sub epithelial
macrophage, DC, T-cells and AM, whilst also having a range of affects on
structural cells such as the fibroblasts, myofibroblasts and smooth muscle
cells which constitute the subepithelial connective structures. Epithelial
signals such as IL-6 and FGFs can induce proliferation in fibroblasts and lead
to their up regulated production of components of the extracellular matrix,
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aiding wound repair and preventing transudation of plasma factors which
may be detrimental to the restoration of normal lung physiology following a
period of epithelial denudement.
As discussed in Chapter 1, work of this lab had identified alveolar epithelial
cell expression of Shh in areas of disease in UIP & in the FITC model of lung
fibrosis1. Shh expression was observed to be greatest in cuboidal and
metaplastic epithelial cells in areas of inflamed or fibrotic lung, and up
regulated in areas of bronchiolisation in human disease. This expression
pattern matched that observed for many immunologically relevant factors
secreted by proliferating epithelial repair cells in mouse and human lung.
3.1.1 HYPOTHESIS
This chapter will address the hypotheses that
o The up regulation in epithelial Shh expression is a response to
injury
o That this injury also affects other epithelial cell functions,
o Up regulated Shh affects epithelial and fibroblast function.
3.1.2 EXPERIMENTAL METHODOLOGY
The response of epithelial cells to injury was initially investigated using a
reductionist in vitro approach. Type II like epithelial cell lines were utilised,
where the A549 cell line was utilised for human studies, and for mouse
studies, the CMT-64 cell line. In addition to this a mouse pulmonary fibroblast
line was also used CCL-206, described here using the ATTCC nomenclature,
but also referred to as MLg, in the literature160.
EPITHELIAL CELL ASSAYS
Epithelial cell injury assays were developed to investigate the proliferative
and secretory responses of epithelial cell lines to injurious stimuli. As the
nature of the injurious stimulus in human ILD is unknown it was decided to
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investigate responses to a known damaging agent, H2O2, and to the hapten
FITC, which induces fibrosis in the mouse lung. As discussed in Chapter 1,
the epithelium has the capacity to modulate and initiate immune responses
through a wide range of cytokines and chemokines. The work of this Chapter
focused on the inflammatory/anti-inflammatory mediators and conserved
developmental signalling molecules produced.
ROLE OF SHH SIGNALLING IN EPITHELIAL / FIBROBLAST FUNCTION
It is only comparatively recently that Shh has been identified as an active
signalling molecule in post embryonic organisms. Elucidation of its up
regulation in the epithelium of fibrosed lung1, coupled with its potentiation of
immune responses2'3'169, would suggest that Shh expression may be a novel
signal in post embryonic lung cell function.
Previous in vitro investigations into Shh function have been hampered by a
lack of suitable investigative tools, particularly for the measurement of soluble
Shh signal. Only a very limited number of antibodies were available, no
ELISA could be commercially obtained, and bioassay applications were
notoriously variable. This necessitated the development of quantitative
methods of measuring soluble Shh protein levels for the analysis of cell line
supernatants. Two approaches were taken, a bioassay system and a novel
ELISA based system which I developed. These were used to measure
whether the exposure of epithelial cells to injurious stimuli affected their
production and / or release of soluble Shh.
The results reported here will first address the development of the cell line
injury assays and subsequent cytokine analysis, followed by detailed
coverage of the steps taken in the development of the analytical tools for
measuring Shh release, and their application to these in vitro studies.
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3.1.3 AIMS OF CHAPTER
- Establish an in vitro damaging assay system
- Identify epithelial cytokine response to in vitro injurious stimuli
- Develop a quantitative method of detecting Shh
- Investigate the postulated link between Shh and injurious stimuli
- Determine whether Shh exposure alters fibroblast activity
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3.2 RESULTS
3.2.1 EPITHELIAL INJURY ASSAY DEVELOPMENT
ESTABLISHMENT OF OPTIMAL CELL DENSITIES
Preliminary attempts at developing cell line injury assays used 96 well culture
plates, but within these excessive lifting of cell monolayers was observed
during media replacement. This was overcome via use of 24 well plates,
where wells were sufficiently small to minimise the number of cells required
for the relevant number of replicates and the amount of reagents required,
but large enough to ensure the maintenance of a robust cell layer during
media replacement. Thus all subsequent injury experiments were performed
in 24 well plates.
In order to facilitate consistent and healthy cell growth in injury assays, A549
and CMT were serially plated from a top concentration of 1x106 cells/ml and
the optimum plating density that would allow continuous proliferation
throughout the duration of the assay determined. This was assessed with the
MTT assay system (see Chapter 2). In this assay, mitochondrial enzyme
mediated conversion of a pale yellow substrate into an insoluble purple
compound, yields a colourimetric signal proportional to viable cell number.
From these studies (Figure 3.1) the optimal plating cell densities for both cell
lines were identified as 2.5x105 per ml, plated as 500[il per well. This gave
the maximum number of cells per well for the generation of detectable








Figure 3.1: A549 and CMT Cell Density Titration
Error bars denote standard error of 3 separate experiments using cells not
more than 3 passages apart. Cells plated in 500pl volumes, media
unchanged through time course.
FITC EXPOSURE
Initial experiments using FITC powder in media had serious limitations.
Despite apparently being in solution, once administered to cells, FITC formed
clustered aggregates on the surface of cells which were impossible to
remove without injuriously forceful wash steps. The continued presence of
FITC caused sustained injury and reduced viability of the cells, as measured
by MTT (data not shown), and inhibited the colourimetric and fluorometric
analysis of cell supernatants.
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FITC retention as aggregates was avoided by pre-solubilisation of FITC in
DMSO, prior to its addition to serum free media. Whilst this did slightly
reduce the affects of FITC on the epithelium, it allowed efficient removal of
the compound and reduced variability. The effect of FITC on CMT cells was
ascertained via titration starting at a high of 1mg/ml in serum free media, and
MTT values recorded up to 48hrs post exposure.
Administration of FITC in a DMSO carrier solution to CMT cells results in
complete loss of the MTT signal at 1000p,g/ml, where DMSO alone had no
effect. A 250[xg/ml solution reduced the increase in the MTT signal over 24-
48hrs, when compared to cells alone, whilst 125[a,g/ml exposure had only a
marginal affect on cells. This would suggest that whilst FITC can affect the
number of viable CMT cells, persistent affects on viable cell number occur
only within a limited range, from almost complete loss of viability with
500|ag/ml to almost no affect with 125ng/ml (Figure 3.2[A]).
Analysis of supernatants taken from FITC/DMSO exposed CMT cells did not
yield any substantial difference in cytokine production compared to non
exposed cells, as discussed below. This may indicate that although FITC has
inherent toxicity, it does not stimulate epithelial cytokine secretion. Although
possible, such a finding is highly at odds with experience in vivo, where FITC
administration is found associated with an acute subepithelial inflammatory
infiltrate. What is perhaps more likely is that FITC stimulates pathways not
analysed here or that the solubilisation step necessary for in vitro application
has altered the response of epithelial cells to FITC exposure.
h2o2 exposure
H202 was always used from a fresh sterile bottle and was titred into serum
free medium from a high of 40mM, prior to addition to cells. H202 addition
was performed with both A549 and CMT cultures (Figure 3.2[B]&[C]).
H202 exposure in CMT cell cultures resulted in a titration profile similar to
FITC, but with broader inhibition of temporal increase in MTT signal (Figure
3.2[B]), which continued with further titration (data not shown). Cells exposed
to concentrations of H202 between 10mM and 2.5mM illustrated a
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stabilisation of viable cell number, suggesting either a loss of proliferative
capacity or persistent cell death equal to that of proliferation. Concentrations
of H202 capable of inducing complete loss of MTT signal were used for
reasons discussed in Section 3.2.7.
H202 exposure in A549 reduced the MTT signal up to 72hr after addition, and
this was not a consequence of symbiotic reliance on cell number, as shown
by the cell density titre in Figure 3.1. Contrary to the stabilisation of the MTT
signal observed in CMT cells with H202 exposure, A549 exhibited an active
reduction in the MTT signal over the same time period, suggesting a non
recoverable reduction in cell proliferative capacity or an elevated rate of cell
death following H202 exposure. (Figure 3.2[C]).
3.2.2 H202 EXPOSURE AFFECTS EPITHELIAL CELL CYTOKINE
PRODUCTION
In the mouse CMT cell line, of those cytokines analysed by CBA and ELISA
(TNF-a, TGF-p, GM-CSF, IL-12p70, IFN-y, MCP-1, IL-10, IL-6) only GM-CSF
and MCP-1 demonstrated any consistent expression. In the human A549 cell
line, of those cytokines analysed by CBA and ELISA (GM-CSF, IL-8, IL-1 b,
IL-6, IL-10, TNF, IL-12p70), only IL-8 demonstrated any consistent
expression.
CMT CELLS EXPRESS GM-CSF AND MCP-1
Constitutive production of GM-CSF by CMT cells was below the standard
curve of the GM-CSF Duoset ELISA (R&D). However, its detection in CMT
cell supernatants was significantly increased by exposure to H202 (n=6), but
not by FITC/DMSO (n=3 data not shown) (Figure 3.3). Both agents resulted
in a reduction in viable cell number, thus it was concluded that upregulation
was an agent specific response. Whether the FITC or H202 is representative
of a normal GM-CSF response to injury would require trials with a greater
variety of agents.
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A FITC EXPOSURE REDUCES MTT IN CMT
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Figure 3.2: FITC & H202 Reduce MTT
Cells plated at 1.25x105 per well, 24 hours prior to a 1.5 hr damage step, n
refers to number of experiments incorporating duplicate wells. [A] FITC
powder dissolved in 500pl DMSO added to >15ml serum free media; n=3. [B]
H2O2 in serum free media; n=6. MTT assay performed over 3hrs [C] A549,
n=3. MTT performed for 45mins. All medium wells treated with highest
concentration of injurious compound to control for any possible FITC or H2O2
carryover affect. All error bars denote Standard Error. Statistical analysis
*p<0.05, **p<0.01, ***p<0.001 by parametric tests.
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Figure 3.3: H2O2 Exposed CMT Release More GM-CSF
Exposure to 2.5mM of H2O2 for 1.5hrs resulted in a 14 fold increase in GM-
CSF detected by ELISA (low standard 7.8pg/ml shown by red line) 48 hours
after damage. Legends refer to time after agent removal. Cells were plated
24hrs previously at 1.25x105 cells per well. n=6. Error bars denote Standard
Error. Statistical analysis *p<0.05, **p<0.01, ***p<0.001 by parametric tests,
refer to values vs. 6Hrs.
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h2o2 exposure increases gm-csf
mrna expression
6Hrs 18Hrs 24Hrs 48Hrs
TIME POST H202 REMOVAL
Figure 3.4: GM-CSFmRNA Increases Following H202
RNA extracted from CMT exposed to 5mM of H2O2 for 1.5hrs in serum-free
media as described previously. 2% agarose gel OD values and relative band
size were analysed following 27cycle (fi-Actin) and 35 cycle (GM-CSF) PCR
from a common mastermix following PCR with annealing temperature of
60°C. Data here are representative of three repeats.
True up regulation of GM-CSF over release of stored cytokine was confirmed
by semi-quantitative RT-PCR for GM-CSF compared to /3-Actin. Untreated
CMT cells had mRNA levels below the level of detection. Following H2O2
exposure, mRNA levels increased to a maximal expression of >80% of fi-
Actin, 24hrs after the removal of H202 and 24hrs prior to the peak in protein
expression (Figure 3.4). OD values were obtained from Gel blot pro software
analysis of RT-PCR product bands in 2% agarose gels on a visible UV
transilluminator. Gels were loaded with a 1:1 ratio of orange g to sample in a
10pl volume per lane.
MCP-1 secretion (data not shown) was not affected by either H2O2 or
FITC/DMSO, but increased with time in culture to a high of 55 pg/ml at 96hrs
with a plating density titration of 5x105 cells per well. Values were below the




















A549 CELLS EXPRESS IL-8, BUT NOT GM-CSF
No GM-CSF or MCP-1 were detectable in this cell line. However, IL-8 was
detected. In untreated cells, expression of IL-8 correlated with cell number,
as shown in a cell density titre (Figure 3.5).
However, supernatants taken from A549 cells exposed to H2O2 demonstrate
that H2O2 exposure increases constitutive levels of IL-8 production from
<200pg/ml to a high of >700pg/ml Figure 3.5. This was interesting given that
previous reports have suggested that A549 up-regulate IL-8 in response to
AM derived IL-1p and TNF170 and that MCP-1 is also normally up-
regulated171, which was not observed with H2O2 exposure. Data here, in the
absence of detectable TNF, could suggest that these cells can produce IL-8,
in the absence of MCP-1 as a direct response to injurious stimuli. However
an analysis of IL-1 p levels would be required to confirm this.
IL-8 PRODUCTION BY A549 CELLS











Figure 3.5: A549 IL-8 Production
20 10 5
H202 (mM)
Cell density titre demonstrates constitutive release relative to cell number.
A549 cells were plated at 12.5x104 per well for addition of H2O2.
Representative of 2 repeats. A549 altered their IL-8 release in response to
H2O2 exposure. Legend times refer to time after removal of H2O2. CBA low
detection limit 20 pg/ml, shown by red line.
3.2.3 EXPRESSION OF THE SHH PATHWAY SIGNALLING
COMPONENTS IN THE CMT, A549 & CCL-206 CELL LINES
In order to determine whether epithelial cell injury affected Shh signalling it
was necessary to establish the presence of components of the signalling
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pathway in these cells. A549, CMT and also the mouse pulmonary fibroblast
cell line CCL-206 were assessed for Shh signalling components via RT-PCR
(Figure 3.6). The expression of Shh and Ptc by A549 has previously been
published by this lab3, but owing to conflicting reports73, 172, this was
confirmed with new primer sets, along with expression of Smo, and GH1&2.
The mouse cell lines were also analysed for Shh pathway components along
with a mouse brain positive control. The mouse Shh primers were designed
using the primer express software and all sequences were checked in the
Amplify software package to confirm band size and check for primer dimers
and secondary products. Both A549 and CMT cells exhibit all of the major
pathway components, including Shh, Ptc, Smo & Gli (Figure 3.6). This
demonstrates that these cells have the capability to both produce and
respond to a Shh signal, if protein expression mirrors the mRNA profile. In
contrast, the fibroblast cell line, lacked Shh expression and was positive only
weakly for Ptc, but with strong Smo expression, demonstrating a potential
responder profile to a Shh signal. Negative GIH signal in these cells (where
GH1 is induced via signalling through GH2) confirms an absence of Shh in this
monoculture.
Cell lysates were taken at 70% confluence as this represents the average
confluence of the cells in tissue culture plates during injury assays. This is
crucial as expression profiles might be expected to change within a confluent
monolayer.
The mouse primers presented a number of optimisation problems, which
deserves some discussion here,, notably, the Gli1 primer, which was taken
from a published paper by Outram et al64. When these primers were
processed through the Amplify software, three bands of 221, 404 & 743bp
were generated. Thus optimisation problems were attributable to the original
sequence rather than the mastermix conditions used. Whether the optimised
band at 404bp represents the strongest possible product has not been
ascertained. Subsequent analysis of recently published mRNA sequences
during the preparation of this thesis, has shown that this primer set also has
high affinity with GH2 when run through a pubmed BLAST search. However,
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artificial PCR in the Amplify package would suggest that this does not yield a
product. Thus these primers can be considered GIH specific. Subsequent
attempts at generating new primer sequences for this mRNA sequence
comes too late for inclusion in this thesis.
Mouse Shh RT products were unpredictable in quality and quantity and
particularly susceptible to freeze thaw degradation. Best results were
obtained with fresh RNA and cDNA. Prolonged storage on ice during PCR
preparation was also found to be detrimental to efficient amplification. Similar
problems were experienced in real time primer-probe design and would
suggest that some element of secondary folding or short half life interferes
with effective detection of this transcript.
Figure 3.6: mRNA of Shh Signalling Components in Cell lines
RNA isolated from cell lines at 70% confluence in vented flasks. Mouse
primer product sizes and references are as follows: Shh 261 bp, designed
with Primer 3 Express primer design software, Ptc 466bp, Smo 465bp & GIH
404bp64. Embryonic mouse (Balb-c) brain tissue was homogenised prior to
normal RNA isolation. A549 product sizes and primer references are as
follows: Shh 211 bp 127 Ptc 202bp 127, Smo 140bp167, G//2 200bp168 GIH
244bp 127
3.2.4 IMMUNOHISTOCHEMICAL DETECTION OF SHH AND PTC IN
CELL LINES
Immunohistochemical analysis was utilised to confirm translation into protein
in the CMT cell. CMT cells were also exposed to FITC and H2O2 to see if
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exposure altered the localisation of Shh or Ptc in these cells. CMT cells were
fixed 1 day after exposure to H202 or FITC for 45 minutes or 1,5hr in Nalgene
chamber-slides. Immunohistochemistry was performed using the Santa Cruz
antibodies for Shh (N19) and Ptc (C20) at a 1 in 30 dilution (Figure 3.7). Shh
appears membranous after a 45 minute exposure to FITC [A] & H202 [B], and
staining was almost completely lost after 1.5hr, whilst Ptc remains relatively
unchanged. Negative controls in this study were omission of the primary
antibody on cells not exposed to either FITC or H202.
The specificity of this immunohistochemistry was checked by pre-incubation
of primary detection antibody with commercially available blocking peptide.
This required a reduction in primary concentration to a dilution of between 1
in 60 & 1 in 80. Use of the C20 (Ptc) blocking peptide, completely blocked
immunohistochemical detection (Figure 3.8), showing signal specificity.
However, use of the N19 blocking peptide in my hands, results in increased
signal, where blocking peptide alone was negative. Use of neat blocking
peptide with a 1 in 80 dilution of N19 further increased immunohistochemical
signal (data not shown). Thus Shh staining could not be validated with the
blocking peptide, although there are a number of possible explanations for
this. If the blocking peptide was significantly similar to the Shh peptide itself it
is plausible that the N19 antibody containing bound peptide might bind to Ptc,
Hip or indeed Megalin and the postulated HSPG modulators of Shh. Equally,
the N19 may have greater affinity for the native peptide, thus displacing the
blocking peptide.
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Figure 3.7: CMT Immunohistochemistry For Shh & Ptc
CMT cells grown on Nalgene chamber slides for 24 hours, exposed to
damaging agent, washed and left 24hrs prior to fixing. [A] FITC exposure
(250pg/ml), [B] H202 exposure (5mM). Ptc staining with C-20, Shh staining
with N19, using a 1:40 dilution of stock (200pg/ml) in Dako diluent. Times
and reagents as sequenza protocol (Section 2.8.1), 250pl of each reagent
per well. Negative controls are primary antibody exclusions.
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NEG 1/60 1/60C20+1/16p 1/60C20+1/12p
NEG 1/80 1/80N19+1/16p 1/80N19+1/12p
Figure 3.8: CMT Immunohistochemistry with Blocking Peptides
CMT epithelial cells on Nalgene coverslides at x200 magnification. Neg
controls are omission of primary. Ab and peptide concentrations given as
dilutions of 200pg/ml stock. Ptc antibody blocks, Shh antibody does not.
3.2.5 SHH ELISA
The aim of the work described in this section was to develop a Shh specific
ELISA system. The initial focus was to develop a method whereby Shh
containing samples coated onto a 96 well plate could be detected and
quantified with the addition of Shh specific antibodies, aka a "one way"
ELISA. Following this it was hoped to increase the sensitivity and specificity
of the one way ELISA system, via the pre coating of the wells with a different
Shh specific antibody, prior to sample addition, aka a "sandwich" ELISA
system.
ONE WAY ELISA
One way ELISA s involved coating of high binding EIA plates with a sample
to be tested, followed by a protein rich blocking step, to prevent subsequent
non-specific binding. One of two available anti-Shh antibodies were then
added as a "primary detection", either the mouse monoclonal anti-Shh
antibody (5E1), or the goat polyclonal anti-Shh antibody (N19). Bound anti-
Shh antibody was then detected via the addition of biotinylated antibody
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raised against the relevant species of the primary antibody, termed a
secondary detection step.
Biotinylated antibody binding was then quantified using a
Streptavidin/substrate development system as used by most commercial
ELISA systems, e.g. R&D, whereby a colourimetric signal quantifies bound
biotinylated antibody.
Initial experiments characterised relative binding capabilities of the secondary
detection antibodies when added to plate bound primary antibodies as a
chequerboard of 10 fold dilutions of biotinylated anti-goat/mouse secondary,
added to 10 fold dilutions of plate bound N-19 or 5E1 (data not shown).
This identified that the anti-mouse and anti-goat antibodies had similar
sensitivity for plate bound Shh specific antibody, and that dilutions in the
range 500-1 OOng/ml of anti mouse/goat antibody were likely to be the most
suitable.
In order to analyse the relative sensitivity of the N19 and 5E1, a high binding
ELISA plate was then coated with 10, 1 and 0.1ng/ml of r-Shh peptide,
blocked, then detected with the N19 and 5E1 antibodies at 1000, 300 and
10Ong/ml, using a low concentration of secondary detection antibody
(1 OOng/ml) to avoid competitive exclusion (Figure 3.9[A&B]). These studies
illustrated that both antibodies had similar detection profiles, thus both
warranted further investigation.
126
A PLATE BOUND r-SHH WITH N-19 TITRE
AND 100ng/ml OF SECONDARY
DETECTION
D PLATE BOUND r-SHH WITH 5E1 TITRE




























r-Shh 11000 ng/ml b300 ng/ml □ 100 ng/ml n0 ng/ml
Figure 3.9: Primary & Secondary Antibody Titres
[A & B] 50pl volumes of r-Shh peptide in bicarbonate buffer were incubated
overnight at 4°C in 96 well high binding EIA plates (see legend), prior to non¬
specific protein blocking and primary detection (X-axis). Both assays used
100ng/ml of relevant biotinylated secondary detection. Development of
streptavidin activity with colourimetric substrate was extended from the
standard 20 minutes to 40 minutes to facilitate further development and
elucidation of signal. This was suitable for comparative analysis of antibody
sensitivity with r-Shh, as shown here, but found to be unsuitable for the
generation of an accurate standard curve with r-Shh. Data here are
representative of two replicates.
In order to increase detectable colourimetric signal, without extending the
duration of substrate development, the next stage of investigation utilised
increased concentrations of primary antibody, titred from approximately
700ng/ml to 20ng/ml, and increased concentrations of secondary antibodies
(250ng/ml and 500ng/ml) applied to plates coated with a serial dilution of r-
Shh ranging from 200-0.2ng/ml. Antibody concentrations were selected on
the basis of previous chequerboard titres and those used in commercial
ELISA assays for other cytokines.
Both primary antibodies gave similar profiles of colourimetric development
with 250ng and 500ng/ml secondary detection antibody concentrations,
where approximately 160-80ng/ml of primary antibody in conjunction with
500ng/ml secondary detection gave the most sensitive r-Shh titre detection
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(data not shown). However, this gave an exceptionally steep standard curve,
only accurately displaying 2 values within a linear range. A more inclusive
linear profile could be observed with a primary antibody concentration of
640ng/ml and a secondary antibody concentration of 250ng/ml for both
primary antibodies. This was utilised in subsequent experiments where 5E1
was selected as the primary of choice for economic reasons (a producing cell
line maintained in house) and for specificity considerations, given that it is a
monoclonal antibody vs. the polyclonal N19.
Previous experiments had used r-Shh diluted in bicarbonate buffer to coat
high binding plates overnight at 4°C. However, analytical samples will
generally be supernatant media, where the high concentrations of r-Shh used
in the standard curve negate substantial dilution in bicarbonate buffer. It was
therefore necessary to assess the affect of coating medium on relative
antibody detection. r-Shh was plated in bicarbonate buffer, bicarbonate buffer
plus cell culture medium and PBS (Figure 3.10[A]).
PBS and cell culture medium did not generate comparable standard curves
to bicarbonate buffer alone (Figure 3.10[A]). PBS markedly reduced r-Shh
detection and use of 200ng r-Shh titres in this coating solution generated a
steep standard curve with only two linear data points (data not shown).
Dilution of bicarbonate buffer with medium resulted in a reduced OD signal,
but with a similar linear distribution (Figure 3.10[A]). Further experiments with
a titred dilution of bicarbonate buffer with medium, demonstrated a
proportional reduction in signal (data not shown). Thus for subsequent ELISA
experiments supernatants were plated 1:1 with carbonate buffer and the
standard curve generated with carbonate buffer 1:1 with sample medium.
Use of this technique generated standard curves similar to that shown in
Figure 3.10[B]. This system was hence forth defined as the 5E1 ELISA
system.
128































6 25 ^ ^





Figure 3.10 Coating Buffers & Standard Curves In 5E1 ELISA
[A] demonstrates the affect of different coating media on the efficiency of the
5E1 ELISA. Coating media are shown on the x-axis where bicarbonate is the
standard bicarbonate buffer. Medium is Waymouths CMT media with 5%
FCS (see Chapter 2). [B] shows an average standard curve obtained with the
5E1 ELISA using the protocol described in Chapter 2. The concentrations of
r-Shh (ng/ml) added are given beside each data point.
ELISA plates were run with multiple controls; most commonly an
appropriately diluted complete cell lysate of the cell type being analysed
along with a control r-Shh peptide aliquot of 50ng/ml. This allowed for the
rejection of data sets if values were too variable. Supernatants were
assigned units rather than ng/ml quantities as antibody affinity for r-Shh may
differ from that of native cholesterol modified and palmitoylated Shh. The
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specificity of the 5E1 ELISA system was confirmed via pre-incubation of 5E1
with r-Shh peptide as shown in Figure 3.11.
PRE-INCUBATION OF 5E1 WITH
r-SHH REDUCES ELISA SIGNAL
0 3.1 6.3 12.5 25 50 100 200
PLATE BOUND r-SHH (ng/ml)
Figure 3.11: Pre-incubation Validation of ELISA
Overnight pre-incubation of 5E1 with r-Shh reduces signal in the 5E1 ELISA
system. Complete blocking (<0.05) achieved with >1pg peptide (data not
shown).
SANDWICH ELISA
Given that the linear range of the 5E1 ELISA system is in nanogram
quantities, sandwich ELISAs were investigated as a means of increasing
sensitivity to a picogram range.
The sandwich ELISA involved pre-coating high binding EIA plate in anti-Shh
antibody (N19 or 5E1) as a "capture" layer, followed by a protein rich block to
prevent non-specific binding. Sample was then added, followed by the anti-
Shh antibody not used in coating ("primary detection"), then the relevant
biotinylated anti-lg against that antibody ("secondary detection") for
streptavidin/ substrate visualisation.
Sandwich ELISA's were attempted utilising the N19 and 5E1 antibodies in
both orientations. Initial studies concentrated on plate bound monoclonal
5E1, with N19/antigoat detection, but failed to generate a specific ELISA.
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This was not improved by reversing the orientation, alterations in blocking
protocol, or concentrations of constituent antibodies, suggesting a non
specific signal. Pre-incubation of component antibodies overnight at 4°C with
goat or mouse serum did not affect non specific signal.
Due to these limitations the one way 5E1 ELISA system has been used for
the work in this thesis. However, a Shh sandwich ELISA system has
subsequently been marketed by R&D labsystems and has been run
concurrently with the 5E1 ELISA system. R&D kits detected Shh in both
embryonic and adult mouse brain homogenates titred from a concentrated
stock, but at a greatly reduced level compared to the 5E1 ELISA system.
Adult brain was calculated at 7000 units (ng/ml) using the 5E1 ELISA whilst
the R&D kit gave a value of just 82pg/ml. Equally in the embryonic brain, the
5E1 ELISA gave a value of 141000 units (ng/ml) vs. a 3.2ng/ml value for the
R&D kit. Thus it was not surprising to find that the R&D ELISA failed to detect
Shh in CMT supernatants, or those of T-cell preps, where western and
immunohistochemistry have previously shown the presence of Shh
(J.Lowrey, personal communication). Personal communication with the
supplier has confirmed that this assay system has never been validated
against native Shh, as all studies were performed using a cell line transfected
with recombinant protein where cholesterol and palmitoylation do not occur.
More recent attempts at generating a Shh sandwich ELISA with new N19
have yielded excellent results, with sensitivity above that of the current 5E1
ELISA system and commercial kits, but came too late for data analysis in this
thesis. A standard curve using this system has been included in an Appendix
to this thesis (Figure 7.1). Thus it would seem that the original cross reactivity
problems found in the generation of an in house sandwich ELISA system
may of lain in some component of the Santa Cruz N19 antibody, although
variation in batches of r-Shh cannot be excluded.
3.2.6 SONIC HEDGEHOG BIOASSAY
The Shh protein is a heterogeneous molecule, given that it can be released
with a range of differing chemical modifications, which markedly affect its
signalling ability 20. Whilst the Shh ELISA system gives an indication of the
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relative concentration of Shh, it does not quantify this variation in
functionality. Given that hypothetical^, a cell could up-regulate Shh signalling
in response to a stimulus, by just fully modifying all of the Shh released from
the cell, a bioassay approach was also taken.
Initial investigations into a bioassay system concentrated on the use of the
C3H10T1/2 cell line. Addition of r-Shh to cultures of C3H10T1/2 has been
shown to induce differentiation into osteoblast like cells, positive for alkaline
phosphatase (ALP) activity 173'174. Despite repeated experiments with new
batches of cell line at low, medium and full confluence culture, in 6, 12 and
24 well formats and with normal and charcoal stripped serum at various
concentrations, it has not been possible to repeat this observation with >1ug
r-Shh. The Shh signalling blockers Cyclopamine and 5e1 had no effect on
cellular MTT signal in these cells (data not shown).
Given the difficulties encountered with the C3H10T1/2 cells, a vector
containing a luciferase under the control of Gli responsive promoters was
obtained via personal communication with the lab of Beachy et al 126. Using
this system it was hoped to obtain a directly proportional readout of Shh
activity, as Shh signalling involves Gli activation and up regulation, which in
cells transfected with a Gli responsive luciferase, should result in increased
luciferase expression, quantifiable on a luminometer.
Lipofectamine was used, following optimisation (Figure 3.12) to transfect
permissive NIH-3T3 cells with the Gli reporter construct along with a control
firefly luciferase construct, for use in Promega's stop and glow dual
luciferase system. This too has failed to yield the expected results, with
supernatants and recombinant peptide failing to induce significant levels of
luminescence. Initial studies were hampered by use of a dual
fluorescence/luminescence system, which lacked sufficient sensitivity.
Improved results were obtained with a single function luminometer, but
results were highly variable and will require transfection and protocol system
re-optimisation before yielding interpretable results. Thus at the time of
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Figure 3.12: Lipofectamine Titration with NIH-3T3
NIH-3T3 cells plated at 2x105 per well in 24 well plates. Viability values taken
from MTT assay (1 hr cell culture, 350pl DMSO, 100pl per well in 96 well
plates). Legend refers to pi of lipofectamine used in transfection mix (see
Chapter 2). Vectors in absence of lipofectamine did not affect cell viability.
ISM.
3.2.7 SHH RELEASE BY H202 EXPOSED EPITHELIAL CELLS
Given the interesting changes in Shh immunohistochemistry following H2O2
and FITC exposure, the 5E1 ELISA system was used to analyse the
supernatants taken from the cell injury assays for expression of soluble Shh.
This was performed with both the human (A549) and Mouse (CMT) epithelial
cell lines as described previously.
CMT
Shh production by CMT cells was within the lower region of the 5E1 ELISA
standard curve (Figure 3.13), but would appear to be constitutive given the
statistically significant increase between 6 and 48hrs without treatment,
although given the small increase in this expression it is unlikely to have
biological significance. Other than being proportional to cell number, Shh
release was not affected by plating density (data not shown).
Exposure to FITC/DMSO for 1,5hr did not affect Shh production other than to
reduce values in those wells where MTT assays would indicate a reduction in
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the number of viable cells. These experiments were repeated six times (data
not shown). Exposure to H2O2 for that same period resulted in a 25 fold
increase in ELISA signal at 6hrs post exposure to 40mM H2O2, decreasing
with time in culture, and with the concentration of H2O2 used (Figure 3.13).
The temporal decline in Shh levels continues up to 96hrs post H2O2 exposure
(data not shown).
No difference in Shh mRNA expression could be identified with semi¬
quantitative RT-PCR through 6-48hr post H2O2 exposure.





















Figure 3.13: Shh Detection In CMT Supernatants
Cells plated at 2.5x105 cells/ml, 500|il per well of a 24 well plate, 24hrs prior
to H2O2 exposure for 90 minutes. Times denote time post H2O2 removal.
40mM H2O2 gave a 25 fold increase in soluble Shh at 6Hrs. Red line denotes
lower range of the ELISA detection (3 units/ml). n=12. Error bars denote
Standard Error. Significance of *p<0.05, **p<0.01, ***p<0.001 by parametric
tests.
A549
A549 release Shh constitutively when passaged. Maximal levels were
reached by 48hrs (post plating) regardless of plating density (Figure 3.14).
Suggesting either release rather than active production, or a method of
autocrine controlled release. Given the rapid detection of Shh following H2O2
exposure in CMT cells, when these experiments were performed on A549
cells, the supernatant containing H2O2 was collected following the 90 minute
exposure period and corresponds to the OHr value in Figure 3.14.
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A549 cells exposed to H2O2 show maximal Shh ELISA signal at 6hrs in the
top three titrations of H2O2 used. Notably, exposure to 40mM and 20mM
leads to increased soluble Shh within 1.5hrs of the addition of H2O2 (blue OHr
bars, see below) Use of lower concentrations of H2O2 with A549 resulted in
correlating increases in MTT and decreasing soluble Shh as observed in
CMT cells.
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Figure 3.14: H2O2 Exposure Results in Increased Soluble Shh
Values have medium alone controls subtracted. H2O2 exposure for 1.5hrs in
serum free media results in increased ELISA signal. OHrs represents 1.5Hr
damaging solution prior to removal for wash step. Representative of three
repeats. Red line denotes limit of sensitivity.
3.2.8 SHH RELEASE INCREASES WITHIN 1 HR OF EPITHELIAL H202
EXPOSURE
As peak soluble Shh levels were detected less than 6hrs post removal of
H2O2 in CMT cells and within 90 minutes of addition in A549 cultures, shorter
time point studies were undertaken with CMT cells.
CMT cell supernatants, containing the H2O2, were taken at intervals up to two
hours after H2O2 addition. Both 40mM and 20mM concentrations resulted in
a significant increase in Shh ELISA signal by 100 minutes post damage
(Figure 3.15 [C]).
Cellular integrity and viability were measured with a commercially available
Lactate dehydrogenase (LDH) kit, where colourimetric detection of LDH in
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media signifies a loss of cellular retention, and therefore reduced membrane
integrity.
LDH levels increase significantly, correlating with a H2O2 specific fall in MTT
signal over the same time interval (Figure 3.15 [A] & [B]). The possible
effects of injurious agents in media causing artefacts in LDH, MTT, ELISA
and CBA applications were assessed by equalising the concentration in all
samples following collection and application. No interference was identified,
(data not shown)..
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a decreased mtt signal correlates with duration and
concentration of h202 exposure
duration of h202 exposure (MINUTES)
-*-40mM -*-20mM
b ldh release correlates with duration and
concentration of h202 exposure
duration of h202 exposure (MINUTES)
C sonic hedgehog release correlates with duration
and concentration of h202 exposure
20 40 60 80 100 120
duration of h202 exposure (minutes)
■ 40mM □20ml\/l nOmM
Figure 3.15: Short Term Response To H202 Exposure
[A] MTT data [B] LDH release [C] 5E1 ELISA data all n=3 with Medium Alone
controls subtracted. Derived from cells not more than three passages
different from long time point damage experiments. Supernatants contain
H2O2, which does not affect MTT, LDH, Shh or Duoset ELISA detection, as
determined by equalised supernatant controls (data not shown). Error bars
denote Standard Error. Red line denotes limit of sensitivity. Statistical
analysis *p<0.05, **p<0.01, ***p<0.001 by parametric tests.
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Semi quantitative RT-PCR for Shh was performed in CMT cells exposed to
H2O2 at 5mM. This reduced concentration was chosen to maximise RNA
recovery from cellular material, but at a concentration where preliminary
studies had confirmed an increase in soluble Shh protein to approximately 20
Shh units, 120 minutes post H2O2 administration. Although subsequent
studies have shown that viable cellular RNA with no evidence of laddering
can be obtained from non-adherent cells centrifuged from injury assay
supernatants prior to sample freezing. This would suggest that RNA data
may be obtainable from 40 and 20mM concentration experiments, by pooling
floating and adherent cells. The occurrence of viable RNA in floating cells
also has important implications for cellular viability assays as one of the
assumptions of the MTT assay used here is that adherent cells are the viable
population and that floating cells are non-viable. A viable floating population
of cells might explain the protein release observed in Figure 3.14 in the
absence of viable cells, when using the MTT assay.
Studies identified Shh mRNA as being highly susceptible to freeze thaw
degradation and prolonged storage on ice. However two of three studies
demonstrated an up regulation in mRNA in response to H2O2 as shown in
Figure 3.16. GM-CSF mRNA expression was not detected during the H2O2
exposure period or up to 1 hour post H2O2 removal, thus initiation of
transcription must occur between 1 hour post H2O2 and 6 hours (Figure 3.4).
Shh
p-actin
5 10 40 160
Figure 3.16: Shh mRNA Increases Following H2O2 Exposure
Semi quantitative RT-PCR for Shh mRNA at 35 cycles including p-Actin
loading controls at 26 cycles. Products loaded in orange g on a 2% agarose
gel. Numbers refer to minutes post addition of H2O2 (5mM).
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3.2.9 r-SHH INCREASES IL-6 PRODUCTION IN CELL LINE
FIBROBLASTS
Having identified Shh up regulation and release in response to injury,
preliminary investigation was made into potential affects of this signal on
other pulmonary cells. Given the expression of Shh in areas of fibrosis in
human and induced mouse disease, fibroblasts were investigated as a
potential responder population to the Shh signal.
A mouse fibroblast cell line CCL-206 (ECACC) was used to investigate the
potential effects of r-Shh and CMT cell supernatants on proliferation and
cytokine production. Addition of r-Shh to CCL-206 had no effect on
proliferation when measured by MTS (a variant technique of MTT which
includes viable floating cells) or tritiated thymidine, and neither did 5e1
controls (Figure 3.17). This was reciprocated with H202 exposed, 6hr CMT
cell supernatants and Cyclopamine treated (5^iM) controls (data not shown).
CCL-206 were found to produce MCP-1 constitutively, but did not express
detectable levels of the cytokines TNF-a, IL-12p70, IFN-y, MCP-1 and IL-10.
This expression profile was not altered by r-Shh or CMT supernatants.
However, IL-6 production was identified in CCL-206 exposed to the highest
dose of r-Shh used, but represents only one experiment and is close to the
lower level of sensitivity in CBA applications, although titration would indicate
a potential trend in response (Figure 3.17[C]). This will require replication.
Changes in collagen expression were not investigated.
3.2.10 THE GM-CSF AND IL-8 RESPONSES ARE NOT AUTOCRINE
Given the expression of ligand and receptor on the same cell it was
hypothesised that Shh release might represent an autocrine signal involved
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Figure 3.17: r-Shh Increases IL-6 Release from a Fibroblast Cell Line
Without Affecting Proliferation
Fibroblasts plated in 500pl from 1x105 cells/ml in 24 well plates, 24 hrs
previous to the addition of agents to be tested. Shh pre-incubated with 5E1
for 1hr at 37°C prior to addition. [A] MTS signals (viable cell no) were not
affected by Shh or 5E1 addition, representative of 2 repeats. [B] Tritiated
thymidine incorporation was not affected by addition of Shh or 5E1 (n=1). [C]
Addition of r-Shh resulted in increased IL-6 (n=1), red line denotes limit of
CBA sensitivity.
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Addition of r-Shh titrated to >1ug failed to induce any proliferation or cytokine
response in either CMT cells or A549 cells, as measured by MTS and
ELISA/CBA. Further to this, injury of CMT cells in the presence of
Cyclopamine, a Shh inhibitor, had no affect on GM-CSF response. Addition
of 6hr CMT cell supernatants to undamaged CMT cells also failed to yield
any cytokine response, although proliferation was highly variable, likely a
complication of differential nutrient depletion (data not shown). These
experiments would suggest that Shh release was not a soluble autocrine




By utilising a mouse type II like epithelial cell line (CMT) an immediate up
regulation and release of soluble Shh in response to H202 has been
identified, with both RT-PCR and a novel Shh ELISA developed here.
Release continued for between one and six hours post H202 removal,
followed by an up-regulation and release of GM-CSF 24-48hrs later, which
was shown to be Shh independent. Human epithelial type II cells (A549)
demonstrated a similar release of Shh post H202 exposure, suggesting a
common pathway in both species. In contrast GM-CSF was not up regulated
in human cells, but IL-8 up regulation did occur. Preliminary investigations
would suggest that cell line fibroblasts may up regulate IL-6 release in
response to r-Shh, but not proliferation.
For reasons of clarity, given the broad scope of data presented in this
chapter, the findings summarised above will be addressed according to the
aims presented in Section 3.1.3, these were as follows:
- Establish an in vitro damaging assay system
- Identify epithelial cytokine response to in vitro injurious stimuli
- Develop a quantitative method of detecting Shh
- Investigate the postulated link between Shh and injurious stimuli
- Determine whether Shh exposure alters fibroblast activity
3.3.2 THE ESTABLISHMENT OF AN IN VITRO DAMAGING ASSAY
SYSTEM
Establishment of the damaging assays fulfilled one of the aims of this chapter
and facilitated later cytokine analysis. Whilst addition of H202 was relatively
straightforward, addition of FITC in vitro proved problematic (Section 3.2.1),
necessitating its prior suspension in DMSO; a step which may have affected
the epithelial responses observed, thus limiting its comparative value with the
FITC in vivo model. To fully characterise the response of epithelium to FITC,
it may be necessary to develop a different manner of administration, perhaps
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using pre-conjugated FITC. However, given that FITC normally persists in the
lung, and that its persistence is in part due to its ability to conjugate itself with
host proteins, use of pre-conjugated formulations, such as those with bovine
serum albumin (BSA), may not be instructive. It may be that accurate, in vivo
/in vitro relevant data can only be obtained using FITC as insoluble clumped
aggregates in cell medium. This may no longer be such a complication for
downstream applications as BD now produce CBA cytokine arrays with a
choice of a variety of fluorescence and bead size choices, which will facilitate
cytokine detection without the use of FITC conjugated beads, thus avoiding
supernatant interference, although the extent of fluorescence into the red
channel would also have to be compensated for.
MTT was the main assay utilised in the measurement of cellular number.
This assay utilises cellular mitochondrial activity to convert a pale yellow /
green substrate into an insoluble purple substrate for colourimetric analysis.
When considering data derived from this assay, it is important to appreciate
that it represents an accumulation of MTT over the duration of the assay; 45
minutes for A549 cells and 3 hours for CMT cells. Thus whilst high
concentration H202 exposure in CMT results in a low MTT signal, there are
actually viable cells remaining at the start of the assay, but these are lost into
the supernatant during the period of the assay, leading to a low final MTT
value. Equally, high quality un-laddered RNA can be retrieved from non
adherent cells following injurious exposure. Thus it is likely that these cells
could persist to release protein, where adherent MTT values would suggest
the absence of viable cells. As an approach to address this problem, studies
were conducted with MTS, a Promega product which produced a soluble
colourimetric signal, thus giving an estimation of both adherent and non¬
adherent viable cell number, (see Figure 3.17 for its use in fibroblasts).
However, this was unsuitable for injury assays due to the variation in phenol
red colouration in medium and arising from this, the limited availability of
phenol red free Waymouths medium used for the culture of CMT cells.
Another consideration when using the MTT assay is that MTT is itself
inherently toxic, and although titres of concentration and duration were
prepared for each cell type, injured or activated cells may be more
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susceptible to its toxicity, thus artificially reducing the apparent number of
viable cells following injury.
The assumption that reduced MTT signal represents a reduction in viable cell
number would appear vindicated by the correlation of decreased MTT signal
with increased LDH in medium (Figure 3.15). Data presented here clearly
indicate that this reduction in cell viability (MTT) and loss of membrane
integrity (LDH) is associated with an immediate increase in the release of
Shh, preceding a subsequent increase in detectable GM-CSF (mouse) or IL-
8 (human).
3.3.3 THE EPITHELIAL CYTOKINE RESPONSE TO INJURIOUS STIMULI
Unlike the increase in Shh with H202 exposure, the increases in GM-CSF
(CMT cells) and IL-8 (A549 cells) were more typical up regulation responses,
occurring within 6hrs of stimuli, and increasing subsequently. Up regulation
has been confirmed at the genetic level for GM-CSF (Figure 3.4), but this has
yet to be confirmed for IL-8. The up regulation of GM-CSF in CMT cells but
not A549 cells could represent a species difference, but could also represent
a variation in epithelial subtype.
GM-CSF
GM-CSF can act as a macrophage activator and AM differentiation
polarisation signal106, enhancing the removal of damaging agents and
necrotic epithelium175, whilst also maintaining an anti-inflammatory
environment, via the generation of new unactivated AM. GM-CSF also
stimulates DC maturation and migration to the lymph nodes, facilitating a
rapid adaptive response to damaging pathogens. But it is the ability of GM-
CSF to promote monocyte and polymorphonuclear cell survival that is
probably the key to its function in pulmonary systems, when up-regulated in
response to H202 injury.
GM-CSF may also function as an anti-fibrotic signal, as knockout mice exhibit
exaggerated fibrotic disease103. Thus up regulation of epithelial GM-CSF in
response to oxidising injury could represent an attempt by the epithelium to
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limit profibrotic side effects to mediators produced by cells infiltrating the site
of injury or by the epithelium itself.
IL-8
IL-8, increased in H202 exposed A549 cells, acts as a chemotactic factor
recruiting neutrophils, T-cells and basophils to sites of infection, and is key to
the management of infection, as discussed in Chapter 1. However, over
expression can lead to chronic inflammation and fibrosis through the
secondary function of mediators produced by inflammatory infiltrates, and
has been postulated as the initiating factor in a number of chronic
inflammatory / fibrotic disorders176.
MCP-1
Interestingly, there was no up regulation in MCP-1 in mouse epithelium with
either FITC or H202 exposure, where knockouts of the MCP-1 receptor
(CCR-2) protect against pulmonary fibrosis121' 177, and in vivo studies have
shown strong up regulation associated with FITC models of lung
inflammation / fibrosis121'177, suggesting that MCP-1 is crucial in pulmonary
fibrosis. A possible explanation for the absence of MCP-1 effects in the
studies presented here when compared to those of others 121,177 comes from
the use of whole lung homogenates in published studies, thus MCP-1 up
regulation may be a feature of another pulmonary cell type, such as the
fibroblasts, rather than epithelial cells, alternatively, epithelial MCP-1 up
regulation may require a signal or co-factor not present in in vitro
monocultures or carcinoma derived cell lines.
3.3.4 SHH DETECTION SYSTEMS
Immunohistochemistry on cells grown on Nalgene coverslides and exposed
to FITC or H202 would suggest that Shh becomes membranous within 45
minutes in response to both stimuli, and that subsequent time points show
less Shh than controls. This correlates with the observations made in H202
studies concerning the release of soluble Shh, but not FITC, where FITC was
not found to alter soluble Shh at 6hrs post removal, (short time course
studies were not performed).
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There are four possible explanations for this observation.
i. Soluble Shh is released and up regulated in H202 injury whereas FITC
induced injury only results in release, which is recycled by the
epithelium itself by 6hrs post removal
ii. The presence of FITC hides or sequesters soluble Shh either directly
through covalent attachment, or indirectly through up regulation of a
scavenger such as Hip or HSPG's.
iii. Shh immunohistochemistry is not Shh specific
iv. Shh, induced by FITC exposure, is modified in a manner making it
undetectable to either the 5E1 (ELISA) or N19 (IHC) anti-Shh
antibodies.
In addressing the third explanation listed above, it is important to appreciate
that Shh data presented here and discussed subsequently relies heavily on
the selectivity and sensitivity of anti-Shh antibodies, as does the original
premise of Shh involvement in interstitial lung disease. Thus this issue is
central to the work presented in this Chapter and warrants further discussion.
Whilst standard immunohistochemistry on tissue sections has been blocked
routinely in the lab by myself and others (Figure 7.2), it was not possible to
block Shh staining on cell lines grown on cover-plates. This was not a feature
of secondary cross reactivity as both Shh and Ptc used an anti goat
secondary, where primary omission controls were negative. The blocking
methodology would also appear to be correct given that Ptc staining could be
blocked. Thus, the failure to block was a feature restricted to Shh staining. A
reaction of blocking peptide with substrate or secondary antibody can be
excluded given that blocking peptide with no primary antibody control was
negative (data not shown). Some insight into this apparent failure can be
drawn from the fact that staining actually increased with an increased ratio of
peptide to antibody. From this data a hypothesis could be drawn that the N19
antibody blocking peptide, originating as a sequence of the Shh peptide, is
bound by Ptc. Thus when N19/peptide is added it binds to Ptc, generating a
positive signal. The greater the concentration of peptide the greater the Ptc
binding.
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Whatever the cause, the occurrence of the protein in a validated and blocked
ELISA (Figure 3.11), and the identification of mRNA sequence (Figure 3.16)
would suggest that wholly non specific Shh immunohistochemistry is highly
unlikely, and the observations are more likely an erroneous feature of the
blocking process.
A failure to replicate the observations made with the in house 5E1 ELISA
system, using the commercial ELISA can be explained through a personal
communication conducted with representatives of R&D, who produce the
commercial Shh ELISA. They confirmed that validation was limited to
recombinant Shh and that the assay had never been applied to native
protein. Thus an absence of Shh signal from supernatants in this system
could be a result of steric interference resulting from the modifications
present in native peptide. Indeed, the 5E1 monoclonal used here is the only
currently available Shh specific antibody to have had its binding specificity
intensively investigated and established, where binding has been localised
outside of these modification sites162.
Certainly, comparisons between the in-house and commercial assays would
suggest that whilst the commercial kit has higher recombinant sensitivity, its
detection of native protein is highly restricted. Embryonic brain homogenate,
required only a 1 in 5 dilution to reach the linear phase of standard curve in
the commercial kit, compared with a 1 in 1000 dilution required for the 5E1
ELISA system.
Attempts to confirm ELISA data with a bioassay as a non-antibody
dependent measure of Shh release and functionality were not successful.
Studies here concluded that the C3H10T1/2 assay was not sensitive or
robust enough for use with culture supernatants. Initial characterisation of the
assay may also require a greater concentration of r-Shh than is economically
practical in this lab, without in house isolation, purification and quantification
of the more active native protein 126 20. Preliminary Gli luciferase construct
experiments concluded that highly variable transient transfections were not
suitable for regular use and that dual function fluorometer / luminometers did
not posses sufficient sensitivity to be compatible with this assay. Other
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explanations for the failure to reproduce the results observed by Taipale et
a!126 with this peptide include loss of functionality at some point in the
amplification and isolation process, which would seem unlikely given
restriction digest analysis (Section 2.4.2) or loss of patched expression in the
transfected cell line. Although others have shown that both C3H10T1/2 and
NIH-3T3 cells posses this molecule this was never undertaken in this lab, but
could be easily performed in future studies at mRNA and protein levels.
Taipale et al. also used in house generated Shh with both cholesterol and
palmitoyl modifications, thus it is possible, although unlikely, that this assay
requires Shh to have these modifications. A more likely interpretation is that,
similar to the C3H10T1/2 assay, the use of the fully modified, and therefore
>40 fold more active protein than r-Shh may make the investigative
approaches taken here with r-Shh, both uneconomical and un-physiological.
If the latter explanation holds true then the failure of epithelial supernatants to
induce fluorescence in this assay can only be attributed either to its absence
and therefore erroneous ELISA data, the absence of modifications on this
protein, or some inhibitory factor also contained within the supernatant. The
solution to this conundrum will undoubtedly lie in the modification of the
plasmid vector to facilitate the generation of a stable transfection in the NIH
3T3 cell line to allow procedural optimisation, perhaps with the newly
commercially available modified r-Shh peptide (R&D) alongside supernatant
additions with and without this peptide.
3.3.5 SHH SIGNALLING FOLLOWING INJURIOUS STIMULI
Given the prompt release of Shh, some 100 minutes post H202 exposure,
and the identification of transcriptional up regulation, it is likely that increases
in Shh represent a release of intracellular stores with necrotic injury (LDH
release), but that those cells which survive exposure up regulate Shh
expression, perhaps as a means to replace released stores, or as a means to
increase release. It is possible that this up regulation is inconsequential and
that soluble Shh is primarily a necrotic leakage. This does not negate its
potential as a signal, indeed it could be hypothesised that this release might
represent an in vivo danger signal, a means to preserve immune function,
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through preserved T-cell function2, 3, or act as a functional signal to
neighbouring epithelial / fibroblastic cells178.
However, such release would seem unlikely in an in vivo setting, due to the
sentinel engulfment function of the AM. Although, there may be a limit to the
level at which necrosis can be controlled in persistent inflammation and
fibrosis. Certainly, necrotic cells have been identified in UIP sections179 18°,
although more recent studies would suggest that apoptosis may be the
dominant cell death process in UIP biopsy.181 Such conflicting studies may
be rationalised if necrosis is considered a feature of exacerbating disease,
over and above persistent apoptosis in UIP.
If the observed up regulation is considered a significant finding then this
could have important implications for Shh expression in human disease. If
Shh is considered a marker of injurious up regulation, then its expression in
regions of disease could indicate the involvement of some persistent injurious
stimuli, leading to the chronic up regulation observed in UIP.1
The release of Shh by injured cells positions Shh, an epithelial mitogen,
centrally within areas of potential epithelial denudement, thus here it could
represent a normal repair mechanism, equally its interactions with the FGFs
in development, if recapitulated, could represent a means of inducing
changes in the extracellular matrix or fibroblastic growth and activity to
induce sealing of denuded areas preventing transudation of fibrotic growth
factors from the serum into the air spaces. Such activity could place Shh as
both an ameliorative and a pro-fibrotic factor in disease.
The underlying premise of this Chapter has been that by using cell lines, it is
possible to avoid the injurious extraction and isolation of primary epithelial
cells, facilitating a more accurate analysis of cellular response to injury in a
defined population. Whilst this is undoubtebly true for inflammatory cytokines,
and signals not involved in epithelial proliferation and viability; use of cell
lines in the analysis of remodelling and developmental signals may be
fundamentally flawed. Both cell lines shown here are derived from
carcinomas, where the most common cancer associated genes in epithelium
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are developmental. A549 are well characterised producers of Shh protein, an
epithelial mitogen, and in that sense do not represent a normal epithelial cell,
where expression has been found lacking1. Similarly, CMT are constitutive
producers of Shh protein, where my primary cell work, (Chapter 4) and that of
others would indicate that this is not the case in normal mouse epithelium1,73'
74. In addition, cell lines, by their very nature, are immortal thus an analysis of
proliferation following injury, whilst indicative, yields little of comparable value
for in vivo systems.
However, given that Shh has been hypothesised as an indicator of epithelial
activation and/or injury, primary isolation work is also impractical. Human
primary epithelial cells are also rarely available, and primary pulmonary
epithelial cell yields from mice are low, thus requiring sufficient mouse
numbers to make studies such as those conducted here, restrictive both
ethically and economically.
An ideal analytical tool would be a more specific advancement on the
combined immunohistochemical and in situ RT-PCR techniques currently
used for Shh in the gut 182. This would address the immunohistochemistry
concerns expressed here and in Chapter 4 and would confirm producer cell
populations, over those which may have received protein in a Ptc, Megalin or
Hip associated manner. This approach is discussed further in Chapter 5.
3.3.6 EFFECT OF SHH ON FIBROBLAST ACTIVITY
Given the hypothetical role of Shh as an indicator of injury and the
localisation of Shh epithelial expression in vivo to epithelium in areas of
fibroblastic foci in both mouse and human1, it was postulated that Shh might
modulate fibroblast function. Neither the addition of exogenous Shh, nor
blockade of Shh signalling resulted in any change in fibroblast proliferation
(Figure 3.17). Once again this study was limited by the use of a cell line.
These studies could easily be extended to primary cell isolates, better suited
to a proliferation readout. However, there can be significant variations in
primary fibroblast isolate subtype, affecting both their response and
proliferative rate. Thus the passage number at which the experiment is
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performed could determine the fibroblast population and therefore the
response obtained. A future point of analysis might be the real time analysis
of procollagen expression in cell line and primary fibroblasts when treated
with Shh blockers or agonists.
Interestingly, addition of r-Shh induced an up regulation in IL-6 production in
these fibroblasts, albeit to just above the limit of detection of the CBA assay.
However, this finding is tempered by a lack of comparable proliferative data,
as the concentration which gave detectable levels of IL-6 is a titre above the
upper value used in proliferative studies. Although the concentration of r-Shh
used here is almost certainly un-physiological, native fully modified Shh
would likely generate a similar response at a much lower, more physiological
concentration.
Expression of IL-6 is particularly interesting given its anti-proliferative affect
on pulmonary fibroblasts and the suggestion that it is spontaneously
produced by epithelium as an autocrine growth factor, in addition to its role
as an acute phase signalling molecule. Thus if Shh release is considered as
an indicator of danger, it could up regulate IL-6 production in receptive
fibroblasts to perpetuate this signal and as a means of preventing
overzealous fibro-proliferation in the recovery from minor denudation, whilst
stimulating epithelial proliferation, although given the substantial quantities of
IL-6 which the epithelium is capable of synthesising in response to loss of
contact inhibition, particulates and interaction with allergens such as Der P1,
the affect of sub-epithelial fibroblast IL-6 production may only be marginal in
this process.
3.3.7 EFFECT OF SHH ON EPITHELIAL ACTIVITY
Given the expression of ligand and receptor by the same cell it was
hypothesised that Shh release might represent an autocrine signal involved
in the up regulation of GM-CSF/IL-8 in the CMT and A549 lines respectively.
Addition of r-Shh and 6hr supernatants, demonstrated that this was not the
case, as did injury in the presence of the Shh inhibitor Cyclopamine, where
no alteration in cytokine response was observed (data not shown).
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A more speculative hypothesis, given Shhs role in maintaining a pluripotent
haematopoietic progenitor population 127, might be that the Shh signal is
there to prevent the differentiation of all type II cells into type I / repair cells,,
thus maintaining the lung progenitor population. Such an explanation could
be extended to the disease phenotype of up regulation observed in FITC and
human lung disease by Stewart and colleagues 1. Erroneous up regulation of
the Shh pathway, either through an upstream signalling event or repetitive
injurious stimuli, might result in hyper-proliferation of type II cells, which
would be visualised as bronchiolisation, which is indeed a feature of human
inflammatory fibrotic disease. Equally, an increase in type II cell number
would increase the pool of cells capable of producing cytokine and
chemokine up regulation in response to injury, which might in some way
explain the hyper-responsive exacerbations observed in patients with IPF,
where Stewart et al observed up regulated Shh1.
Such a role for Shh could only be investigated through the addition of
exogenous Shh to primary epithelial explants, which normally spontaneously
differentiate from type II to type I.
3.4 CONCLUSIONS
The aims set out for this Chapter were achieved in that a successful in vitro
cell injury assay was established, cytokine responses identified and
analysed, a means of quantifiably measuring Shh was developed, and its
release identified from injured epithelium.
The hypothesis posited at the start of this chapter was as follows:
"The up regulation in epithelial Shh expression observed in fibrotic disease is
a response to injury, and that this injury also affects other epithelial cell
functions. Further to this it is hypothesised that up regulated Shh affects
epithelial and fibroblast function."
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Data presented here suggest that soluble Shh release is indeed a response
to injury and that injury also induces changes in epithelial cytokine
production. However, although identifying a marginal increase in IL-6, these
investigations did not conclusively characterise a function for soluble Shh. It
is possible that Shh modulates responses or cells not characterised here, or
that it requires the presence of an intermediate cell type to mediate its
downstream effects.
3.5 FUTURE WORK
In covering the hypothesis and aims for this Chapter, the results presented
here have raised a number of potentially interesting questions for further
work.
3.5.1 DAMAGING ASSAYS
The issue of FITC application needs to redefined, and could be used as a
clumped suspension if analytical techniques progress sufficiently to allow
supernatant analysis, without the complication of fluorescent carryover.
Human experimental data here are limited to H202, and whilst FITC/DMSO
and H202 are relevant in vitro / in vivo comparable reagents for mouse
models of lung disease, H202 injury has only limited analytical value when
compared to human conditions. Certainly the differences exhibited in data
presented here would suggest that the nature of the cellular injury has
important implications as to the cytokine expression profile induced in injured
ceils.
Another more relevant approach might be an investigation into mechanistic
immunological damage at epithelial surfaces, such as the studies conducted
by Wallace et al113, where incubation of antibodies against an epithelial IPF
auto-antigen with A549 cells in-vitro, resulted in reduced A549 cell number
and up regulation of TGF-(3 and tenascin. Should Shh be identified here,
using better characterised diagnostic tools it would provide a crucial link
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between immunohistochemical observations in patient sections and in vitro
mechanistic causation. Another approach might be a renewed attempt at
incorporating bleomycin injury into the assays.
3.5.2 SHH ELISA AND IMMUNOHISTOCHEMISTRY
Solving the issue of r-Shh vs. native Shh will ultimately lie in the optimisation
of the bioassay. This will allow the confirmation of supernatant Shh positivity
in a manner not requiring antibodies, which persist in most diagnostic tests,
i.e. westerns, immunohistochemistry, elispots etc.
3.5.3 SHH AS A SIGNALLING MOLECULE
Further investigation into the response of the fibroblast to r-Shh certainly
merits further investigation, as IL-6 could be a key player in a number of
pulmonary conditions.
Thus, in summary, the focus of future work arising from this work should be
the development of a reproducible and reliable bioassay for Shh, further
fibroblast studies with exogenous Shh and expansion of the compound
selection in the injury assays.
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CHAPTER 4: THE FLUORESCEIN




The initial objective of this work was to further characterise the effects of
transoral intratracheal administration of the hapten fluorescein isothiocyanate
(FITC) into the lungs of Balb-c mice; specifically its effects on both the
immune response generated and the Shh signalling pathway.
Aspects of the FITC-mediated immune response were investigated through
the development of novel ELISAs for FITC specific serum antibodies and
through histological examination of archive T-lymphocyte depleted studies.
The involvement of the Shh pathway in this model was assessed through
Immunohistochemical analysis and primary cell studies.
Since its original conception in this lab, the FITC model has undergone
substantial development from its original form and has been used to
investigate both acute and chronic conditions by ourselves and others123 1'
121. The following sections detail these alterations, including some discussion
of the findings made using the differing modifications.
4.1.1 MODEL ONE
The FITC model was first reported in 1995123. Initial studies utilised both HAN
rats and Balb-c mice 123, later focusing on mice1.
Mice were anaesthetised via inhalation of halothane, an incision made to
expose the trachea, and FITC suspended in PBS to 3mg/ml. This was
delivered intratracheal^ in a 50pil volume (approx 0.007mg per g body
weight). Rats were anaesthetised via intraperitoneal injection of Valium™
(diazepam) and intramuscular Hypnorm™ (fentanyl/fluanison) and had 0.5ml
of 1mg/ml FITC instilled intratracheally.
At three days post administration there was an increase in BALf protein
levels, indicating damage to pulmonary structures facilitating exudation of
serum proteins into the airspaces. This was associated with a marked
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inflammatory infiltrate, predominantly of neutrophils, but also including a
significant mononuclear cell population. The infiltrate penetrated both the
interstitium and the alveolar spaces, with corresponding high BALf cell counts
up to seven days after instillation. Alveolar oedema was also observed, along
with epithelial hyperplasia; findings consistent with FITC induced acute injury.
Neutrophil infiltration resolved after this initial acute response, but interstitial
mononuclear infiltration persisted up to five months post instillation, where it
was found associated with focal destruction of lung architecture. These
regions were patchy in distribution and exhibited features of fine
honeycombing, reminiscent of that observed in UIP, and were restricted to
areas of persistent FITC, where neighbouring FITC negative areas appeared
to retain normal architecture1.
The resolution of neutrophil infiltrate and protein exudation early in the acute
response would suggest a mechanism other than neutrophil mediated
damage or prolonged epithelial denudement be responsible for the chronic
fibrotic response observed. The occurrence of serum antibodies to FITC and
the continued lymphocyte infiltrate would suggest a T cell dependent
immunological basis to the FITC disease process. Unpublished mouse data
by Steve Roberts of this lab demonstrated a two fold increase in serum
aFITC IgG titre between normal/3day and 3 weeks post instillation in FITC
treated mice.
What has yet to be investigated using model one, or subsequent models,
described below, is the specific disease inducing activity of FITC at the
pulmonary surface, why is inflammation and fibrosis induced upon its
administration and why does it persist.
A few hypotheses can be posited as to potential reasons for the pathology
observed. FITC (Fluorescein isothiocyanate) is a fluorescent compound
whose isothiocyanate group reacts with amino terminal and primary amines
in proteins. Such a process occurring in the lung, cross linking and attaching
to epithelial structures, would be expected to disrupt normal lung flexibility,
and might result in the initiation of pro inflammatory and profibrotic activity.
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Equally, FITC crosslinking might interfere with or inactivate normal pulmonary
cellular signalling mechanisms or may act as a toxic agent inducing both
acute and chronic cellular injury. Whilst these hypotheses will not be
investigated directly within this Chapter it is hoped that through the study of
histology and immunological responses to FITC instillation, the manner in
which it induces disease may become evident.
4.1.2 MODEL TWO
The surgical technique employed in model one induced a 5-10% mortality
rate within 24hrs. In accordance with the Flome Office policy of replacement,
reduction and refinement, Dr GA Stewart of our lab modified the model to
incorporate a transoral intratracheal delivery system, which markedly
reduced the mortality of the procedure (<1%)183. With this method, mice were
anesthetised with avertin (tribromoethanol anaesthetic) at a dose of 0.2ml per
10g body weight prior to instillation of 50[xl of 2mg/ml FITC via non surgical
intubation with a blunted 25G needle, as described in Chapter 2.
However, no fibrosis was observed in these mice by six weeks post
instillation and much of the FITC had been cleared, thus a second instillation
was performed at this time point. Studies by Dr S.A Ahmad of our lab
demonstrated fibrosis in 100% of FITC positive mice using this method,
greatest at fourteen weeks post a second FITC instillation184.
ACUTE EFFECTS
Just 24hrs after FITC instillation there was a marked increase in BAL
neutrophils, some six fold greater than controls, decreasing to near PBS
controls by 7 days post instillation. Using a novel scoring system on 10
random fields including at least one bronchiole (less than half field width in
diameter), a blood vessel and an airway, Dr Ahmad also demonstrated
increased infiltrate at 24hrs post instillation continuing through 7 days in the
perivascular compartment, alveolar walls and peri-bronchiolar alveolar tissue,
with the exception of the bronchiolar epithelial compartment itself, which
decreased to near control levels by 3 days post instillation, indicating a
dynamic infiltrate process184.
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During the initial seven days after instillation the FITC was observed in
large/small bronchi, blood vessels and alveolar walls, with heavily stained
tissue and alveolar macrophages. Alveolar thickening and infiltrate were
observed by 7 days post instillation and IHC staining with a TGF-p antibody
was markedly increased in FITC vs. PBS treated mice, peaking at 5 days,
particularly in alveolar macrophages.
Of particular note is that both PBS and FITC intratracheal delivery induced
measurable TNFa levels in BALf fluid, peaking at 24hrs post instillation,
which was 2 fold greater in FITC mice than PBS mice. This provided further
evidence of the acute processes initiated through FITC instillation over that
induced by PBS instillation.
LONG TERM RESPONSE
FITC was observed retained in the lung up to six weeks post first instillation,
although somewhat reduced in intensity. A second instillation of FITC at this
time point generated a similar acute inflammatory infiltrate to that of the first,
when observed 7 days post instillation, becoming predominantly
mononuclear through 6 weeks post 2nd instillation, up to 14 weeks184.
By 14 weeks post secondary instillation, FITC treated animals had developed
fibrotic changes in the lung, presenting with areas of severe fibrosis with
complete obliteration of alveolar architecture associated with residual FITC
deposition184.
Although there was no clear association of lymphocyte cell type with fibrotic
areas, mononuclear aggregates containing T & B lymphocytes similar in
composition to those observed by Wallace et al in patients with UIP, occurred
with increasing intensity over 6 and 14 weeks time points, and were
suggestive of a local humoral response, a feature suggested by the
development of FITC specific antibodies in the single instillation model.
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4.1.3 THE MICHIGAN MODEL
Colleagues at the University of Michigan School of Medicine, Ann Arbor,
have also published data using the FITC instillation model. This centre uses
a method similar to model one, briefly, FITC was sonicated as a 1.4 mg/ml
PBS solution at 50% power for 30 seconds, later adapted to 2.1 mg/ml121,185.
Mice were anaesthetised with pentobarbital, a small incision made into the
neck and the trachea exposed by blunt dissection. The animals were
restrained at 60° angle and 50pJ FITC delivered directly into the trachea
through a 26g needle. This solution was vortexed vigorously prior to each
instillation121. This group has focused on the initial innate and adaptive
responses to instillation, using short recovery time points as a means of
studying inflammation and acute interstitial scarring.
FITC staining remained largely peribronchial, although the authors suggest
that the occurrence of alveolar wall oedema is evidence for FITC mediated
affects outside its area of deposition185. Although possible, our experience
with anti-FITC staining would suggest that oedema is also directly FITC
associated and that this would be visualised with more sensitive
immunohistochemistry.
Eosinophilic exudates, haemorrhage and acute inflammation were observed
within the first few days of injury, with dense consolidation of PMNS and
mononuclear cells by days 3-5 post instillation, persisting to the final 21 day
time point. By day 21 patchy areas of increased ECM were observed, with
relative increases in collagen greater in the Balb-c mouse strain when
compared with the C57/BL6 strain185. Balb-c have a well characterised
propensity to develop humoral (Th2) responses compared to primarily
cellular (Th1) responses in C57/BL6186. This was suggestive of an immune
polarisation effect on the initial scarring response, however both strains
produced specific IgG antibodies against FITC, which although not instructive
as to polarisation (isotypes lgG2a (Th1) and lgG1 (Th2) not supplied), would
indicate that the type of response is not dissimilar in the two strains. Equally,
the 21 day fibrotic response observed in these mice is identical in RAG-KO
(no T/B lymphocytes) and SCID (no immune system) mouse strains
suggesting that this initial scarring may occur in the absence of active
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immunity, possibly involving a local up regulation in TGF-p observed
following the first instillation in model 2184.
MCP-1
Although apparently T-cell independent, the Michigan model does feature
significant inflammatory infiltration, and repetition of this model in knockouts
of CCR2 a chemokine receptor for MCP-1, resulted in a protection against
fibrosis.121
MCP-1 is a chemo-attractant produced by monocytes and their derivatives,
macrophages, and by endothelial, epithelial and fibroblastic cells. It may
recruit CCR2 expressing cells to sites of injury, where expressors of this
receptor include monocytes, macrophage, activated T-lymphocytes, B-cells,
mast cells and fibroblasts. This would suggest that disruption of inflammatory
recruitment, protects against fibrotic development.
However, the authors claim that protection was not linked to differences in
the initial inflammatory cell response as this was similar for both wild type
and knockout mice, although notably, plasma leak resolution was more rapid
in CCR2-/- and later mononuclear infiltration was also reduced121. The
authors instead, referencing studies in Acute Respiratory Distress Syndrome
(ARDS)187 suggest that MCP-1 serves an activating function in this model,
increasing cytokine production.
GM-CSF
CCR2 knockouts were also found to produce markedly decreased levels of
TNFa, a cytokine with well characterised pro-inflammatory and fibrotic
function, and greater amounts of GM-CSF than wild type mice treated with
FITC.
GM-CSF is an epithelial mitogen with the capability to influence the number
and activity of alveolar macrophage and mature dendritic cells. Its up
regulation here is crucial given the findings of this same group with the
bleomycin model of lung injury103' 122 Here, GM-CSF was shown to be
essential for the maintenance of PGE2 levels, an anti-fibrotic eicosanoid.
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Thus increased levels of GM-CSF in CCR2 knockouts may be responsible for
reduced fibrogenesis in response to FITC, although whether this represents
true protection in these mice or merely delayed progression, was not
addressed in these studies121,121,122.
4.1.4 REMODELLING, FIBROSIS OR REVERSIBLE INFLAMMATORY
ATELECTASIS?
Remodelling is a term commonly attributed to conditions where pathologically
there is evidence of lung damage or chronic progressive fibrosis. This is
associated with inflammatory atelectasis and general deformation of normal
lung architecture. Increasing use of this term in mouse models has been
necessitated by lack of a clearly defined terminology for descriptions such as
chronic and acute fibrosis, scarring and interstitial vs. sub epithelial fibrosis,
as defining features often differ or are absent in mouse compared to human
diagnostic criteria, and this has led to their incorrect attribution to a number of
mouse lung models, where remodelling would have been a better attribution.
An example of this might be the 21 day post FITC instillation time point
described by Christensen et al in the Michigan model185. Whilst a process
which undoubtedly involves fibroblasts and increased collagen deposition is
initiated in these mice, they have never been pursued to later time points
(personal communication), thus it may not be accurate to define these as
fibrotic, which by classical definition is an overzealous healing response to an
acute or chronic event which results in permanently dysfunctional areas of
lung through establishment of fibroblastic proliferation and collagen
deposition.
The level of dysfunction resulting from fibrosis is perhaps the area where
most variation occurs in experimental definition. Where more acute scarring
might be expected to result in retention of thickened areas of epithelial
mesenchymal tissue following resolution, which does not irrevocably reduce
the functionality of that airway, end stage fibrosis, more typical of chronic
progression, results in enlarged disorganised macrostructures, which are
functionally redundant, produced by contractile restriction of surrounding
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fibroblastic bundles and interstitial connective tissue deposition. Thus what
some describe as acute fibrosis, such as in the 21 day Michigan model,
others would define as early remodelling or more specifically, loss of
structural integrity through a persistence of inflammatory infiltrate.and
associated atelectasis.
Experience would suggest that much of the early airway collapse and
alveolar thickening observed in FITC mice is attributable to the inflammatory
infiltrate and that in the absence of a secondary instillation of FITC much of
this architecture returns to normal. In our hands, fibrosis in model one only
occurs as a chronic response, and in the transoral delivery method utilised in
model two, fibrosis also occurs as a chronic response, following a second
instillation.
4.1.5 HYPOTHESIS AND AIMS
Previous studies of Shh at the pulmonary surface utilised model one where
100% of FITC positive mice developed fibrosis following a 3mg/ml surgical
instillation1. Subsequent transoral dual instillations used 2mg/ml of FITC, and
although all FITC positive mice developed fibrosis, up to 25% of FITC
instilled mice could be FITC negative by 12 weeks post second instillation184.
The dose used in transoral dual instillations used here was increased from
2mg/ml to 3mg/ml, with the aim of increasing the proportion of mice retaining
the FITC and developing fibrosis.
Given the findings discussed in the previous sections and introduction to this
thesis, the first hypothesis proposed by this Chapter is that Shh is a signal
found associated with areas of chronic fibrosis in the dual instillation model of
FITC instillation, signalling through interactions with epithelial cells, AM and
fibroblasts.
A second, broader hypothesis, is that the FITC model represents a model of
acute inflammation, which primes the immune system to make an injurious
and profibrotic response upon secondary instillation of FITC. A continuation
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of this hypothesis was that FITC instillation induced a Lipopolysaccharide
(LPS) hypersensitivity response in AM, leading to inappropriate cytokine
secretion, with potential profibrotic side effects
The aims of this chapter were therefore to:
- Compare the immunohistochemical observations from the surgical
model with the transoral model
- Characterise the morphological alterations and inflammatory
recruitment induced by dual instillation of an increased
concentration of FITC
- Screen Alveolar Macrophage isolates from FITC and PBS treated
mice for differences in cytokine production in response to r-Shh
and LPS
- Screen fibroblast and epithelial isolates from FITC and PBS treated
mice for differences in cytokine production and responses to r-Shh




4.2.1 INTRODUCTION TO MOUSE EXPERIMENTS
Four mouse studies were undertaken through the course of the work detailed
in this Chapter, as summarised in Table 4.1. Study 1 centred on the isolation
of primary cell populations for in-vitro culture. Alveolar macrophages were
taken to investigate potential differences in LPS responsiveness between
FITC and PBS treated mice, both in viability and cytokine secretion. Epithelial
cell populations and fibroblasts were also analysed. Lungs were also frozen
in OCT/Saline for use in studies described in Chapter 5, and for the
development of an anti-FITC western on whole lung homogenates. This
western will be used to identify the size of, and further analyse, those
proteins to which FITC conjugates in the lung. The development of this
system was underway at the time of writing, but is only in its preliminary
stages and thus will not be eluded to further in this Chapter.
Study 2 also involved epithelial isolation for culture, and in this case RNA
isolation, but concentrated primarily on the generation of long time course
points for immunohistochemical analysis and collagen content estimation.
Findings drawn from studies 1 and 2 highlighted a number of differences
between model one (single surgical halothane instillation of 2mg/ml FITC)
and the current model two (two instillations, non-surgical, under avertin of
3mg/ml FITC).
This was partially addressed in Study 3 by using halothane and avertin
methods of anaesthesia for FITC administration. Variations in surgical vs.
non surgical were prohibited by the current animal licence. Halothane was
introduced as described for model one in the previous section, and avertin as
in materials and methods. No difference was observed in any of the
parameters analysed (sera, histology scores, IHC, procedural mortality), thus
is not discussed further in this section. Data from this study were pooled and
used to address intermediate; 2 week & 6 week post first instillation and
2weeks post second instillation time points not addressed in the previous two
studies. This study also involved non-terminal bleeds for a more complete
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serum antibody profile. Study 4 used archival lung blocks derived from a
previous model 1 experiment conducted by S Roberts in this lab, where
specific T lymphocyte populations were depleted in FITC treated mice. These
were analysed both as a model one comparison with the current model two,
and as a means of assessing the potential role of T-lymphocytes in FITC
mediated disease.
For clarity these studies are addressed in combination unless otherwise
indicated. Time points are defined post the first instillation, thus 6wks refers
to 6 weeks post first or only instillation, whilst 6wks + 2wks refers to 2 weeks
post the second instillation, this is illustrated in the time line in Figure 4.1.
Immunohistochemical analysis is defined per time point in the subsequent
sections, followed by details of quantitative counts and scores performed on
section and cytospin preparations. The final material presented in this results
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Table 4.1: Summary of mouse investigations
All FITC instillations were performed as described in Chapter 2. Cytokine
levels in all BALf were assessed by CBA. AM culture was undertaken in
Studies 1 and 2; only cytospin preparations were taken for study three. Only
6wk + 6wk data for fibroblasts are included in this chapter as 12wk cultures
were found to contain fungal contamination. Terminal bleeds alone were
taken from study 2, study 3 used tail and terminal bleeds. *Lungs were snap



























FITC Sera 16 16
PBS Sera 14 14
No. FITC Mice .





for Histology '®.V \ :
Figure 4.1: Timeline Diagram of FITC instillation Experiments
Illustration of the timeline used in studies 2 & 3 and the relative numbers of
mice involved. Numbers here are used in subsequent IHC in histology
studies. Study 1 is not included as these mice were primarily used for primary
cell isolation, where anti-FITC IHC and H&E were only performed in
representative mice per group to ascertain that FITC had been correctly
instilled and mice had a similar phenotype to that expected for that time point.
Mice were left for two weeks following arrival at the animal facility prior to
initial FITC instillation to facilitate acclimatization. 6wks samples were taken
one day prior to second FITC instillations. Only two exclusions were required,
one 6wk+6wk mouse had no FITC evident in biopsy, (likely a feature of
cutting location) thus was excluded from sera and histology data, and one
PBS mouse at 6wk+6wk which showed histological evidence of a
pneumonia. These were excluded from the numbers shown above.
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4.2.2 SIX WEEKS POST FIRST FITC INSTILLATION
Mouse lung histology six weeks post the first instillation of FITC had multiple
foci of mononuclear infiltrate, as observed in Figure 4.2, with both H&E [A]
and trichrome [B] stains (described in Section 2.8.5). The foci can be
identified by the cluster of purple nuclei observed in the top left of each
image. The darker blue areas of [B], and at higher magnification in [C]
illustrate areas of cellular thickening and increased connective tissue. For
comparison, an area of relatively normal alveolar structure can be seen in the
bottom of [E] in Figure 4.3. However, fibrosis was not observed with either
trichrome or picrosirius stains (data not shown).
Mononuclear foci and cellular thickening were features restricted to areas of
FITC deposition [D] where FITC was found in both large and small airways
and associated with alveolar and interstitial structures. Most apical epithelial
cell surfaces were FITC -ve, but strong sub-epithelial staining was observed
in most small and large airways. FITC -ve areas did not appear to differ from
comparable areas of PBS treated mice. Although inflammation was relatively
mild in these mice at this time point, it was observed in all mice.
In contrast to previous histology from 2mg/ml transoral studies, all FITC
instilled mice were FITC+ve upon Immunohistochemical examination (Figure
4.2), suggesting that either the use of 3mg/ml in these studies has been a
sufficient increase to maintain a greater quantity of FITC in the lung, or that
perhaps anaesthesia & delivery were more effective in these studies.
Figure 4.3, illustrates immunohistochemistry studies from this time point. Shh
expression was negative in most areas, and expression did not correlate with
FITC deposition or differ from that observed in localised areas of PBS mice
[E], although in 1 of 4 mice Shh expression was found to be increased in an
area of distorted and irregular alveolar arrangements. These could be
features of poor inflation during fixation, but visible extracellular connections
across these areas would suggest an irregular structure to this region prior to
death, perhaps attributable to prolonged atelectasis [A,B & C]. Primary
omission controls for Ptc and Shh in this region were completely negative [D].
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This mouse had an apparent unilobal FITC deposition pattern, generating
one highly inflamed lobe, (shown in Figure 4.3) where the vast majority of the
lung was normal and FITC negative, suggesting that increased Shh in this
area may have been attributable to a greater local concentration of FITC.
Although there was a marked inflammation in FITC mice including a
mononuclear infiltrate, which has been shown previously to be Ptc positive1
there was no difference in Ptc expression in FITC mice compared with PBS
control mice [F]. CC10 also remained unchanged (data not shown).
Therefore these data would suggest that neither Ptc or CC10 expression, or
epithelial progenitor population density, is altered by FITC instillation.
Figure 4.2: 6wk Post First FITC Instillation
[A] x100 magnification of a H&E stain of a focus of mononuclear infiltrate in
an area of abnormal alveolar architecture. [B] x100 magnification of a
trichrome stain of the same area shown in [A]. [C] x200 magnification of a
trichrome stain illustrating alveolar thickening and mononuclear infiltrate. [D]




Figure 4.3: 6wks Post First FITC Instillation (2)
[A] x25 magnification of Shh expression in an abnormal area of lung which is
positive for FITC. [B] x100 magnification of Shh expression around a large
airway containing thickened epithelium. This is shown at x400 magnification
in [C], [D] is a x400 primary exclusion control for Shh and Ptc. [E] x100
magnification of Shh expression in PBS mouse epithelium. [F] x400
magnification image of Ptc expression in a FITC treatment mouse, where
similar expression is observed in PBS control mice.
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4.2.3 TWO WEEKS POST SECOND FITC INSTILLATION
Mouse histology from two weeks after the second FITC instillation (Figure
4.4) showed a similar distribution of alveolar FITC to six weeks mice, but with
markedly more FITC localised in sub-epithelial areas of the larger airways
[E], similar to observations made in 2mg/ml studies. This was frequently
found associated with an apparent detachment of connective structures
between the overlying epithelium and underlying alveolar structures.
Increased FITC deposition was not associated with either increased
inflammatory infiltrate or increased collagen deposition as determined by
trichrome staining [B], although there appeared to be marked alveolar
thickening in areas of alveolar FITC deposition as shown in the cental area of
a H&E stained section in [A], where comparatively normal structures (bottom
right of [A]) are retained in areas shown to be FITC -ve (data not shown).
This marked epithelial thickening was not as apparent in 6 weeks mice, as
reflected in the Ashcroft scores which are discussed later.
Shh and Ptc expression was similar in both PBS and FITC instillation mice
[C&D], where the greatest levels of Shh expression were localised to the
cuboidal epithelial cells of the larger airways [C], particularly at airway
junctures/bifurcations. Ptc expression was also greatest in cuboidal epithelial
cells.
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Figure 4.4: 2wks Post Second FITC Instillation
[A] x200 magnification of an H&E of an area of FITC deposition showing
abnormal alveolar thickening in the absence of infiltrate. Increased collagen
deposition was restricted to the larger airways at this time point as shown in a
x200 magnification of a trichrome stain [B]. Shh [C] and Ptc [D] expression
was restricted to the cuboidal epithelium of the large airways. Ptc expression
did not differ between PBS and FITC treated mice. Shh expression in FITC
treated mice exhibited marginally greater expression in some areas of FITC
deposition. [E] FITC deposition occurred in clumped pattern localized to the
main airways, sub-epithelial and associated with disrupted connective tissue.
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4.2.4 SIX WEEKS POST SECOND FITC INSTILLATION
Mouse histology and IHC from six weeks post second instillation (Figure 4.5)
were notable for a more diffuse pattern of FITC deposition, extending further
into alveolar structures than previously [D], pronounced atelectasis, restricted
to areas of FITC deposition [B & C], and by an increased prevalence of
mononuclear foci [A, D, E & F].
Although mononuclear foci were features observed in both six week post
first, and two weeks post second instillation mice, previous foci were isolated
to areas of heavy FITC deposition and abnormal architecture. Their
increased prevalence at this time point appeared to coincide with their
appearance in areas of lesser FITC deposition. IHC conducted by Dr S.A
Ahmad at this time point indicated similar foci of mononuclear cells and these
were shown to be almost entirely B-cells, as defined by expression of the
B220 protein, with occasional T-cells, identified by CD3 expression (See
Appendix - Figure 7.3).
Mononuclear foci were frequently associated with a halo of FITC deposition
[E] and increased collagen deposition. Airway collapse was associated with
increased collagen staining in both trichrome stains [B&C] and weakly in
picrosirius stains (not shown), but in the majority of areas, this occurred in the
absence of fibrotic banding.
Shh expression did not differ between PBS and FITC mice at this time point
(data not shown). However, increased interstitial staining for Ptc was
observed in areas of substantial FITC deposition combined with mononuclear
foci [F], suggesting that at least some of the cells contained in these foci are
Ptc positive cells.
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Figure 4.5: Six Weeks Post Second FITC Instillation
[A] x200 magnification of an H&E stain of a mononuclear aggregate in an
area of abnormal alveolar architecture. [B] x100 & [C] x400, are trichrome
stain images illustrating the loss of architecture, taken from a FITC positive
area shown in [D] at x25 magnification. FITC IHC illustrated halos of FITC
deposition around many of the mononuclear foci [E] which were found only in
FITC positive areas. Ptc IHC [F] demonstrated increased staining in some
areas of mononuclear foci, but not all
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4.2.5 TWELVE WEEKS POST SECOND FITC INSTILLATION
Histological examination of lungs from mice twelve weeks post second
instillation, shown in Figure 4.6. had the most pronounced pathology of all the
time points examined. FITC +ve areas were associated with abnormal lung
architecture almost without exception, as confirmed by Ashcroft score,
discussed later. Studies with the 2mg/ml method at a 14 week time point had
shown similar findings to those represented here, although not as
reproducibly and with less destructive fibrosis.
Loss of lung structure is most easily visualised in [A], where large honey
comb like structures can be observed. Comparing the complete loss of
alveolar structure in this FITC +ve area (and in higher magnification in [B]),
with a FITC -ve area to the bottom left of [A], the localised nature of this
response is clear. This collapse in structure is associated with a substantial
mononuclear infiltrate and increased collagen, observed both through
trichrome [C & D] and picrosirius stains [E & F].
Immunohistochemical analysis shown in Figure 4.7. confirmed the
localisation of FITC to areas of honeycombing [A] and iBALT [B].
Honeycombed areas appeared to contain a slightly higher proportion of
CC10 positive cells [C] & [D] than in normal airway although this was a purely
qualitative observation. No differences in Ptc or Shh expression could be
observed in the honeycombed areas described thus far for this time point, but
in a neighbouring FITC+ve area of abnormal lung architecture, there
occurred an apparent co-cellular localisation of Ptc and Shh expression in
individual cells, not observed at previous or later time points, or elsewhere in
the section [E & F]. Thus, it is likely an isolated event or process, such as the
development of a cluster of carcinoma cells, with which Shh and Ptc
expression are commonly associated, and which FITC mice have been
shown to have a greater susceptibility to (Roberts et al, unpublished
observations).
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Figure 4.6: Twelve Weeks Post Second FITC Instillation
[A] x25 magnification of an H&E stain of a fibrotic, honeycombed area of
mouse lung, with an area shown at x200 magnification in [B], Panel [C] is a
x25 magnification of a trichrome stain of the same area at a greater depth
into the lung, this is shown at x400 magnification in panel [D], [E] Picrosirius
stain at x200 and at x400 [F], from the same area, confirm the observations
drawn from the trichrome stains.
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Figure 4.7: Twelve Weeks Post Second FITC Instillation (2)
[A] x100 image of FITC IHC, establishing FITC deposition central to areas of
honeycombing. [B] x400 image of FITC located around a mononuclear cell
foci. [C] x400 image of CC10 IHC illustrating an area of epithelial proliferation
over a fibrotic focus, shown at x1000 magnification in panel [D], Shh [E] and
Ptc [F] expression in isolated cells in an area of abnormal lung at x400
magnification.
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4.2.6 EIGHTEEN WEEKS POST SECOND FITC INSTILLATION
Histological examination of the lungs of mice eighteen weeks after the
second FITC instillation (Figure 4.8), demonstrated FITC retention largely
restricted to the sub-epithelial regions of the medium and large airways [B &
C], where interstitial and alveolar retention was much reduced compared to
twelve weeks mice. There was also some qualitative amelioration in
inflammatory infiltrate.
FITC associated histology was highly variable ranging from completely
normal to honeycomb, and whilst areas of honeycombing and atelectasis
occurred less frequently in these mice than at previous time points, alveolar
structures appeared thickened and disorganised, but in the absence of
fibrotic deposition or inflammatory infiltration, suggesting that some epithelial
mediated event must be inducing this response, or that these cells have
remained activated following the removal of either FITC or a cellular infiltrate.
In these mice areas of Shh expression were marked in specific sub-epithelial
cells in areas of FITC deposition [D]. It is important to note here that smooth
muscle stains positively for Shh, thus it is possible that these cells represent
a myofibroblast population. Equally these could represent positively staining
blood cells contained within a capillary bed. However, these cells were not
observed in PBS mice [F], where Shh IHC was almost completely negative,
and have not been observed previously.
Ptc expression did not differ between PBS or FITC treated mice in level of
expression, but gave more cellular staining in areas of FITC deposition,
compared to a largely membranous profile in PBS mice.
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Figure 4.8: Eighteen Weeks Post Second FITC Instillation
[A] x400 magnification of a H&E stain showing a typical alveolar structure in
the lungs of FITC treated mice at this time point. [B&C] show FITC IHC at
x100 & x200 magnification, where FITC staining was restricted to sub¬
epithelial regions of large airways. In some regions such as that shown in [C]
there was also Shh [D] and Ptc [E] staining observable. Whilst Ptc expression
was similar in PBS mice, Shh was almost completely absent in PBS mice as
shown in panel [F] at x400 magnification.
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4.2.7 WHOLE LUNG COLLAGEN CONTENT DOES NOT CHANGE WITH
FITC INSTILLATION
Given the qualitative differences in collagen deposition observed through
trichrome and picrosirius stains, a quantitative approach was taken to confirm
these observations. Lungs were taken from 3 mice per group at 12 and 18
weeks post second FITC/PBS instillation. The assay used detected soluble
collagen (recently deposited material), utilising a variant of the picrosirius
stain, where bound material in lysates can be isolated by centrifugation and
solubilised for colourimetric measurement (see Chapter 2).
Assays for 12 week and 18 week time points were conducted on separate
occasions, but with internal collagen controls and against a collagen standard
curve. Samples could not be rerun on a second occasion as they were
unstable following freeze thawing.
No difference was observed between PBS and FITC mice, which is perhaps
not surprising given the limited collagen deposition identified by picrosirius
staining and the diffuse nature of the disease. Differences between 12 and
18 week mice could be a feature of aging, but more likely represents more
effective digestion of lungs at the 18 week time point (Figure 4.9).
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Figure 4.9: Total Lung Collagen Content is Unchanged by FITC
Administration
Three lungs per group, per time point were taken, wet weight taken, and
material digested acidicly according to the protocol described in Chapter 2.
Collagen levels are expressed as a percentage of total protein, as estimated
by BCA kit. Error bars denote standard deviation.
4.2.8 FITC EXPOSED MICE HAVE AN INCREASED ASHCROFT SCORE
Elucidation of a quantitative indicator of disease using whole lung collagen as
a qualifier was likely inhibited through a dilution effect of normal pulmonary
structures in what is a very patchy disease. To account for this variation, a
quantitative scoring mechanism was used on anti FITC stained sections,
based on a system developed by Ashcroft et al164 detailed in Chapter 2.
Briefly, 36 fields at x400 magnification are scored according to fibrotic
progression on a discrete scale of 0-7, where zero is normal and seven is a
severe distortion of structure with large fibrous areas. Panels A and B in
Figure 4.10 detail the score for those fields where over 50% of the area was
FITC +ve. Values for FITC -ve fields can be found in panel C of the same
Figure, along with those of PBS mice. No significant difference was observed
between the FITC -ve areas or PBS mice, although a slight, but not
significant increase was observed in group median value for FITC -ve vs.
PBS at 12 weeks post second instillation, consistent with an increased score
of FITC +ve areas. Most abnormal FITC -ve areas were clustered around
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high scoring FITC +ve areas and may represent a non-specific bystander
affect of inflammatory infiltrate.
The scores shown in panel A reflect those observations made through
immunohistochemical observation, discussed previously, where evidence of
active disease was most pronounced 12 weeks after the second instillation,
decreasing by 18 weeks. Equally from the frequency of scores shown in
panel B it can be seen that whilst at 12 weeks post second instillation, scores
are skewed towards 3-7 with virtually no normal areas, at 18 weeks, normal
areas return and the skewing is reduced, suggesting some remission.
However, the definition of fibrosis is that it is a permanent disruption of
normal architecture. Therefore if 12 week mice are truly representative of
previous histology in 18 week mice, then it must be accepted that some of
the 12 week fields scored as fibrosis were in fact severe atelectasis and that
this may have been responsible for the apparent fall in score.
Alternatively, given the diffuse nature of the disease and mouse to mouse
variation, it may be that the sections cut from 12 or 18 week mice were not
truly representative of the whole lung or group of mice. Further cutting into
the blocks and increased numbers of replicate mice could address this issue.
However these experiments have yet to be performed.
Figure 4.10 Ashcroft score & Frequency [Overleaf]
[A] Illustrates the average median of FITC+ fields for each group (study two
and three combined). Where the number of mice is given in the base of each
bar. FITC-ve fields and PBS treatment mice Ashcroft values are given in the
table below [C]. Panel B shows the relative frequency of each score in each



























































































































































































































































































4.2.9 FITC EXPOSED MICE HAVE FITC SPECIFIC IgG ANTIBODIES
Given the chronic occurrence of mononuclear foci and a significant
mononuclear infiltrate, it appeared that the immune system could be
prominently involved in disease progression. Given that previously
unpublished observations by S Roberts had identified FITC specific IgG
antibodies in these mice, as had others185, bloods were taken from mice in
study 2 and 3 to look for FITC specific IgG over a more inclusive and longer
time course than previously, where published studies are <21 days post
instillation185 and S Roberts looked in model one up to 3 weeks post
instillation (Unpublished observations).
In addition to longer time points, novel ELISA's were developed to determine
the subtype of the IgG antibody, revealing the polarisation of the immune
response (lgG1-Th2 : lgG2a-Th1) and therefore the likely cytokines secreted
by, and the effector function of, the infiltrating cell population.
lgG2a is an indicator of a cellular T-cell response, as switching to the
generation of this antibody by B-cells will require stimuli from FITC specific
Th1 T-cells which are involved in the activation of macrophage (see Figure
1.5). lgG1 is an indicator of a humoral response, as switching to this antibody
will require Th2 T cell stimuli, a cell involved in the propagation of B-cell and
therefore antibody responses.
Sera were titred out until their OD fell within 10 standard deviations of the
mean of 16 negative control wells per plate, and the value of that dilution
given as the end titre. The high concentrations of antibody identified, required
a three fold serial titre (125\i\ into 250^il) such that all low and high values
remained within the linear phase of detection of the plate reader. However,
this titred approach means that some values may be markedly out of range of
the true value, but each data set was analysed identically, thus are internally
comparable.
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Values are given here per study, due to different time points being taken and
ELISAs were run on separate occasions for each study, thus the data are
non-comparable as the ELISA does not contain a standard curve function.
FITC exposed mouse sera were found to contain substantial levels of lgG1
(Figure 4.11), which were exponentially increased over 2, 6 and 12 week
time points following the second instillation of FITC. Specific lgG2a levels
were undetectable. Thus of lgG1&2, lgG1 appears to be the main IgG
subclass involved in this system.
Figure 4.12 includes Ashcroft scoring data along with the average titres for
those particular mice and would indicate a correlative trend, however, the
numbers used in these studies negate any truly reflective correlative
statistical examination of this data.
Such an association is further characterized in Table 4.2, where the average
lgG1 levels of individual mice for each tail and terminal bleed would appear
to match their Ashcroft score, again in the absence of any correlative
statistical significance due to small sample numbers.
185
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Figure 4.11: FITC Specific IgG Titres
Bars denote median values. [A] Study 2 sera had an increased lgG1 titre at
18wks vs. 6 & 12wks, 6wks n=8 mice, 12wks n=9 mice, 18wks n=8 mice.
Median values for PBS mice were negative for specific lgG1 at each time
point tested. 6wks included 8 mice, 12 & 18wks included 9 mice. [B] Study 3
sera had a reduced lgG1 titre 6wks post first instillation, which became
boosted exponentially post second instillation. PBS were negative. Mice per
time point were 2w (16), 6w (16), 6w+2w (12), 6w+6w (8), 6w+12w (4).
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Figure 4.12: lgG2a FITC Titres & lgG1 / Ashcroft Correlation
Data represent average end titres of terminal bleed mice & their average
Ashcroft score. Mice, running left to right across the x-axis are as follows:
7,4,4,4,4,4,4.
MOUSE TIME POINT AV lgG1 AV ASHCROFT
2W 6W 6W+2W 6W+6W 6W+12W TITRE SCORE
1 100 100 2700 300 800 1.5
2 300 100 900 2700 1000 2.4
3 8100 300 1800 200 2600 2.8
4 900 100 200 2700 100 800 2.6
5 8100 900 2700 2700 24300 7740 4.3
6 2700 300 24300 24300 72900 24900 4.8
7 100 100 300 900 900 460 2.8
Table 4.2: lgG1 Ashcroft Correlation
Antibody profiles of study 3 mice until terminal bleed, combined with
respective Ashcroft scores as an approach to illustrate the potential
association of prior antibody profiles on observed pathology in mice at the
terminal time point.
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4.2.10 VARIATION IN ELISA AND ASHCROFT SCORES
Considering the sample size of 36 fields the standard error bars of Ashcroft
score remain fairly substantial (Figure 4.10), illustrating variation from mouse
to mouse, which may also be influenced by the depth of section cutting,
which was, where possible, standardised to the first full face available. The
individual mouse serum titres for IgG ELISA are also highly variable (Figure
4.11) attributable to mouse-mouse variation and the three fold titre technique
employed in ELISA. Median values have been used in these studies to
lessen the influence of these outlying values. For example, in a worst case
scenario, the median for all the 12 weeks study 2 mice titres (n=9) is 300,
where 4 of the 9 values are 100, whilst the average is 55450, due to the three
fold titre utilised, generating large differences in end titre values. Variation
was more commonly similar to that of 18wks mice (n=8) where the median is
5400 and the average 9225.
However, variation is most notable when comparing individual mice. Figure
4.11 details titre medians for 6wk (n=9),12wk (n=8) and 18wk (n=9) mice.
When this profile is re-illustrated with only those mice for which there are
Ashcroft scores, i.e. those mice not used for primary cell culture and collagen
content estimation, the profile is completely different (Figure 4.12). Whilst this
is undoubtedly affected by the use of average values in the latter figure, it
highlights the analytical uncertainties associated with such a variable data
set.
In light of this observation is the observed drop in Ashcroft score at 18 weeks
post second instillation a feature of random sampling, selecting healthier
mice for embedding and scoring? Closer analysis of the data contained in the
previous figures would suggest no, if the serum values are taken as an
indicator of Ashcroft score.
The average end titre value of all the 12wks study two mice together is
55450, which is higher than the average for those mice from this group which
were taken for histology (27477). Thus, if the observed correlation holds true,
then a remission in Ashcroft score would still have been expected were all
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the 18wks mice taken for embedding, as the average titre of those taken for
embedding (7650) is approximately the same as that of the whole group at
9225, both of which are substantially less than the 12wks data.
4.2.11 MOUSE SERUM DOES NOT CONTAIN FITC SPECIFIC IgE
Given that lgG1 is a Th2 associated antibody, it was hypothesised that these
mice, due to the chronic persistence of the FITC, might also develop FITC
specific IgE antibodies. These are also Th2 associated but are more
characteristic of allergic diseases such as asthma and allergic
bronchopulmonary aspergillosis (ABPA). ABPA, a complication commonly
seen in Asthmatics, is a particularly interesting comparison given that it
arises from a failure to clear epithelial associated Aspergillus fumigatus and
patients can go on to develop end stage fibrosis188, albeit in a bronchial
rather than alveolar setting.
Bloods from study two were assessed for total IgE using a sandwich ELISA
system detailed in Chapter 2, then FITC specific antibody identified using a
novel ELISA system developed here. FITC specific IgE identification
necessitated prior IgG antibody depletion to prevent competitive binding.
When utilised in the specific ELISA, these samples were found to be
completely negative.
4.2.12 BALf SHOWS NO EVIDENCE OF ALVEOLAR INFLAMMATORY
INFILTRATE
BALf were taken from all mice used in this Chapter. The data in Figure 4.13
detail counts performed on those obtained from studies two and three. The
airway cell populations of FITC and PBS mice did not exhibit any marked
differences at early time points, although the occurrence of lymphocytes at
later time points (panel D) might suggest specific infiltration. Underlying blood
contamination can be dismissed, as neutrophil levels remain low in the BALf.
Data from twelve weeks post the second instillation could be attributable to a
condition common to the groups as it occurs in both. However, there is a
significant difference between the treatment groups at 18 weeks post second
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Figure 4.13: BALf Cell Populations
[A]-[D] Represent the percentage cell population of the four cell types
counted. Only BALf for which there were corresponding sections were used,
and the data from study 2 and 3 pooled. Replicate numbers are displayed in
the base of the bars in panel [C]. Error bars denote Standard Error *=p of
>0.05 with parametric tests.
4.2.13 INTERSTITIAL INFLAMMATORY INFILTRATION INCREASES IN
THE TWELVE WEEKS FOLLOWING FITC INSTILLATION
Analysis of mouse histology during the treatment period identified variable
numbers and size of mononuclear foci and focal areas of infiltrate mediated
atelectasis. However infiltrate counts illustrated in Figure 4.14 would suggest
that there is a trend for increased inflammatory infiltration over the twelve
weeks following the second FITC instillation. It is important to note here that
this scoring process does not discriminate between FITC positive and FITC
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Figure 4.14: Inflammation Scores of FITC Treated Mice
Represents the relative inflammatory infiltrate identified in H&E sections of
study three mice
4.2.14 MICE DEPLETED OF T-LYMPHOCTYES HAVE A REDUCED
ASHCROFT SCORE
Given the prominence of lymphocytes in previous analysis, Study 4 was
instigated. This utilised archival paraffin wax embedded, formalin fixed lung
tissue obtained from T-cell depleted mice used in model one experiments by
S Roberts. These were scored for Ashcroft and inflammatory infiltrate, the
results of which are displayed in Figure 4.15.
The small replicate number negates any true analysis, but the trend would
indicate that depletion of T-cells reduces atelectasis and fibrosis, as
measured through the Ashcroft score, and that this affect was greatest in the
CD4 T cell depleted mice (Figure 4.15[A]). Depleted mice had a greater
percentage of ones, over controls, whose frequency distribution was
concentrated at three (Figure 4.15[B]). Of particular note is the reduced
infiltration score for CD8 and total T-cell depletion, whereas CD4 depletion
retains a control level of infiltration (Figure 4.15[C]), despite a lower Ashcroft
score. The pictures shown in Figure 4.16, are from total T-lymphocyte
depletions, but represent features observed in all four groups
INFLAMMATION SCORES FOR
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Figure 4.15: Scores for T-Lymphocyte Depleted Mice
Score data from study four, model one mice, killed 6 weeks after a FITC
instillation. CD8 (n=3), CD4 (n=3), Total T-lymphocyte (n=2), control
depletion (n=3). Error bars denote standard error. No error bars appear for
total T cell depletion (due to number in group) or for control bar (due to
absence of any variation). [A] Ashcroft scores, (there was no standard error
in Ashcroft score for total T lymphocyte depletion). [B] Frequency distribution
of Ashcroft score [C] Illustrates the inflammatory infiltrate scores from H&E
sections with the average of each group displayed.
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Figure 4.16: Histological Analysis of T-Lymphocyte Depleted Mice
Model one mice, killed 6 weeks after a FITC instillation, and seven days after
addition of depleting antibodies. [A] x100 H&E stain showing loss of normal
alveolar structure in areas of mononuclear cell foci. [B] x25 image of aFITC
IHC illustrating the restriction of structural disruption and infiltrate to areas of
FITC persistence, areas marked by increased collagen deposition, shown
here in a trichrome stain (x200 magnification) [C]. [D] Shh expression was
identified associated with foci of mononuclear infiltrate, (x400 magnification).
[E] Illustrates an epithelial cross cut, such that Ptc expression can be
observed as a patchwork at x200 magnification, the insert shows a normal
Ptc profile at x400 magnification. [F] Shh is not expressed to the same
magnitude as Ptc in the epithelial cross cut, but does appear localized,
(x200).
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4.2.15 EPITHELIAL CELL ISOLATES
Given that the epithelium is the first point of contact for the FITC, it was
hypothesised that FITC induced its pro-inflammatory and profibrotic effects in
chronic disease through an early interaction with the epithelium, altering
cytokine release.
To investigate this hypothesis and the capability of these cells to generate
Shh both at the genetic and protein level epithelial cell isolates were taken
from 2 FITC and 2 PBS mice and pooled for culture at 12 and 18 weeks post
second FITC instillation. The data in Figure 4.17 correspond to 12 weeks
data, where 18 weeks data gave similar cytokine expression profiles (data
not shown).
TNF-a levels were similar in each extraction, where as substantially more IL-
6 and MCP-1 were obtained from PBS mouse cultures, than FITC ones.
However, although cells were counted and plated according to an optimized
protocol, there can not be complete certainty that the same number of viable
cells were applied in each culture.
Equally, because no sorting was employed, contaminating fibroblastic
production of these cytokines cannot be discounted, although cytospins of
pre-differential attachment cells would indicate that cell populations were
similar, consisting largely of clumped epithelial cells and contaminating
macrophage with occasional lymphocytes. Studies described in Chapter 3,
have shown that cell line fibroblasts produce MCP-1 and IL-6, but not TNF-
a. Thus given that TNF-a levels were consistent between groups and time
points (data not shown), whilst relative values for MCP-1 and IL-6 were
variable, it is highly likely that fibroblast contaminants may be responsible for
the differences between FITC and PBS epithelial preparations shown in
Figure 4.17.
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4.2.16 EPITHELIAL CELL ISOLATES PRODUCE SOLUBLE SHH
Epithelial prep supernatants were also applied to the 5E1 ELISA system
discussed in Chapter 3. These supernatants demonstrated a positive signal
consistent across 72 hours of culture, where media alone was negative
(Figure 4.17). The FITC 48hr peak is likely an anomalous result given the
standard error displayed from triplicate plating. Thus no difference was
observed in soluble Shh signal. Whether this changed with stimuli was not
investigated, neither was immunohistochemical analysis for reasons
discussed in Chapter 3.
4.2.17 PRIMARY EPITHELIAL CELL ISOLATES CONTAIN MESSAGE
FOR SHH AND GM-CSF
Epithelial cells were isolated from study 2 mice at 6, 12 and 18 weeks post
second FITC instillation. RNA was isolated from all, whilst only 12 and 18wk
isolates were used for culture. All three time points were positive for GM-
CSF, and Shh message, where the 12 and 18wk time points are illustrated in
Figure 4.18. Although non-quantitative, all samples were equally loaded and
appear to lack PBS/FITC mouse differences. All samples were DNase
treated and contamination checked with /3-Actin prior to use.
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Figure 4.17: Epithelial Prep Cytokine Production
Epithelial preparations from 12wk post second instillation mice. Pooled from
2 lungs for each group. Error bars denote standard deviation. Panel A & B
data derived from CBA application where detection cut off is 20pg/ml. the low
end sensitivity of the Shh ELISA data shown in C is 3units/ml (samples 1:1,
thus 6units/ml). Data from triplicate wells, except PBS 72hrs which is from
duplicates. Cells plated at identical densities, subsequent data not adjusted
for cell number as cell counts and MTT were not performed because cells
were taken for RNA analysis.
196
Figure 4.18: SHH & GM-CSF mRNA Profiles of Epithelial Cell Isolates
RT gels of RNA isolated from epithelial cell preparations following a
differential attachment step, reverse transcribed using random hexomers and
PCR processed for 35 cycles. Embryonic brain was used as a positive
control for Shh. Cell culture activated CMT epithelial cells were used as a
control for GM-CSF (not shown). A mouse fibroblast cell line, described in
Chapter 3, was used as a negative control.
4.2.18 ALVEOLAR MACROPHAGE
To address the hypothesis that FITC induced disease was a consequence of
an increased sensitivity of AM to LPS stimulation, altered cytokine secretion
or response to Shh, alveolar macrophages were isolated from BALf via
centrifugation for in vitro applications. No purification method was used as
populations were generally >95% alveolar macrophages (Figure 4.13[A]).
During initial cell titrations for correct culture densities, survival was recorded
via trypan exclusion and given as a percentage of cells and viable alveolar
macrophage could be maintained for greater than four days in culture. During
the culture there was a reduction in cellular number per well, this was not
observed in wells stimulated with LPS (100ng/ml) 2hrs following plating
(Figure 4.19[D&E]). This stimulation did not affect the relative trypan blue
exclusion counts.
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However, this technique, although relatively common, is flawed in two ways
when applied to macrophage culture. Firstly, the majority of necrotic or
unhealthy macrophage will be removed with supernatant extraction, thus will
not feature in the percentage counts. Secondly, retained adherent unhealthy
macrophage will likely be engulfed by neighbouring macrophage, hence the
observed reduction in cellular number over time in the apparent absence of
cell death. However if this is taken as the accepted explanation, this figure
still illustrates that until 96hrs post isolation the macrophage had sufficient
engulfment capability to remove necrotic or apoptotic neighbours, as floating
cells were not observed in supernatants. A better measure of AM number
would have been absolute cell counts or the MTS assay, which uses
metabolic conversion of a colourimetric substrate to approximate cell
number.
The cytokine response of AM to r-Shh and LPS was analysed using an
inflammatory CBA kit. 48hrs after plating, unstimulated AM were found to
produce MCP-1 (75pg/ml), IL-10 (50pg/ml) and TNF-a (100pg/ml), but not
IL-6 or IFN-y.
LPS exposure increased the concentrations of MCP-1 (100pg/ml), IL-10
(68pg/ml) and most significantly TNF-a (608pg/ml) and induced IL-6
(50pg/ml). All concentrations remained at basal level with Polymyxin pre¬
incubation.
r-Shh exposure lead to marginal (<10pg/ml) increases in the above
cytokines, with the exception of TNF-a, where the increase was greater
(Figure 4.20). All increases were returned to basal with Polymyxin pre¬
incubation, suggesting that r-Shh mediated effects were attributable to the
affects of LPS contamination.
Although LPS responses were higher in FITC mice BALf preparations,
unstimulated and polymyxin AM cytokine production was also higher in these
mice suggesting that these differences may have been attributable to the
FITC preparations having higher background expression. Whether this was a
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feature of preparation variability in activating the extracted cells, or a variance
attributable to FITC treatment was not ascertained.
ALVEOLAR MACROPHAGE VIABILITY
HRS POST ISOLATION
Figure 4.19: Alveolar Macrophage Isolation
[A] Cell viability ascertained via trypan blue exclusion counts of >200 cells.
Photos are x200 magnification at 24 [A] 48 [B] & 72 [C] hours post isolation.
Reduced cell numbers were identified at later time points in the absence of
floating cells, suggesting engulfment by neighbouring macrophage. This
reduction could be prevented via addition of 100ng/ml of LPS 2hrs post
isolation, where [D] is a 72hrs post isolation image. LPS addition did not
affect relative trypan counts. This observation was made on two separate












































Figure 4.20: Alveolar Macrophage Cytokine Production
Data from 12wk post 2nd instillation, but representative of 18wk post 2nd
instillation data. AM pooled from 2 mice, total of 4 mice from each group
giving two plates of duplicate wells for each treatment. Cells at 1.5x104 per
well. Media removed after 2hrs, replaced with 150pl to which 150pl of
prediluted agent is added, Polymyxin B (p) (10pg/ml), LPS (50ng/ml) and
Shh (1pg/ml). Supernatants removed 48hrs later and duplicate wells pooled.
IFN^y below detection, MCP-1, IL-10 and IL-12p70 patterns were similar to
IL-6 (data not shown). Optimal scaling has been used to the exclusion of LPS
data, off scale bar values are shown in the base of each bar. Red lines refer
to the lowest standard concentration used in the CBA.
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4.2.19 PRIMARY FIBROBLAST ISOLATION
In order to establish whether primary fibroblasts could respond to a r-Shh
signal, and therefore directly link Shh expression with a profibrotic effect, a
primitive method of fibroblast isolation was devised using the fragments of
lung tissue remaining following epithelial isolation. This used no method of
sorting or immunohistochemical labelling, purely consisting of 2-3 passages
to a point of apparent uniform morphology. Cells obtained in this manner
could be maintained for a maximum of 4 passages, upon which they lost their
ability to proliferate, but could be maintained as a healthy culture. The
different media trialled can be seen in Figure 4.21.
4.2.20 PRIMARY FIBROBLAST PROLIFERATION IS NOT AFFECTED BY
r-SHH
Primary fibroblasts were used following a second passage, where cells were
considered relatively pure, as ascertained by morphological observation
alone. Plating conditions and TGF-p concentrations were taken from Huaux
et al 189. Addition of r-Shh to these cells had no affect on proliferation as
measured by MTT signal/cell number (Figure 4.22). TGF-(3 was used as a
control, where fibroblasts should be responsive. TGF-p was shown to
markedly reduce the MTT signal for these primary fibroblasts. This could
represent cell death, but more likely illustrates an inhibition in proliferation,
revealing the normal rate of cell death in these cultures. Mitomycin C could
be used to confirm this hypothesis, but this has yet to be performed.
Considering the diffuse nature of the pathology induced by FITC it is perhaps
not surprising that no differences could be identified from cell isolates
considering the dilution effect of normal unexposed cells in each of the
isolates. Cytokines were not analysed from this study, which is unfortunate
given that in Chapter 3, r-Shh was shown to induce IL-6 which could be
crucially linked to Shh function as IL-6 not only leads to T-lymphocyte
proliferation, but also up regulates antibody production where the generation
of FITC specific antibodies could be crucial for disease progression, as
discussed previously.
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- COLLAGEN COATING + COLLAGEN COATING
Figure 4.21: Fibroblast Isolation Protocol Development
Fibroblasts were grown out of lung fragments approx 5mm2 (dark areas
above) in differing media, with or without collagen coating of the flask
(5ug/cm2). DMEM in the absence of serum, either with and without collagen
coating was identified as the best means of generating fibroblasts. Serum
positive media supported non-fibroblastic proliferation in the absence of
collagen. Cell applications media proliferation was similar to that observed
with DMEM -FCS, but with additional non-fibroblastic proliferation.
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ADDITION OF r-SHH DOES NOT AFFECT


















Figure 4.22: Primary Fibroblast Cell Number is Unaffected by r-Shh
Cells plated 1x104 cells per well in 96 well plates. TGF-|3 (10ng/ml), Shh
(1.5pg/ml). Cyclopamine (10mM) treated controls were no different to media
and r-Shh treated wells (data not shown). Cyclopamine stock is in a DMSO
carrier, DMSO controls were also no different to media controls. MTT





By maintaining mice for eighteen weeks after a second FITC instillation, it
has been possible to illustrate a persistent mononuclear infiltrate localised to
areas of FITC deposition. These regions had increased Ashcroft scores,
peaking at twelve weeks post second instillation (Figure 4.10). A positive
association between these scores and FITC specific lgG1 titres was
observed, in the absence of specific lgG2a and IgE. Further to this, putative
iBALT structures were observed restricted to regions of FITC deposition and
T-lymphocyte depleted mice had a reduced Ashcroft score with FITC
instillation compared with wild type. These data would suggest dual i.t.
instillation of FITC into Balb-c mice results in an anti-FITC Th2 response,
which is non allergic and may be involved in the fibrotic response of these
mice.
The following sections will discuss these findings and their relevance to
disease, concluding with an evaluation of the hypotheses posited at the start
of this chapter and a brief review of future work that could address some of
the issues raised in this Chapter.
4.3.2 INFLAMMATORY INFILTRATE
The association of FITC with areas of irregular epithelial-mesenchymal
separation observed in these studies (Figure 4.8 [B]) indicates that some
limitation in lung flexibility or cellular function has occurred, either as a direct
consequence of FITC, or resulting from the inflammatory infiltrate. The
occurrence of some of these irregular structures in the absence of significant
infiltrate at two weeks post second instillation and persisting throughout the
time course, could suggest an area of ameliorating infiltration, but given the
chronic nature of this response, it is more likely that at least some component
of the structural disruption induced by FITC occurs as a direct result of its
interaction with pulmonary cells, not involving an inflammatory infiltrate.
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Whilst FITC has the ability to covalently crosslink ECM and cell surface
proteins, disrupting normal cellular interactions, studies from the lab of Toews
and colleagues at the University of Michigan would suggest that FITC
delivery can also directly affect cellular signalling121'185. Whilst these authors
concede that this cellular activation does result in the establishment of an
inflammatory infiltrate, they suggest that the development of fibrosis is
immune system independent185, and that the crucial step in fibrotic
progression is the CCL-2 mediated recruitment and activation of circulating
fibrocytes to produce collagen 119°. This would suggest that the occurrence
of an infiltrate in FITC instilled mice is an aside to the pro-fibrotic recruitment
of fibrocytes. Notably however, these studies identified the peak of CCL-2 up
regulation just 3 days after FITC instillation, returning to baseline by 7 days,
where peak levels of collagen deposition were observed at 21 days, the final
time point investigated. This would suggest that this early up regulation
initiates later fibrotic activity.
However, these authors have never looked at later time points, where our
experience would suggest that this early collagen deposition is an acute
response to FITC instillation which ameliorates and that true permanent
fibrotic architecture occurs chronically. Therefore whilst the initial
inflammatory infiltrate may not be involved in the acute scarring response
described by Toews et al, it may still play a role chronically.
4.3.3 THE ROLE OF THE EPITHELIAL CELL
As the first point of contact for FITC, the epithelium is ideally placed to
orchestrate the pulmonary response. Interestingly, the dynamic apical
surfaces of the stratified and small airways, composed of fast cycling protein
and cell populations appeared clear of FITC by two weeks administration,
whilst sub-epithelial regions, composed of slower cycling proteins remained
positive throughout (Figure 4.8). This would suggest that unless some form of
lineage or functional selection occurs as a result of FITC exposure, the role
of the epithelium in the deposition of collagen may be primarily acute,
perhaps as a source of the CCL-2 observed in the studies of Toews et al,
and not involved in the chronic development of fibrosis. This of course does
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not negate the possibility that these early signalling events permanently alter
the epithelial signalling milieu in areas of FITC deposition. However were this
the situation then areas of fibrosis might be expected where complete
clearance of FITC had occurred and this was not the case.
The absolute association of FITC persistence and fibrosis, coupled with the
requirement for a second instillation of FITC to induce fibrosis in the transoral
model (model 2) indicates that the propensity for fibrotic disease is linked
either to the persistence of the FITC in the lung, or the quantity. Ashcroft
scores recorded here were higher overall than those recorded by Dr Ahmad
using a dose 1mg less than that used here,and qualitatively the level of
fibrosis observed was linked to the amount of FITC present in that area.
These observations would suggest that FITC does not induce a permanent
change in the activity of cells where it has lodged, and that its persistence is
required for fibrosis. Furthermore, if the 12 week mice are accepted as
representative replicates of previous histology in 18 week mice, the
qualitative loss of FITC by 18 weeks is associated with a reduction in
Ashcroft score.
4.3.4 THE ANTI-FITC IMMUNE RESPONSE
If the presence of FITC is required to maintain the fibrotic response, but in
the absence of direct signalling, then perhaps it is not the FITC itself, but the
animals immune response to that which determines the extent of disease.
Given the data presented in this thesis it is posited that whilst the acute
response characterised by Toews et al can occur with or without an
inflammatory infiltrate, the chronic development of fibrosis requires an
immune response.
It is unlikely that fibrosis develops as a result of non-specific inflammatory
infiltrate, owing to the absence of significant neutrophil numbers in a
predominantly mononuclear infiltrate (Figure 4.13 & Figure 4.14), where
neutrophils would be expected to predominate in responses to persistent
injury, or AM induced non-specific recruitment of inflammatory cells.
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Instead, the mononuclear nature of the infiltrate would indicate that, at the
time points investigated here, infiltrates arose as a specific response to FITC
or a FITC specific function.
The correlation of Ashcroft score with FITC specific lgG1 titre (Figure 4.11
and Figure 4.12) and the association of iBALT with areas of FITC deposition,
(structures normally associated with B-lymphocyte activity and isotype
switching), are highly suggestive of antibody being involved in FITC mediated
inflammation and fibrosis. Furthermore, the absence of FITC specific lgG2a
and IgE, suggests that the immune response is Th2, but non allergic.
Whether this immune response is ameliorative, made because of events
initiated during the acute period of FITC delivery and resulting in the
reduction in Ashcroft score at 18 weeks, pathologically crucial, or
inconsequential to the development of disease, is a question worthy of further
discussion.
The deliberating factor in the distinction between these roles is why the peak
in Ashcroft score at 12 weeks and not earlier. It is possible that a persistent
or maximum level of signalling must be reached associated with an
inflammatory infiltrate, before fibrosis occurs, which would also explain the
requirement for a second FITC instillation to act as a booster of the
inflammatory response. However, not all chronic inflammatory conditions of
the lung develop fibrosis, thus for the anti-FITC inflammatory response to be
pro-fibrotic there must be something particular about it to initiate fibrosis.
The mononuclear infiltrate could include B & T lymphocytes and macrophage
precursors, which themselves contain sub-populations. This has yet to be
characterised in this work as preliminary IHC investigation with B220 (B-
lymphocyte) and CD3 anti-bodies (T-lymphocyte) did not generate specific
signals. However, it is likely that the increase in lgG1 observed post FITC
instillation, although an indication of plasma cell number, may also be
representative of FITC positive T and B lymphocyte populations represented
in the infiltrate. Thus fibrosis could result from an increasingly Th2 cytokine
milieu in the lung.
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Alternately, fibrosis could result as a result of direct antibody function.
However, unlike the well characterised association of Th2 polarisation and
fibrosis, the association with antibody remains more contentious191 .
4.3.5 FITC SPECIFIC IGG1
lgG1 is a key opsonising antibody which attached to a cell surface antigen in
conjunction with complement protein 1, can initiate a complement cascade
resulting in the death of the attached cell. This can occur either through
membrane attack complex formation causing membrane permeabilisation, or
through recognition of membrane bound lgG1 by Fc (IgG receptor) bearing
cells such as macrophage, which can phagocytose the cell.
The occurrence of FITC specific antibodies could therefore be suggestive of
the removal of cells to which FITC is attached, and that this process induces
inflammation, maintaining the observed infiltrate, and contributing to the
development of fibrosis, although eventually the removal of the FITC would
reduce inflammation, through a lack of antigen.
Alternately the main pool of FITC may reside attached to ECM proteins.
Were this the case large IgG complexes might be expected, with disruption of
connective structures. Thus the association of FITC and areas of epithelial
mesenchymal separation discussed earlier may be representative of IgG
mediated ECM disruption.
However, when considering the potential relationship between FITC specific
lgG1 and Ashcroft score, it is important to understand the limitations of this
data set. Firstly, there are a wide array of other antibody subtypes that were
not investigated here, Secondly, this system does not discount the possibility
that rather than more antibody, high titres may represent greater affinity for
FITC, or less competitive exclusion from another uninvestigated subtype.
Further to this, unlike common mouse model antigens such as ovalbumin or
dust mite allergen, FITC has the capability to conjugate to host proteins.
Thus an analysis of antibodies specific for FITC-BSA conjugates in ELISA,
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does not negate the existence of antibodies specific for FITC-lung protein
conjugates.
Indeed, responses against FITC-lung protein conjugates could be used as an
argument for an ameliorative role for FITC specific antibody, as the perceived
drop in FITC/BSA specific antibody at 18 weeks could represent a switch, or
affinity maturation to anti FITC-lung protein conjugate antibodies, which are
no longer specific for FITC\BSA, but which clear FITC-protein conjugates
from the lung resulting in reduced FITC, and consequently less inflammation.
Equally the delay in antibody peak could be explained by the gradual
"purification" of these conjugates by the loss of more rapidly turned over
protein conjugates, facilitating, along with affinity maturation, the breakage of
T-cell mediated tolerance against the conjugated self peptide.
However, a direct link between antibody and fibrosis would appear unlikely
as fibrosis would then have been expected by 2 weeks post second
instillation through to twelve weeks post instillation, as this was when the
greatest amounts of FITC was present with steadily increasing
concentrations of antibody.
4.3.6 IN VITRO STUDIES
Full analysis of primary cell function in these mice was inhibited through high
variance in low replicate samples, an endotoxin contaminant in the r-Shh
peptide and a paucity of diseased areas limiting FITC exposed cell numbers
in culture. Given the data elucidated in Chapter 3, the injurious extraction
procedure will have affected epithelial cytokine production, and particularly
that of Shh, thus it is difficult to draw any substantial conclusions from the
data presented here, e.g. the occurrence of Shh message in epithelial
isolates, does not necessarily confirm its occurrence in normal in situ
epithelium, given its rapid up regulation with injury. True analysis of
differences in mRNA and protein expression, when considering inflammatory
and fibrotic processes may require another less injurious process such as
laser microdissection where protein and mRNA can be extracted in situ from
defined cell populations. This approach will be addressed in Chapter 5.
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4.3.7 IMMUNOHISTOCHEMICAL ANALYSIS
Use of a newly optimised Shh and Ptc IHC procedure which takes advantage
of the newly available blocking preparatory steps, has reduced what was
originally a more distributed Shh signal, to an exceptionally marginal one
where perhaps one or two areas of expression could be determined per
section from both PBS and FITC mice. Whether this represents truly
increased specificity or rather a reduced sensitivity from the previous method
is a matter of conjecture. However, that the staining pattern for human
tissues, which was more specific than mouse staining using the previous IHC
methodology, remains the same with the new technique (Figure 4.23), would
argue against a loss of sensitivity, instead suggesting that the reduction in
positive staining in mouse tissues using the new technique is attributable to
greater specificity.
Ptc expression was unchanged in FITC instilled vs. PBS mice and was
constant in areas of normal and inflamed lung. The main area of variation
was a more cellular distribution in the cuboidal epithelial cells of the smaller
airways, versus a largely membranous distribution in the more mucal, larger
cuboidal cells of the upper airways. Near serial sections would suggest that
Ptc expression was commonly observed on CC10 positive cells, but also on
CC10-ve cells, although these observations would require confocal dual stain
conformation.
Regular and distinct Ptc expression on the apical surface of epithelium in the
pulmonary system is highly suggestive for a role for this molecule in post
embryonic systems. Although this need not be active, Ptc expression could
represent a "Shh sponge", to endocytose, in the absence of signalling, free
Shh, as described by Torroja and colleagues192. However, such a function
would be largely redundant, given receptors such as megalin and Hip that
could perform such a regulatory function, thus this is unlikely to be the main
role of Ptc.
It is equally possible that Ptc expression occurs as a consequence of an
upstream event, and that its expression is either non-functional, or related to
another signalling ligand such as Ihh, Dhh or an as yet to be characterised
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molecule56. However, data emerging from studies in the gastrointestinal tract
193~196, where Cyclopamine, a Smo inhibitor, continues to have an inhibitory
effect, in the apparent absence of immuno-detectable ligand194 and in some
cases receptor 195, indicates that more sensitive methods of detecting Shh
signalling may be required to discount Shh as a Ptc ligand in adult pulmonary
systems. Thus, the lack of detectable Shh in this study could be attributable
to a limitation in IHC technique rather than true absence of signal.
Given the findings presented in Chapter 3, it is also possible that as an
indicator of injury, Shh might be a rapidly cycled protein. Thus for correct
detection, more rapid fixation might be required. Certainly, methanol fixed
embryonic brain tissue gave greatly improved immunohistochemistry over
formalin fixed tissues (data not shown). Equally, only chronic time points
were analysed in this study, where the results of Chapter 3 would indicate
that greatest Shh might be expected at more acute time points.
However, what would seem more likely is that Shh expression does not play
a crucial role in this disease and that the expression identified previously was
largely non-specific staining. Such a view appears vindicated by current
studies in the lab utilising the new Shh immunohistochemical techniques on
human UIP biopsies, where Shh is still observed associated with areas of
disease, as observed with the previous IHC protocol (Figure 4.23),
suggesting that in this human condition, but not the FITC mouse model, Shh
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Figure 4.23: Shh Immunohistochemistry in UIP Biopsies
[A&B] Photos taken from Stewart et al1 illustrating Shh expression in type II
cells [A] and the metaplastic epithelium of bronchilarised airways [B] using
the old immunohistochemical technique. [C&D] are photos of Shh visualised
with new immunohistochemical techniques, where [C] are type II cells
overlying a fibrotic focus and [D] are large airway epithelial cells. [E]
represents Shh staining in a comparatively normal field of a UIP patient
biopsy using the new methodology.
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4.4 CONCLUSIONS
4.4.1 HYPOTHESIS AND AIMS
To recap the aims of this chapter were to:
- Compare the immunohistochemical observations from the surgical
model with the transoral model
- Characterise the morphological alterations and inflammatory
recruitment induced by dual instillation of an increased
concentration of FITC
- Screen Alveolar Macrophage isolates from FITC and PBS treated
mice for differences in cytokine production in response to r-Shh
and LPS
- Screen fibroblast and epithelial isolates from FITC and PBS treated
mice for differences in cytokine production and responses to r-Shh
- Characterise the FITC specific antibody profile with dual instillation
of FITC
The aims detailed above were used to address the hypotheses that Shh is a
signal found associated with areas of chronic fibrosis in the dual instillation
model of FITC instillation. A secondary broader hypothesis was that the FITC
model represents a model of acute inflammation, which primes the immune
response to make an injurious and profibrotic immune response upon a
secondary instillation of FITC. Further to this it was posited that FITC
instillation might induce some endotoxin hypersensitivity in AM leading to
inappropriate inflammation.
Whilst the aims detailed above were achieved through the completion of this
Chapter, elements of the data collected here were preliminary. For example
primary cell studies, which in retrospect, given the patchy nature of FITC
induced disease, were never going to yield starkly contrasting data in PBS
vs. FITC comparisons. Equally, data collected through the completion of
Chapter 3 would suggest that the injurious isolation process of these cultures
could mask any meaningful comparison.
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Studies characterising the histological and immune characteristics of the
FITC model illustrated a clear association between a Th2 polarised non
allergic immune response and increased ECM deposition, specific to areas of
FITC deposition, where there was no association or functional role for Shh
identified. Thus to address the hypotheses posited at the start of this Chapter
it would appear unlikely that Shh is associated with FITC induced disease.
This of course does not negate its potential for a role in other disorders, given
the prominent and regular expression of its receptor Ptc.
As to the broader hypothesis relating to immune mediated profibrotic
responses, the data presented here are not conclusive. However the
suggestive correlation of lgG1 (Th2) titre and disease score, along with the
reduction in pathological indicators with T-lymphocyte depletion studies, and
the presence of iBALT, would suggest that Th2 immunity may play a role in
FITC instillation mediated disease. Whether this is ameliorative, pathological
or inconsequential has yet to be determined.
4.5 FUTURE WORK
4.5.1 ANTI-FITC IMMUNE RESPONDERS
Future work should concentrate on characterising the foci of mononuclear
infiltrate observed in FITC areas, specifically to identify whether they are
indeed iBALT via staining for follicular DC (characteristic of these structures)
and plasma cells ( CD138+).
It would also be interesting to use a biotinylated anti-mouse lgG1 antibody or
anti-complement antibody on sections. This may generate too much
background but it would be interesting to see if it localised to areas of FITC
deposition. Another approach might be to take sera from FITC or PBS mice
and use as a primary antibody on mouse sections blocked with un¬
conjugated anti-mouse IgG. This would identify whether the sera of FITC or
PBS mice contain lung or FITC specific antibodies, and the localities to which
they bind.
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Equally it would be interesting to take a whole lung homogenate and extract
the mononuclear cells for fixed co-culture with biotinylated FITC for use in
flow cytometric analysis with a cassette of lymphocyte markers, to identify
whether there were FITC specific immune cell populations in the lung.
4.5.2 FITC CONJUGATES
In order to identify the compounds FITC is bound to in the lung, whole lung
homogenates could be run through an anti-FITC western, isolating bands for
characterisation. Another approach might be to pass whole lung
homogenates through an anti-FITC antibody coated column then use the
elutant both as a coating for a serum ELISA system, and as a way of
isolating conjugated proteins.
4.5.3 SERUM ELISAS
To reduce serum ELISA variation, future serum ELISAs should be modified
to include an anti-FITC lgG1 or 2a commercially produced control which
would be run on every plate. This would be used as a standard curve or as a
way to normalise the results of each plate so that sera from studies can be
run on separate days, enabling combination of study data. This would also
allow triplicate samples of sera to be run, as this was not possible using the
current technique of running whole study samples in one batch. Use of three
fold dilutions and end point titres also complicated this ELISA system, but
was necessary due to the high concentration of antibody. A better approach
might have been to stop the ELISA earlier or use a less sensitive substrate in
combination with a standard serial titre. Alternately a nominal value could be
proposed as a cut off (minus the background value, i.e. a value below 0.25+/-
background OD is taken as negative). Also prior depletion of lgG1 prior to
lgG2a ELISA might confirm true absence of these antibodies.
4.5.4 NEW ANALYTICAL TECHNIQUES
Data presented here highlight the limitations of looking for evidence of
inflammatory mediators and potentially proliferative and differentiation
inducing factors such as Shh, in primary isolates which have endured
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injurious extraction procedures. Equally the pooling effect of analysing total
cell isolates from a patchy disease model makes interpretation of primary cell
data a very marginal process.
The newly established laser microdissection technique may present an
approach that may remove such restrictions and this is addressed in the
following Chapter.
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CHAPTER 5: LASER MICRO-DISSECTION
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5.1 INTRODUCTION
Studies discussed in the previous Chapters illustrated the limitations inherent
in the analysis of injurious or inflammatory signals using both primary cell
isolates and cell lines. This Chapter will describe a novel approach, taking
advantage of recent technological advancements in both RNA extraction and
laser dissection techniques, to analyse in situ mRNA expression in diseased
or inflamed areas and compare them with normal structures.
5.1.1 THE LIMITATIONS OF CURRENT GENETIC ANALYTICAL
TECHNIQUES
EX VIVO
The most frequently used methods for detecting and quantifying gene
expression in lung are northern blotting and real time RT-PCR. However,
since lung is a complex heterogeneous tissue, being composed of over 40
different cell types, use of homogenates is limited in that dominant cell types
will dilute signals from minor populations. Equally, isolation of specific lung
cell populations typically involves enzymatic digestion with or without physical
agitation, cleaving surface proteins and disrupting cell/cell/matrix interactions.
This will undoubtedly induce some manner of cellular change in the isolates.
It is also difficult to obtain a specific cell population from the lung, due to a
paucity of good specific markers for pulmonary structural cells.
IN SITU
In situ hybridisation (ISH) can be used to provide cell specific genetic
information in tissue sections. This avoids complex isolation procedures, but
only a limited number of genes can be investigated by this method. ISH is not
quantitative and has a relatively low sensitivity.
IN VITRO
The most significant limitation of in vitro based systems is that genetic
information derived from immortalised cell lines or primary cell line isolates
may not accurately reflect the molecular events taking place in the tissue
milieu from which they were originally derived and often, events observed at
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the pulmonary interface are reactions initiated, propagated or controlled by
signals or cells derived from other locations in the body; features absent from
mono and co-cultures.
5.1.2 LASER MICRO-DISSECTION TECHNIQUES
Recent advances in laser microscope technology, and low yield RNA
molecular procedures, have facilitated development of a new in situ / ex vivo
technique, namely laser micro-dissection. This began as a means of ablating
non specific material prior to whole section digestion and RNA isolation a
process which was highly time consuming and with limited application.
However, this has now advanced to specific single cell collection, allowing for
the accurate procurement of specific cell populations from heterogeneous
organ systems.
This methodology has facilitated the genetic analysis of purified lung cell
populations derived from their native tissue environment, and has been
successfully used in the analysis of a number of human conditions,
particularly Loss of Heterozygosity and mRNA profiling in cancers197.
There are two distinct laser micro-dissection techniques, namely Laser
Capture Micro-dissection (LCM), and Laser Pressure Catapult (LPC) micro¬
dissection, also known as Laser Microbeam Micro-dissection (LMM). These
are summarised below and in Figure 5.1 & Figure 5.2:
LASER CAPTURE MICRO-DISSECTION
Laser capture micro-dissection was developed at the National Cancer
Institute of the National Institute of Health, Bethesda (USA) and this system
is now available exclusively from Arcturus (Rayne, UK). In this system a low
energy infrared laser pulse is fired through an area of interest in a dehydrated
tissue section. This strikes and melts an overlying thermoplastic (Ethylene
Vinyl Acetate) membrane mounted on an optically clear cap. This causes the
membrane to form a composite with the underlying tissue. Thus when the
membrane cap is lifted it takes with it those areas which have been
selectively attached (Figure 5.2). The advantage of this system is that
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because most of the laser energy is absorbed by the membrane, the
absolute maximum temperature reached by the tissue is 90°C for
approximately a millisecond, thus RNA degradation is limited. Captured
material can be clearly visualised on the cap following lifting, allowing direct
observation of the specific cell types from which the genetic or protein
material is to be isolated. Specialist slides are not required and material can
be stained and processed through a variety of RNase free steps, as long as
the final step involves complete dehydration of the slide, as water interferes
with composite formation. Disadvantages include the long duration of the
procedure and lack of specificity as loose adjacent material can occasionally
lift with the cap.
LASER PRESSURE CATAPULTING
In this procedure sections can be mounted on a selection of slides ranging
from plain or charged to specialist membrane coated slides. The choice of
slides is determined by tissue type, fixative and staining regime. The
membrane coating most commonly utilised is polyethylene naphthalene. At
1.35pm thick this does not interfere with visualisation and prevents non¬
specific dusting of slides prior to section mounting, as only following UV
exposure for 30 minutes at 254nm do they become receptive for mounting.
Full dehydration is not essential for membrane mounted sections, indeed live
cells grown on these membranes can also be catapulted.
In this procedure, slides are visualised on an inverted microscope with a
computer controlled motorised stage. Areas of interest for cutting are drawn
around and highlighted using an outlining tool in the PALM™ imaging
software, not unlike the freehand tool in paint or similar software program
(Figure 5.2). These regions are displayed as "elements", where the computer
software remembers the location of each element on the stage, allowing the
user to review an entire slide before collecting the material.
Rather than melting a membrane as in the LPC procedure, this system
isolates the material contained within element areas by cutting the membrane
and overlying tissue section along the element line with a highly focused
337nm pulsed nitrogen UV laser beam, rather than the infra-red used in
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LCM. At the point of completing the element, near origin, an automatic pulse
is fired, where the photonic force catapults the desired material into a
receptacle above the slide; most frequently the cap of a standard Eppendorf
tube, filled with a capture buffer of choice. Material entering the cap is held in
place by the surface tension of the buffer in the cap.
The main advantages of this procedure are speed and accuracy, but at a
cost of good visualisation of captured material and more restrictive slide
preparatory techniques. The membranes are susceptible to lifting with some
solvents and normal positively charged slides, if fixed excessively or
prematurely, will exhibit reduced catapulting efficiency. However a recent
publication198 would suggest that visualisation can be improved with the
addition of an aqueous gum medium of Pinpoint™ solution and a dark blue
ink stain.
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5.1.3 TISSUE PREPARATION
There have been a great number of studies performed to ascertain how
tissues should be preserved, processed and visualised for efficient laser
micro-dissection. In general precipitating fixatives such as acetone or ethanol
have been found to give better results than cross linking agents such as
formalin. The fixation process is particularly important in relation to mRNA
isolation, as in contrast to DNA, mRNA is more sensitive to fixation, is quickly
degraded by ubiquitous RNases, and requires stringent RNase free
conditions during specimen handling and preparation. To avoid these
complications a number of recent studies have investigated the use of easily
reversible cross linkers instead of formalin, notably dithio-bis(succinimidyl
propionate) (DSP), also known as Lomant's reagent199. DSP links primary
amino groups via an -S-S- bridge that can be cleaved by reducing agents
such as DTT, producing unmodified RNA which exhibits less fragmentation
than comparable formalin fixed tissues. However, for practical use with
archival material, techniques based on formalin fixation are necessary.
5.1.4 IMMUNOHISTOCHEMISTRY
Identification of cell subtypes for laser assisted extraction from complex
heterogeneous tissues can be difficult and time consuming in the absence of
sufficient sub-type specific discriminating features. Standard staining
procedures such as Mayer's haematoxylin and methyl green appear to be
compatible with laser capture micro-dissection200 for DNA extraction. More
complex immunohistochemical techniques require more prolonged periods of
aqueous contact which is deleterious to RNA preservation, and a number of
harsh unmasking procedures, which reduce RNA yield200. However, a
number of studies have now highlighted specific protocols for
immunohistochemistry applicable to laser microdissection201"203.
5.1.5 REAL TIME PCR
The majority of studies in laser micro-dissection involve analysis of the
extracted RNA by quantitative real time RT-PCR. This technique is described
briefly below and in Figure 5.3.
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THE RT STEP
Reverse transcription for the generation of cDNA for real time PCR can be
performed using any standard RT protocol, using either oligo-dt primers or
random decomers/hexomers, with various salt concentrations. However, use
of differing mastermixes requires re-optimisation of the subsequent PCR. Our
lab uses Applied Biosystems default reagents/recipe. Here, oligo dTs can be
used to copy mRNA or random hexomers can be applied, to copy total RNA
including rRNA. The full reaction recipe is supplied in Chapter 2.
THE PCR REACTION
The PCR reaction exploits the 5' nuclease activity of AmpliTaq gold™ DNA
polymerase to cleave a Taqman™ probe during PCR. The Taqman™ probe
contains a 5' reporter dye, typically FAM (6-carboxy-fluorescein) or VIC™
(Applied Biosystems) and a 3' TAMRA (6-carboxy tetramethyl rhodamine)
quencher dye. During the PCR, cleavage of the probe separates the reporter
and quencher dyes, resulting in increased fluorescence of the reporter dye
and reduced quencher fluorescence. Thus the accumulation of PCR products
can be quantitatively defined by measuring the increase in fluorescence of














Intact Probe Cleaved Probe
Wwelength Wawekngth
Figure 5.3: Real Time RT-PCR
(A) The Taqman probe binds to a sequence between the primer sets,
recommended by Applied Biosystems to be no greater than 150bp in length.
(B) Taq polymerase (purple) associates with the primers and transcribes
complementary template where its exonuclease activity results separation of
first reporter (C) then quencher from the probe. Such spatial separation
results in increased detectable florescence from the reporter construct upon
stimulation (D). Pictures modified from Applied Biosystems promotional and
technical materials (www.appliedbiosystems.com).
CONTROL OPTIONS
The Taqman mastermix contains a passive reference to which reporter dye
signal can be normalised during data analysis. However the majority of
investigators utilise multiplex PCR to give optimal normalisation. Two primer
probe sets with differing fluorescent labels are included in each reaction. One
probe, conventionally labelled with VIC™ is specific for a housekeeping
gene, highly expressed and unchanged by the experimental or condition
analysed. The other probe, labelled with FAM, is specific for a gene of
interest. A threshold is set against baseline fluorescence detection and the
number of polymerase cycles at which each sample becomes positive on this
baseline is denoted as a cycle threshold (ct) value. Thus house keeping
genes generally have a low ct, in the range of 17-21 cycles if using approx
32ng of cDNA (16ng RNA), whilst lesser expressed genes of interest have
higher ct values ranging from 22-35. Values above 35 can be difficult to
interpret and highly influenced by minute contaminants or machine
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fluctuations. FAM and VIC™ data can be presented as a direct comparison,
however, Ct values are more commonly normalised and linearised for
presentation, such that only the FAM values are supplied as a fold increase
or decrease of FAM vs. VIC™ ratio, over a chosen negative sample i.e.
untreated.
In our laboratory we utilise ribosomal 18S as the house keeping gene,
necessitating the use of random hexomers in the production of cDNA as
oligos do not prime for ribosomal RNA. Primer probe sets for genes of
interest are designed in house according to Applied Biosystems
specifications, whilst 18S sets are bought as pre-prepared stocks.
5.1.6 FRESH AND FROZEN TISSUES
Most studies have used fresh or frozen tissues for laser micro-dissection as
the mRNA obtained from this material is of high quality, and a number of
investigators have successfully isolated RNA from these tissues without the
need for pre-PCR amplification.
One relevant recent study performed by Betsuyaku et al204 used frozen
mouse lungs to analyse pulmonary epithelial mRNA profiles. Mice were killed
by C02 narcosis and lungs immediately inflated with Tissue-Tek™ OCT
50:50 with RNase free PBS/10%sucrose. The total time from death of the
mouse to frozen tissue was 10 minutes to avoid post mortem changes in
gene expression. Sections were prepared for LCM on glass slides, fixed in
100% ethanol, stained with 0.5% (w/v) Nissl (cresyl violet acetate) and
dehydrated to xylene. The authors used the same PixCell II Laser Capture
Micro-dissection system, which I used for my studies. Typically, 20 sections
were used, where each tissue section contained 5-10 usable airways. 50
laser pulses were applied per airway in a procedure taking 4-5 hours per
mouse.
RNA was extracted with a High Pure RNA Isolation Kit by Boehringer
Mannheim™ and genomic DNA digested by incubation with DNase. They
reported that the LCM isolated RNA was of excellent quality, where
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approximately, 2-6 pg of total RNA was recovered from a captured 7-fxm
thick bronchiolar epithelial cell, so that a typical complete dissection yielded
600-900ng of total RNA. For subsequent real time RT-PCR the RNA isolated
was sufficient for direct use, however, for oligonucleotide arrays, amplification
was required.
cDNA was generated utilising random hexomers with half of the total RNA
isolated used in the RT reaction (15pl RNA + 15pJ Mastermix). 1pJ of this
reaction was then added into each real time PCR reaction mix, composed of
TaqMan™ reagents, for PCR in an ABI Prism 7700 Sequence Detector.
Applied Biosystems™ designed GAPDH was used as the internal standard
(house keeping) gene. Other housekeeping genes were also utilised,
Hypoxanthine Guanine Phosphor-RibosylTransferase (HPRT1) for low levels
of the target or 18S rRNA for high levels. The PCR reactions for the target
gene and GAPDH were performed in separate tubes to avoid possible
competition and/or interference.
Another study by the same group used LCM to harvest terminal bronchiolar
epithelium for quantification of mRNAs by real time RT-PCR. Specifically,
they examined the response of CC10, TGF-/3, Epidermal Growth Factor
(EGF) receptor, and KGF receptor mRNAs to intratracheal administration of
bleomycin205. They identified reductions in CC10 and KGF receptor mRNAs
in both terminal bronchiolar epithelium and whole-lung homogenates 7 days
after bleomycin. In contrast, terminal bronchiolar epithelial TGF-/3 mRNA was
reduced, but whole-lung TGF-/3 mRNA remained unchanged. Findings with
EGF were the reverse, where terminal bronchiolar EGF receptor mRNA was
not changed but whole-lung EGF receptor was reduced. This illustrates the
limitations of relying on whole lung homogenates as a means of analyzing
cell specific RNA modulations in complex tissues.
5.1.7 FORMALIN FIXATION
Histological examination of sections from fresh or frozen material usually
shows poor morphology, making distinct cell types difficult to identify, even
with the development of rapid IHC staining techniques203.
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For this reason human biopsy material exists almost exclusively as fixed and
embedded samples, where the most widely used fixative in pathology
remains formalin. It is comparably cheap, easy to handle, gives good
morphological quality and is compatible with a wide variety of antibodies. The
aim is thus to achieve viable mRNA extraction from formalin fixed paraffin
embedded tissue as this would allow retrospective analysis of large volumes
of archival tissue.
Initial attempts to extract RNA identified reduced yield from formalin fixed
material compared with frozen samples. This was initially attributed to cross
linking induced fragmentation of RNA206' 207. But, a study by Masuda and
colleagues208 suggested that chemical modification is just as important as
fragmentation. Formalin fixation was found to modify all four bases through
the addition of mono-methylol (-CH(2)OH) groups at various levels, varying
from 40% for adenine to 4% for uracil. In addition, some adenines underwent
dimerisation through methylene bridging. This could be resolved to give
approximately 50% of the yield from unfixed material by an increase in
temperature of the formalin free buffer following extraction.
Some studies had suggested that RNase activity prior to fixation of tissue,
such as prolonged post mortem periods could also play a role in reduced
yield209. Equally, some had suggested that the size of a biopsy might
influence RNA integrity, due to internal variation in fixation speed. Flowever,
Specht and colleagues210, taking serial sections every 1 cm through a 7cm
solid biopsy, where central fixation would be expected to be slower or
incomplete, found that degradation during the fixation process was not a
factor in reduced RNA yield, although observations made by Lehmann et al
and discussed in a methods review211, would suggest that fixation for greater
than a week in standard formalin completely destroys nucleic acids.
Thus in conclusion, current literature suggests that LCM suitable samples are
those which have a short post mortem storage time prior to fixation and are
fixed for not more than a few days. Observations made by Mizano209 would
also suggest that when dealing with samples embedded decades apart, time
and preservation matched controls should be included, to track post
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embedding degradation of RNA sequences and ensure that this does not
bias the RNA profile of the samples.
One of the first papers to utilise real time RT-PCR with laser micro-dissected
material was that of Specht and colleagues210. Samples of oesophageal
adenocarcinoma fixed in 10% formalin overnight were cut to 5fxM, H&E
stained for 45 seconds and dissected using the LPC system to collect approx
1,000 cells. In this early version of the current equipment adjacent areas of
tissue to the area of interest were ablated and the area of interest transferred
to a vessel via mechanically aided sterile needles. RNA was isolated via a
phenol chloroform method and Phosphoglycerate Kinase 1 and HPRT were
used as internal controls for real time RT-PCR. Importantly this study
highlighted that real time amplicon sizes up to 122bp had no affect on
amplification yield, but values from real time RT-PCR were reduced above
this size, and no product could be obtained with amplicons greater than 374
bases apart, where frozen samples were unaffected. This suggested that
formalin fixed material contained only short sequences of material viable for
transcription. Others have suggested that 200bp is the average size fragment
available211.
Subsequent studies have also reported good success using real time RT-
PCR and nested RT-PCR on laser dissected cells from paraffin wax
embedded archival tissue, fixed in either methacarn or formalin212 213 214. A
number of interesting gene expression profiles have also been demonstrated
through the use of microarrays in some studies215' 216, although this has
necessitated amplification of RNA prior to PCR, due to the poor quality of the
isolated RNA. Such amplification raises a number of procedural bias issues,
such as transcript stability and size, which although also an issue in normal
RT-PCR, is more notable in amplified microarray applications.
5.1.8 THE FUTURE
Establishment of a reliable, high-throughput method of RNA/DNA recovery
from formalin fixed tissue, has the potential to unlock a huge archive of
material for retrospective analysis of case studies209. This would enable a
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rapid advancement in understanding of disease initiation and progression,
and the elucidation of differentially expressed genes as novel therapeutic
targets or prognostic indicators.
Genotyping for hereditary conditions such as breast cancer, cystic fibrosis
and Down's syndrome has revolutionised the preventative and ameliorative
treatments available to patients and has facilitated a greater understanding of
many of these conditions. Laser micro-dissection also offers the opportunity
to perform similar prognostic testing, but with the advantageous ability to
perform cell specific diagnostic screening. This could be used to identify
locally induced cancerous mutations and erroneous signalling, such as the
identification of loss of heterozygosity in neoplasias/cancers217"219, mutations
of p53 & K-ras in colorectal carcinomas220 or differential mRNA expression in
biopsies of renal transplant rejection221. Recent developments utilising
reverse phase protein microarray analysis may also allow the application of
the laser micro-dissection technique to protein signalling222. Combined, these
techniques will generate a greater understanding of the cell specific signalling
interactions which occur in both healthy and diseased tissue, allowing more
specific targeting of future therapies.
5.1.9 HYPOTHESIS AND AIMS
The aim of the work presented in this Chapter was to develop the laser
micro-dissection technique and apply it to the study of developmental genes
in pulmonary fibrosis.
The following hypotheses were addressed:
— Formalin fixed material contains viable RNA that is suitable for RT-
PCR and real time RT-PCR
— Formalin fixed human and mouse adult lung contains detectable Shh
and Ptc mRNA sequence
— Epithelial cells represent a putative producer & responder population




At the time of initial investigation kits for use with laser micro-dissection were
emerging from Ambion™, (Paraffin Block RNA isolation Kit, Cells to cDNA II
kit) designed specifically for the extraction of RNA from very small numbers
of cells obtained from frozen or formalin fixed, wax embedded, tissue
sections.
For this investigation both of these kits were utilised, with a number of
variations to the standardised protocols. Initial trials used solid tissue such as
mouse kidney, heart and spleen fixed in formalin and paraffin embedded in
conjunction with the LCM technique. Sections were prepared as for
immunohistochemistry, i.e. 10 minutes in xylene to dewax, an alcohol
rehydration, standard haematoxylin staining, alcohol dehydration to xylene,
all with RNase free reagents. Section thicknesses ranging from 5-12^im were
cut onto standard superfrost slides and remained adherent to the slide
despite a range of treatments. Complete dehydration of the sections was
found to be crucial, as the presence of water inhibited the binding of tissue to
the cap membrane.
No positive RT-PCR data were obtained with laser micro-dissected and
isolated RNA with mouse (3-Actin RT primers (Table 2.5), nor real time RT-
PCR data with commercially prepared 18S primers. The Ambion™ kit
controls were also notably inconsistent. These controls consisted of RNA
template enveloped in a protein coat, supplied with specific RT primers. The
protein coat acted as a measure of the proteinase efficiency in the RNA
isolation process. Repetition of the suggested protocol produced differing
yields of control with each experiment (n=5), where cell line RT and PCR
controls of known cell number or cDNA concentration with our usual fi-Actin
primers were consistent. This would suggest that some variation occurred
with the supplied controls, rather than the extraction method, a conclusion
confirmed by personal communication with Ambion™.
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Addition of supplementary proteinase K to the extraction buffer (original
concentrations are patent protected), extending 55°C incubation times from
the suggested 10 minutes to 2 hours and use of water baths and PCR
blocks, rather than incubators, for high ramp temperature, also failed to
produce detectable RT-PCR products.
Despite its advertised application, a number of workers have reported
problems using these kits in combination with formalin fixed paraffin
embedded material (Ambion™ technical services, personal communication).
This would suggest that the observed difficulties may represent a general
procedural limitation.
5.2.2 WHOLE SECTION FROZEN MATERIAL
To address the problems encountered with the kits for RNA extraction from
formalin fixed biopsy sections, another approach was undertaken. This
initially used frozen sections with the intention of defining an extraction
protocol, before attempting the more complex isolation of RNA from formalin
fixed paraffin embedded material. This new approach utilised a micro column
system (Qiagen), which enables the on-column isolation of RNA and elution
in a small water volume. These experiments were performed with the
assistance of Ms Su Haley, a technician in our lab.
For these studies initial optimisation was performed in a manner similar to
that performed by Rupp and Locker using frozen sections206, where 1-3
whole sections of frozen mouse lung tissue were placed in an Eppendorf
tube. RNA was isolated from sections via the Qiagen™ column method. This
was first run in a standard p-Actin PCR from RNA to check for genomic
contamination (Figure 5.4). Negative samples were then reverse transcribed
using Applied Biosystems™ reverse transcription reagents with oligo dTs,
then a PCR performed with an Access PCR kit (Promega). Eluted column
material (approx 12-14^1) was sufficient for 1 fi-Actin check gel and 1 reverse
transcription (see Chapter 2). The cDNA mix was then sufficient for 4 wells of
a realtime plate (5^il each) or 2 RT-PCR reactions (1 Opil each), where the
total volume was 25pJ.
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RNA could be reverse transcribed and entered into a 40 cycle PCR to
produce a viable 2% agarose gel band from both freshly cut sections and
those stored at -70°C. This is important as the laser micro-dissection process
is very time consuming, thus it is likely that at some stage of the procedure
samples would have to be stored. Given the small volume / concentrations of
the samples, data may be more consistent if all material is processed
together. Thus preservation following isolation is perhaps the best time for
storage without a detrimental affect on mRNA isolation.
Lane no:
0 1 2 3 4 5 6 7 8 9 10 11 12 13
+ve -ve 1s 2s 3s 1s 2s 3s +ve's -ve's DNA
ACCESS RLT LYSIS
Figure 5.4: Frozen Sections Yield Viable RNA
Frozen sections taken directly to Eppendorf tubes following cutting. RNA was
isolated using RNeasy micro columns and reverse transcribed and PCR
amplified using the Access RT-PCR system and fi-Actin primers (153bp). [A]
Fresh sections [B] Sections stored for 7 days at -70°C. Upper gel PCR
products, Lower gel identical PCR using RNA to check for DNA
contamination. Lane 0: ladder. Lane 1: Access kit positive control (323bp).
Lane 2: a negative control. Lanes 3-5: 1, 2 & 3 sections per Eppendorf tube
in RLT lysis buffer (Qiagen). Lanes: 6-8: 1, 2 & 3 sections per Eppendorf
tube in a PALM™ recommended lysis buffer. Lane 9: Mouse epithelial cell
line lysis control, Lane 10: Mouse epithelial cDNA control. Lanes 11 & 12:
Negative controls. 13: DNA positive control. A band in Lane 5 of [A] upper is
absent due to loss of a pellet during a wash step. Future studies could
incorporate molecular grade glycogen to secure material during wash steps.
The second band in Lane 1 [B] upper, is genetic material from an E. coli
carrier used in the production of control RNA (Promega technical services).
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5.2.3 WHOLE SECTION FORMALIN FIXED MATERIAL
Having established viable RNA extraction from frozen sections, the same
approach was utilised for formalin fixed, paraffin wax embedded material.
Sections were cut at lO^im and either, one, two or three sections placed in an
Eppendorf tube. These samples included the complication of paraffin wax,
which is normally removed via a 10 minute submersion in xylene when
mounted on a slide. This was completed within the Eppendorf tube by
addition of 1ml of xylene for 10 minutes, followed by centrifugation steps
associated with 100% alcohol and rehydration procedures as discussed in
Chapter 2. Once ultrafuged from water, the resulting pellet was re-suspended
in RLT buffer containing (3ME and proteinase K. The proteinase K is
necessary for protein degradation, and specifically the removal of the
formalin cross links generated during fixation. This enzyme is ideal as it
operates in conditions inhibitory for nucleases. RT-PCR was performed using
the real time reagents as this is the intended final investigative tool, but PCR
was performed in a standard PCR block.
Various proteinase K digestion buffer incubation times were tested from 1 hr
to 5 days. Data presented in Figure 5.5[A] would suggest that the 24 & 48hr
periods were sufficient to obtain RNA from tissues. Real time RT-PCR
primers for CC10 were used in these studies to demonstrate that a gene
other than p-Actin could be detected, and that the biochemistry of real time
RT-PCR primers was compatible with transcripts isolated from formalin fixed
material.
Increased RT-PCR yield of /3-Actin signal was obtained when oligo dT was
substituted with random hexomers (Figure 5.5[B]), and also allowed for the
use of 18S as an internal control in subsequent real time RT-PCR. In these
studies 24hrs was sufficient to obtain RNA. The signal reduction in Lane 6 of
[B] in Figure 5.5 is attributable to a partial loss through processing, as section
material was easily lost with viscous wax removal. Although a problem here,
loss of material with wax was not an immediate concern, as these steps
would not be necessary in the final laser micro-dissection technique.
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Figure 5.5: RT-PCR Optimisation For Formalin Fixed Material
[A] One Mouse lung section per Eppendorf tube, incubated for up to 5 days in
proteinase K supplemented RLT buffer. The positive control is mouse
epithelial cDNA (CMT). MM refers to PCR mastermix, containing negative RT
fraction as a negative control. CC10 real time primers used in an Access kit,
product size 68bp.
[B] Material titration of 1, 2 & 3 sections per Eppendorf tube, incubated at
55°C overnight for either 24 or 48 hours, -ve, as above. Random hexomers
and real time reagents used with /3-Actin primers, product size 150bp.
[C] CMT cell line lysate spiked with acidified H&E or methyl green to an equal
OD of overnight digestion of one section. Extracted and processed as above.
/3-Actin primers were used, product (150bp), in an Access kit reaction,
performed in duplicate. Controls are single replicates, positive control (5) is
unspiked. Negatives are MM plus stain in the absence of cell line lysate.
To ascertain whether genes of interest were highly expressed or stable
enough to be suitable for analysis in dissected samples of human lung
biopsies, and as proof of concept, whole sections were analysed with primers
for genes of interest in RT-PCR using real time reagents in standard PCR
blocks (Figure 5.6). Biopsy sections were classified as b1, 2, 3, 4 according
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to the number of biopsy pieces visible on each block face. Thus b1 -b4 can be
considered an increasing gradient of biopsy material per section.
This study demonstrated that whilst transcripts such as TGF-pi and 3, MMP-
7, GAPDH, Ptc and Smo could be detected, others such as TGF-p-2, Gli-1-3,
Shh, BMP-4 and FGF-10 could not. This was interesting as
immunohistochemistry in the lab has identified GN1-3 and Shh protein in
these sections. This could represent an absence of mRNA, indicating slow
turnover protein, or incorrect antibody / primer function. Alternatively, it could
be postulated that these sequences were not detected as they were more
susceptible to formalin fixation related degradation. These hypotheses could
be confirmed through the use of frozen material taken from similar biopsies.
This comparison remains to be performed.
Once effective retrieval of viable RNA from formalin fixed material had been
established it was necessary to identify the optimum method for mounting
and staining of sections to enable specific laser micro-dissection of cells. The
gel in Figure 5.5 illustrates the affect of spiking PCR reactions with quantities
of stain equal to that obtained from the lysis of a whole section overnight.
Methyl green was found to inhibit the PCR, where as the addition of acidified
H&E had no affect on the PCR versus the control in lane 5. H&E was
therefore selected as the preferred stain, but was not required in these
preliminary studies as specific cell types were not selected in either whole
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Figure 5.6: Whole Sections of Human Archive Lung Biopsy Yield
Viable RNA
A single section of a block containing one (b1), two (b2) three (b3) or four
(b4) lung biopsy pieces were placed in an Eppendorf tube and processed as
previously described, except in that the proteinase K digestion concentration
was doubled and the digestion performed at 24hrs. Real time reagents were
used as described in Chapter 2. Primer probe sets that failed on sections but
were successful with control human cDNA include: TGFJ3-2, GH1-3, Shh,
BMP-4, FGF-10.
Whilst cutting and slide mounting of solid tissues such as kidney and spleen
had been relatively straight forward in preliminary kit studies, use of a more
aerated tissue, such as lung, necessitated titration of conditions to enable
optimum lifting. The most important steps were identified as dehydration
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(Figure 5.7), particularly the duration of xylene exposure (Figure 5.8), and the
temperature used to mount the section onto the slide (Figure 5.9).
Dehydration was likely essential to prevent water in the section interfering
with the formation of a composite with the overlying cap membrane. The
temperature of incubation altered the lifting efficiency of the cap, presumably
by increasing the adhesion of the section to the superfrost slide. Room
temperature incubation resulted in some non-specific lifting, whilst lifting
following 37°C resulted in highly specific lifting, but leaving some material
behind. 52°C incubation resulted in a highly reduced lifting efficiency. Thus
the preparatory steps for superfrost slide mounted, formalin fixed, paraffin
embedded lung sections, for use with laser capture micro-dissection are as
follows:
Section cut at 10^m on DNase washed microtome
Floated on RNase free water at 42°C in a water bath for 2 minutes
Mounted on superfrost slide
Incubated at room temperature overnight in silica gel box
Dewaxed for 10 minutes in xylene
Rehydrated in alcohol series
Optional staining with counter stain
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5.2.4 LASER CAPTURE MICRO-DISSECTION
Once the optimum conditions for section preparation had been established,
laser capture micro-dissection was performed using the Pixcell II system, as
used in the preceeding figures. Material fixed onto the cap following laser
dissection was transferred to a 450pJ solution of proteinase K digestion buffer
in a 0.5ml Eppendorf tube and digested for 24hrs. The use of a shaker
platform (see Chapter 2) was found to increase yield following this
incubation. Real time RT-PCR reactions were prepared using standard 18S
endogenous control and a gene of interest. These were then run on an ABI
7700 sequence detector in 96 well plates, Figure 5.10 shows results for
CC10 in mouse and Ptc in human.
What was notable from these experiments was that the 18S amplicon
detected by a VIC™ labelled probe, was only marginally more frequent than
the mRNA of interest detected with a FAM labelled probe. As a
housekeeping gene 18S would normally be substantially higher in
abundance, i.e. have a lower ct value. This is most striking when comparing
the positive cell line control CC10 values with those obtained from the LCM
cap (Figure 5.10[A]). Given the findings of others concerning the importance
of the size of the PCR amplicon in laser capture micro-dissection210, 211, the
products of the RNA positive reaction in Figure 5.10[A] were run out on a 2%
agarose gel electrophoresis, and the size of the products confirmed (Figure
5.10[D]). The CC10 amplicon, generated from a primer probe set designed in
the lab, was 68bp in size. Guite unexpectedly, given Applied Biosystems own
guidelines on amplicon size (<150bp), the amplicon from the Applied
Biosystems™ 18S primer probe set was 200bp in size.
Applied Biosystems do not routinely reveal the specifics of their pre-designed
primer probe sets, thus it was assumed they conformed to their
specifications. However upon communicating my problems and reservations
concerning product size, another internal control primer probe set was
suggested by Applied Biosystems technical services. This set, specific for j3-
Actin was also unsuitable as its amplicon was found to be 300bp in size.
Further communication with Applied Biosystems technical services
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concerning their endogenous control selection plate, (a pre-designed method
of identifying appropriate experimental controls from samples added to a
selection of differing house keeping genes), would suggest that the majority
of their designed sets would be "unsuitable" for laser micro-dissection. The
most recent real time RT-PCR experiments have utilised GAPDH primers
with VIC™ labeled probes as a control (Figure 5.11), designed in house
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5.2.5 LASER PRESSURE CATAPULT MICRO-DISSECTION
Due to a number of technical and mechanical failures with the laser capture
micro-dissection system, Laser Pressure Catapult micro-dissection was then
tried. These studies centred primarily on human tissues where, in
collaboration with Dr William Wallace and Ms Su Haley, human lung biopsies
with BOOP (Figure 1.6) and UIP (Figure 1.7) patterns of disease were
dissected and extracted using the methods previously described in the
introduction to this Chapter. It was hoped that by using two differing
morphological patterns of fibrosis, it might be possible to identify differential
gene expression in alternate patterns of fibroplasia.
This switch in technique necessitated an alteration in slide preparation. LPC
membrane coated slides were utilised. One of the major problems with these
slides is lifting in the presence of xylene, a necessary step to remove the
paraffin wax component of the section. By reducing this step to two washes
of two minutes it was possible to remove wax without lifting the section. To
allow the visualisation of morphological features a wide range of stains were
tested including H&E, Giemsa and acridine orange. Of these Giemsa was
found to give the best visualisation with minimal detriment to incubation or
processing steps. This stain was not applicable to previous LCM studies due
to its solubility in alcohol, where dehydration was essential. Dehydration was
not necessary in these studies, as the membrane acts as a support to
dissected section material. Slides were prepared as follows:
Slide washed in DNase and RNase free water
Slide UV exposed to activate LPC membrane
Section cut at 5-10p,m on DNase washed microtome
Floated on RNase free water at 42°C in a water bath for 2 minutes
Mounted on LPC membrane slide
Incubated at 37°C overnight in a silica gel box
Dewaxed for 2x2minutes in xylene
Rehydrated in alcohol series
Giemsa staining
Minimum of 30 minutes in a silica gel box
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Recent studies in the laboratory have shown that use of Histoclear™ as a
substitute for xylene increases micro-dissection efficiency and reduces the
lifting phenomenon, but comes too late for inclusion in this thesis (data not
shown).
In order to evaluate the catapulting technique as a means of concentrating
RNA, whole biopsy sections of either UIP or BOOP were mounted onto
membrane slides, and the areas of active fibroplasia present in one 5pm
section dissected out and catapulted into lysis buffer by an experienced
pathologist (Dr WAH Wallace). This material was then processed as a pair;
catapulted material, which can be considered as "fibrotic enriched" (Figure
5.11 [E] lane 2), and the remainder of the section placed in an Eppendorf
tube, considered "fibrotic depleted" (Figure 5.11 [E] lane 3). A mounted but
un-dissected section from the same block was also processed (Figure
5.11[E] lane 1), as was a cut but un-mounted section (Figure 5.11[E] lane 4),
to ascertain the affect of the attached membrane on down stream
applications.
No interference from the membrane on RNA digestion and isolation was
identified and a viable signal could be obtained from the enriched and
depleted material using GAPDH primers. Giemsa staining was also shown to
have no affect on processing through the analysis of unstained membrane
mounted sections vs. stained (data not shown).
BOOP studies are illustrated in Figure 5.11 as the most complete data set at
the time of thesis submission. Subsequent collaborative work with others in
the lab has demonstrated similar data for UIP sections where the intention is
to compare the relative expression of signalling pathways such as Shh in
BOOP vs. UIP as a means to elucidate the mechanisms which lead to
luminal vs. sub epithelial fibrosis.
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Figure 5.11: GAPDH RT-PCR from Micro-Dissected Formalin Fixed
Human Tissues
[A]&[B] BOOP biopsies, where the H 'n [A] denotes an area of deregulated
fibroblast proliferation and collagen deposition, compared with a relatively
normal area of neighbouring lung, denoted jQ|. [B] Yellow areas are
catapulted to form a fibrotic enriched sample, whilst remaining tissue makes
up a fibrotic depleted sample, the area denoted by a H is not catapulted as
this is fibrosed blood vessel unlike the fibroblastic foci circled. [C]&[D] UIP
Biopsies, where the in [C] denotes an area of deregulated fibroblastic
proliferation and collagen deposition. [D] is a 10pm giesma stained section.
Catapulted areas marked in yellow. [E] A 2% gel electrophoresis of GAPDH
real time primer use in standard PCR of Giemsa stained, formalin fixed
BOOP biopsies; 1: Whole section taken immediately after staining. 2: BOOP
fibrotic enriched catapulted material, 3: Fibrotic depleted section, 4: Un




Viable RNA has been isolated from single sections of frozen mouse lung
without DNA contamination, both from freshly cut and -70°C stored sections.
Viable RNA has also been obtained from freshly cut and room temperature
stored, single sections of formalin fixed, paraffin embedded human and
mouse lung. Processing of this material incorporated proteinase K
supplemented lysis buffers, Qiagen™ RNA isolation columns, and real time
RT-PCR reagent mediated amplification step. Preparatory techniques for
sections destined for LCM and LPC were developed here and used in the
LPC isolation of active fibroplasias in BOOP biopsies. Viable RNA could be
isolated from this fibrotic enriched material and from the remaining, fibrotic
depleted section. This establishes this technique as a means of mRNA
expression profiling diseased and non diseased areas of patient biopsies.
5.3.2 MICRO-DISSECTION KITS
Initial experiments were conducted primarily with the Ambion™ cells to cDNA
kit supplemented with highly sensitive supertaq for PCR, as per
manufacturers recommendation. Failure to detect message in dissected
material, and inconsistent recovery of the protein encapsulated control,
suggests that the limitations experienced with these kits reside in the
digestion process. The RT and PCR steps themselves were correct as they
generated products from cell line control RNA of comparable, if not greater
amplification, than in standard RT-PCR using the Promega™ Access RT-
PCR system. This conclusion would appear vindicated by subsequent work
with RLT digestion buffers in the Qiagen column system where the active
ingredient, as with the Ambion™ kit, is proteinase K. Using this buffer no
mRNA could be recovered from 3hr incubations (data not shown), such as
those used in the longest digestion periods with the Ambion™ kit. The
discovery that correct protein digestion requires up to 24hrs with the
Qiagen™ RLT proteinase buffer would suggest that the problems
encountered with the kit, and indeed the protein encapsulated control, were
attributable to an insufficient digestion period.
249
It would be interesting to see whether products could indeed be acquired
from these Ambion™ kits with longer digestion steps, as the kits are very
quick, and it would be expected that less material would be "lost" during the
procedure as no on column isolation step is involved, i.e. the lysis and RT-
steps are all performed on un-purified RNA.
Early studies were also likely inhibited by use of the (5-Actin RT primers as
the product is greater than 150bp in length, where work here with 18S and p-
Actin controls on VIC™ primer probe sets with amplicons in the range of 200
and 300bp respectively would suggest that the greater amplicon size, the
lower the PCR yield.
5.3.3 HISTOCHEMISTRY
A further complication in RNA isolation was histochemistry. Contrary to
published reports200, I found the presence of methyl green to be seriously
detrimental to PCR yield, whilst H&E and Giemsa had no affect. Although
Giemsa was found to be the best and most convenient stain for differentiating
between fibrotic and non-fibrotic areas in sections ranging in thickness from
5-12|^m, H&E would likely be a better stain for routine dissection on material
<5fxm as it also gives more precise definition to the immunological cell types
present than Giemsa. Picrosirius red and trichrome would ultimately be
preferable, for collagen/fibroblast immunohistochemical imaging, as they
would clearly mark fibrotic foci rather than atelectasis. However this would
likely necessitate too many potentially RNA degrading steps.
5.3.4 PROTOCOL DEVELOPMENT
By beginning with whole sections of frozen lung, then moving on to formalin
fixed material and finally dissected material, it was possible to optimize the
protocols in a logical stepwise fashion, facilitating the optimization of RT and
PCR steps without time consuming and costly micro-dissection. Thus when
dissection was undertaken, a clear protocol had been established and
suitable targets had already been identified. Any future substantial alterations
to these protocols, principally the incorporation of rapid immunohistochemical
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treatment, should also utilise this approach. New genes of interest, or primer
probe sets should first be analysed on whole sections. This will limit the time,
cost and material wasted on unsuitable targets with laser micro-dissection.
Lack of detection with a primer probe set does not of course guarantee the
absence of mRNA from lung as the sequence may have a short half life or be
primarily composed of those bases most susceptible to formalin induced
chemical modification. Also the sections used in this study were mainly from
BOOP biopsies. Normal or otherwise diseased lung may present with a
substantially different profile.
5.3.5 APPLICATION OF THE MICRO-DISSECTION TECHNIQUES
How feasible is laser micro-dissection as a medical tool? The dissection of
relevant material requires a practiced and trained eye and whatever method
of dissection is used, remains relatively time consuming. Implementation of
laser dissection as a diagnostic or prognostic tool would also require that
strict controls were placed on the variables discussed in Section 5.1.7
concerning biopsy preparation. Such requirements would likely make this
procedure too expensive to become a routine NHS tool. What is more likely
is that this technique will be used to identify a gold standard of candidate
disease associated factors for further investigation at the genetic and
molecular level and for the identification of potential drug targets. Once
established more routine methods might then be used to aid the pathologist
in diagnosis, such as in situ PCR or immunohistochemistry.
The development of the protocols shown here confirmed the original
hypothesis that viable RNA could be obtained from formalin fixed paraffin
embedded material. However, the development of the protocols presented in
this Chapter was more complicated than originally anticipated and thus there
was insufficient time to apply it to the study of disease and address the
hypotheses concerning the involvement of Shh in human fibrotic disease
recapped below:
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"Formalin fixed human and mouse adult lung contains Shh and Ptc
sequence"
"Epithelial cells represent a putative producer/responder population of Shh
signalling whilst mesenchyme is primarily responder in profile"
However these studies are ongoing in the laboratory, and it is hoped that by
pooling large numbers of microdissected fibrotic foci versus normal
morphology, with new more efficient human Shh primer probe sets, it may be
possible to detect Shh mRNA in those cell populations where new
immunohistochemical data would suggest that Shh protein is highly
expressed.
5.4 CONCLUSIONS
Work presented within this Chapter has highlighted both the benefits and
restrictions of the laser micro-dissection technique and has defined novel
protocols for section preparation for two dissecting techniques, clearly
demonstrating that viable RNA can be obtained from less than one section of
formalin fixed, paraffin embedded human lung biopsy.
Whilst the technique of RNA extraction from formalin fixed, paraffin
embedded, laser micro-dissected material has been developed and perfected
here, there was insufficient time to investigate disease specific RNA
expression. Furthermore, several validating and optimising experiments may
be required before this technique can be applied specifically to the Shh
signalling pathway to address the hypotheses set out at the start of this
thesis.
The value of this procedure as a potential diagnostic or prognostic tool in the
treatment of lung disease is currently limited, given the number of issues
which remain to be resolved concerning transcript stability and the vast array
of clinical and histochemical analytical tools already available. Where its
value lies is as a research tool, allowing a greater understanding of the cell
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specific signaling interactions which occur in fibrosis and responses to
treatment. This knowledge may lead to better prognostic staining and in situ
hybridization techniques, allowing the identification of patients with
expression profiles more likely to worsen, exacerbate or be more responsive
to treatments such as corticosteroids.
5.5 FUTURE WORK
5.5.1 REAL TIME RT-PCR STANDARD CURVE
Use of a standard curve of RNA derived from normal formalin fixed lung
material in real time RT-PCR studies could partially address potential mRNA
bias issues, and would allow the pooling of separate real time RT-PCR plate
data.
5.5.2 NEW TARGETS
Although this technique has been validated through the work presented in
this Chapter, there was insufficient opportunity to apply this technique to a
given question. Thus future work should concentrate on applying the
protocols developed here, to the hypotheses stated at the start of this
Chapter concerning the role of Shh in human pulmonary fibrotic disorders.
One attractive experimental approach would have been to compare diseased
and non-diseased whole lung sections, however such an approach suffers
from all the drawbacks of whole lung homogenates of fresh tissue, as the
section will inevitably contain some non diseased areas, and "contaminating"
cell populations not involved in disease. Thus the studies here with whole
lung sections can be considered as a proof of technique and a control for
subsequent experiments. Only by using enriched and depleted isolates from
the same section can a true picture of mRNA expression be elucidated from





Through in vitro and in situ analysis, in conjunction with a mouse model of
inflammatory lung fibrosis, this thesis sought to further the previous
immunohistochemical evidence for Shh expression in the adult lung,
previously identified by this lab1. This approach facilitated the development of
three novel experimental systems; a Shh ELISA system, for quantitative
analysis of culture supernatants; a methodology for RNA isolation and
purification from formalin fixed laser micro-dissected material; and
characterisation of the FITC instillation model of inflammatory fibrosis.
Using these systems the following hypotheses were addressed:
• Shh expression is an indicator of acute or chronic epithelial cell injury.
• Shh up regulation initiates defensive functions independent of
systemic immunity, i.e. the activation of epithelial cytokine production,
maintenance of stem cell function and effects on alveolar macrophage
and fibroblast function.
• Shh expression in UIP and the FITC lung model indicates an active
association of Shh signalling with the development of fibroblastic foci
• Disease progression in the FITC instillation mouse model is
potentiated by Th2 anti-FITC antibody
With reference to the first three hypotheses above, in vitro data clearly
indicated a correlation between reduced viability, increased membrane
permeability and soluble Shh release in a mouse type II epithelial cell line in
response to H202 exposure. This suggested that Shh release might occur as
a response to oxidant exposure or as a more generalised response to injury.
However, Shh was not evident in immunohistochemistry of healthy lung, nor
in FITC instilled mice at 1-14 days post instillation184 or the 6, 12 and 18
week time points illustrated in Chapter 4.
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Despite the observation of some studies that Shh signalling can occur in the
absence of positive IHC Shh detection178, it is my conclusion that the
absence of Shh expression in both healthy and diseased sites indicates that
Shh is not a prominent in vivo signal in FITC induced lung fibrosis, and that
previous IHC detection was attributable to largely non-specific staining.
Moreover, that the absence of prominent Ptc staining on fibroblasts (Figure
4.4[D] & Figure 4.5[F]) indicates that direct epithelial to fibroblast Shh
signalling is also unlikely in this context.
Studies here with r-Shh and mouse epithelium derived Shh, within the
parameters measured, have not shown any physiologically relevant effects in
epithelium, AM or fibroblasts in vitro. It is possible that Shh modulates
responses in cells not characterised here, that it requires the presence of an
intermediate cell type or secondary signal, or that the cells used in these
studies may require other stimuli to induce responsiveness. However, the
general conclusion that can be drawn from murine studies alone, is that
whilst Shh release can be considered as a cellular response to oxidative
damage in vitro, its absence in normal and diseased tissues and its failure to
induce proliferative or cytokine responses in a range of cell types, would
suggest that Shh release in vitro could be an artefact derived from in vitro
culture, and the use of carcinoma derived cell lines.
In contrast, human fibrotic lung conditions such as UIP and BOOP do
demonstrate an up regulation of Shh expression in areas of disease, absent
in normal alveolar tissue. Thus, given the release of Shh identified in human
epithelial cell lines in response to H202, Shh up-regulation could be
considered a fibrosis associated signal in humans, perhaps associated with
persistent injury or oxidant exposure. This difference in mouse and human
could represent a difference in immunohistochemical sensitivity for species
specific Shh or a difference in disease mechanism, between the FITC mouse
model and human UIP. Therefore, it may be that IHC analysis of different
models of mouse lung disease, perhaps including incidences of oxidative
damage, may elucidate Shh signalling, such that in vitro murine data may
indeed be representative of a disease associated signal.
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The lack of functional Shh signalling data with epithelium discussed in
Chapter 3 (p139), could be attributable to the use of cell lines. Certainly the
expression of Ptc by pulmonary epithelium would suggest that autocrine and
paracrine signalling is at least possible, and given data derived from other
cellular systems, the function of such a signalling interaction can be
hypothesised (Figure 6.1).
An oxidative or injurious stimulus might induce Shh release from type II
epithelium, to act as an auto and paracrine proliferative factor for
epithelium139, allowing those cells spreading to fill denuded surfaces, to
replicate and resume their normal physiology and cuboidal morphology
(Figure 6.1 [A]). Alternately, Shh could play a role in the maintenance of
epithelial stem cell populations, as suggested in a recent review178. For
example, injurious stimuli or oxidative damage leads to the shedding of type I
epithelium and the spreading and differentiation of Type II cells into type I
cells to cover denuded areas. Shh expressed by these differentiating cells in
periods of excessive denudement, could act to maintain the type II stem cell
population, as in haematopoiesis127(Figure 6.1 [B]).
However, it could also be hypothesised that the observed lack of functional
data for Shh in vitro may be that Shh up regulation occurs as a response to
the development of the underlying fibrotic foci, and that it performs no active
signalling function in the adult lung. This is unlikely as a role for Shh in the
maintenance of T-lymphocyte responses has already been identified2'3, thus
interactions with other cells of the immune system, such as B cells and APC
are possible, although the role of Shh in T-lymphocyte signalling has only
been confirmed in vitro and awaits validation in vivo.
Shh up regulation could result from a range of factors associated with the
development of underlying fibrotic foci, such as increased ECM interactions,
distension of the epithelium and increased myofibroblast derived signals
(Figure 6.1 [C]).
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Figure 6.1: Hypothetical Roles for Shh at the Pulmonary Surface
[A] Shh upregulation in injured and differentiating (orange) epithelium as a
response to oxidative injury, acting in an auto/paracrine fashion to induce
epithelial activation and proliferation to recover denuded areas. [B] Shh
upregulation by proliferating and differentiating type II cells (orange) following
oxidative injury, in the maintenance of type II stem cell populations. [C]
Myofibroblast derived H2O2 upregulates Shh in epithelium overlying fibrotic
areas. Shh expression in all three hypothetical molecules has the potential to
act with cells of the immune system such as T and B lymphocytes (T) & (B),
Antigen presenting cells (APC) and alveolar macrophage (AM),
One way in which Shh up regulation might be induced by fibrotic foci can be
extrapolated from studies conducted by Waghray et al at the University of
Michigan223. This paper presents evidence to suggest that myofibroblasts,
when stimulated with TGF-p, produce H2O2 which induces epithelial cell
death. Given the data presented here concerning the effect of H2O2 on Shh
expression, it is possible that the expression observed in UIP biopsies
represents a response to myofibroblast derived H2O2 (Figure 6.1 [C]).
However, if a closer analysis of immunohistochemical expression of Shh in
human biopsies is made, another hypothesis can be put forward to explain
the differences in immunohistochemistry between mouse and human. Shh
expression is not observed in all areas of UIP, negating a continuing role in
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fibrotic progression and Shh expression is observed in the epithelium of the
normal upper airways in the absence of fibrotic foci, thus it is not a definitive
fibrosis associated signal. It could be hypothesised that the induced
expression of Shh in the lower airways versus constitutive expression of Shh
in the upper airway cells represents an adoption of an upper airway
phenotype by alveolar epithelial cells, or transmigration of upper airway
epithelium into the terminal bronchioles and acini. This process is already
known to occur in these conditions, and is referred to as "bronchiolisation".
The absence of this phenomenon in mouse may be a consequence of an
absence of constitutive Shh expression in upper airway epithelium in mice.
Replicating the in vivo effect of FITC addition to epithelium in vitro, as a
comparable measurement to H202 addition, was one method employed to
distinguish whether Shh up regulation and release was specific for a H202
response. This proved most problematic, the basis of which lies in our lack of
understanding as to how the delivery of FITC in vivo actually induces
inflammation. It is possible that FITC induces the observed epithelial
shedding and activation in mouse lung184 through direct physical injury,
following the formation of colloidal aggregates, or through its alkaline pH.
Equally, the hyperactivation of alveolar or interstitial macrophages, as an
indirect cause, is also a possibility. However, literature sources would
indicate that the major cause of FITC toxicity could be derived from its ability
to conjugate to proteins, crucial to the functionality and survival of the cell224,
225. This activity is linked to the isothiocyanate structure of the fluorescein
molecule. Studies, reviewed in a recent article by Zhang et al226, have
demonstrated that whilst chronic exposure to some ITC containing proteins
can prevent cancer development and increase cellular tolerance to oxidant
exposure, the acute (1-3hr) response to similar concentrations227 can be
highly injurious itself, causing genetic damage inducing a transitory drop in
glutathione levels (an antioxidant), rendering cells more susceptible to
oxidative damage.
It could be hypothesised that, if cells respond similarly to FITC as to other
ITC containing compounds, responses induced in the epithelial and
mesenchymal cells exposed to FITC might go beyond anti-oxidant activities,
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perhaps including the up regulation of inflammatory pathways, both acutely
and chronically, and that this might be involved in the maintenance of the
chronic inflammatory infiltrate observed in these mice.
Alternatively, as suggested in the fourth hypothesis listed at the start of this
discussion, the acute inflammation induced by FITC initiates an immune
reaction which potentiates the chronicity of the inflammation through the
generation of an antibody response. Chapter 4 demonstrated that there is a
clear association between anti FITC lgG1 antibody titre and fibrotic score in
the FITC model. However, this is far from conclusive, as the nature of this
association, be it ameliorative, pathological or inconsequential, was not
determined. To fully address this observation and the hypothesis posited
above, sera or purified lgG1 antibody transfers between FITC instilled mice
could be performed and the affects on pathology analysed, using the
inflammatory and fibrotic scoring systems described in this thesis.
Furthermore, it could be hypothesised that the continued presence of FITC in
the lung, associated with a persistent inflammatory infiltrate, contributes to
chronic inflammation and fibrosis by facilitating the development of an
autoimmune response. Such a hypothesis could be addressed with sera or
antibody transfers into naive mice or through in vitro co culture of sera with
pulmonary cell types, similar to those conducted by Wallace et al113, where
antibodies against an epithelial antigen stimulated TGF-p and tenascin
production; both profibrotic factors.
Whilst the level of anti-FITC antibody participation in disease awaits further
investigation the elucidation of the lgG1 class of this antibody, in the absence
of FITC specific IgE or eosinophils infiltration, has firmly established that
FITC instillation initiates a Th2 dominant, non allergic inflammatory fibrotic
response. This information along with the predominance of mononuclear foci
has confirmed an immuno-modulatory role in this mouse model, which when
altered, perhaps through the use of T regulatory cell studies, may elucidate
the role played by the immune system in inflammatory lung fibrosis.
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Thus in conclusion, it is my belief that the development of fibrosis in the FITC
instillation model is initiated through a combination of factors. Acutely, the
delivery of FITC causes cellular death and the initiation of oxidative damage.
This leads to an inflammatory response and the adoption of new, potentially
proinflammatory characteristics in surviving cells, located in areas of FITC
deposition. This along with the persistence of FITC, maintains a Th2
polarised inflammatory infiltrate, incorporating anti-FITC antibody producing
cells. These may aid in the clearance of FITC, but this very process could
maintain the infiltrate, through complement deposition, until the majority of
FITC has been removed from the lung. Any fibrosis that develops in areas of
FITC deposition is attributable to cytokine signalling associated with this
inflammatory process and does not involve the Shh signalling pathway in any
way. The expression of this pathway in human fibrotic conditions is
representative of an adoption of a larger airway phenotype by lower airway
epithelial cells and this is not a prognostic factor in the development of
fibrosis. The potential recipients of this Shh signal in UIP and BOOP biopsies
may be identifiable in future through the use of the laser catapult and RNA




7.1 SANDWICH SHH ELISA STANDARD CURVE
SANDWICH ELISA
r-SHH (ng/ml)
Figure 7.1: Sandwich ELISA Standard Curve
Curve generated with N19 capture (2pg/ml) on high binding EIA plates
(Corning-Costar) in Carbonate-Bicarbonate buffer, 50pl per well. Left
overnight at 4°C. All subsequent steps separated by wash steps with wash
buffer (Tween20/PBS). Blocked for 2hrs at RT with standard blocking
solution. Triplicate standard curve of recombinant Shh prepared in diluent
with a top standard of 200ng/ml, loaded in 50|jJ volumes per well and
incubated overnight at 4°C. 5E1 was added at 700ng/ml in diluting fluid
(50pil/well) RT 2 hours. Biotinylated anti-mouse (R&D) was then added at
250ng/ml in diluting fluid (50pl/well). Developed using Streptavidin/substrate
system using 50pl of Streptavidin (R&D) for 20 minutes RT, followed by 3,3,5
TMB for 25 minutes, stopped with 2NH2SO4.
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7.2 SHH IMMUNOHISTOCHEMISTRY BLOCKING
ABC
Figure 7.2: N19 Blocking Peptide on Immunohistochemistry
All images at x400 magnification. [A] Shh staining in mouse epithelium using
standard N19 IHC conditions [B] Staining following an overnight pre¬
incubation of N19 with a five fold greater concentration of commercially
available blocking peptide (Santa-Cruz). [C] A primary omission control.
Immunohistochemistry performed by Anne Grant.
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Figure 7.3: CD3 & B220 Immunohistochemistry
Photos from the thesis of Dr S.A Ahmad. [Top] x200, Illustrating the presence
of both B-cells (B220) and T-cells (CD3) in mononuclear infiltrates in FITC
positive areas. [Bottom] x 800, Later time points (14 weeks post second
instillation (2mg/ml)) saw the occurrence of mononuclear foci containing both
B & T cells.
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